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ABSTRACT 
I 
An ECD investigation aiming at assessing the critical main-chain length for peptide 
helix formation in water solution is reported. To this goal, it was synthesized by a 
solution step-by-step protocol a complete series of N-terminally acetylated, C-
terminally methoxylated oligopeptides, characterized only by alternating Aib and Ala 
residues, from the di- to the nonamer stage. All of these compounds were investigated 
by ECD in the far-UV region in water solution as a function of chemical structure, the 
presence/absence of the ester moiety at the C-terminus and temperature. The critical 
main-chain lengths for 310- and α-helices, although still formed to a partial extent, in 
aqueous solution are six and eight residues, respectively. 
II 
A whole series of AuNps was synthesized from mercaptopropionic derivatives of 
alternating Aib/Ala peptide series. Our studies established the occurrence of chiroptical 
properties in peptide-coated 2 nm diameter gold nanoparticles. The peptides induce a 
chiral effect onto the plasmon resonance band detectable via ECD. Such a behavior 
appears to be strongly influenced by the secondary structure assumed by the coating 
peptides. 
III 
The water solubility displayed by alternating Aib/Ala peptide series was investigated. 
The evidences of the formation of self-assembled structures in water, likewise 
responsible for the unexpected solubility properties, are presented. These peptide 
aggregates are spherical, with diameters up to 100 nm. They can also incorporate other 
molecular structures of relevant size, such as Au nanoparticles. Such systems may 
widen the number of applications currently accessible to self-assembled aggregates in 
the fields of biomedicine and materials science. 
IV 
Two new Cα-tetrasubstituted α-amino acids bearing two identical azobenzene-derived 
side chains have been synthesized. Photo-reversible isomerization process was detected. 
Intermediate chiral species are generated during the isomerization process driven by 
iii 
 
light. Diastereomers where generated when a chiral protein amino acid was inserted. 
The conjugation of one of the bis(azobenzene)-derived amino acids with different metal 
nanoparticles allowed the isomerization process to be detected even in solid state. 
Furthermore, the Au-derived nanoparticles exhibit a magnetic susceptibility dependence 
on the light-driven isomerization state that can be simply detected by 1H-NMR 
spectroscopy. Based on this behavior, these amino acids are of relevant potential for the 
development of a novel class of materials. 
V 
A series of Ferrocene and Pyrene labelled helical peptides containing one or more 4-
amino-1,2-dithiolane-4-carboxylic acid (Adt) residues have been synthetized. Such 
peptides have been prepared to be employed in the formation of SAMs over gold 
surfaces (by means of linkage with the dithiolane Adt side chains) for electrochemical 
applications. In particular, the peptides have been designed for ensuring: (i) an high-
rigidity of the peptide scaffold and (ii) a parallel disposition of the peptide axle respect 
the metal surface. Conformational characterizations and CV tests on a Ferrocene 
binding 6-mer are presented. Preliminary experiment on the photo-current generation 
property has also been performed. 
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 RÉSUMÉ 
I 
Au fin de déterminer la longueur critique de formation de hélices peptidiques en eau, on 
a effectué des mensurations de dichroïsme circulaire sur une série complète de peptides 
acétylés, composés par résidus alternés de L-Ala et Aib et terminant avec l’ester 
méthylique. Même s’ils n’ont pas fonctionnalités chargées ou polaires, ces peptides sont 
hydrosolubles. On a effectué les mensurations dans la région entre 250 et 190 nm, où le 
dichroïsme est sensible à la conformation peptidique. On a testé aussi les effets de la 
substitution de l’ester méthylique avec la fonctionnalité carboxylique ou carboxylate, 
ainsi que la variation de la température. On a trouvé que les longueurs critiques pour la 
transitions de structure random à hélice 310 et de 310 à α sont le esapeptide et le 
octapeptide.  
II 
On a synthétisé une série complète de nanoparticules d’Or en départant de les peptides 
de la série alternée Aib/L-Ala, après fonctionnalisation avec l’acide 3-mercaptan-
propionique. L’étude a investigué la présence de effets chiraux sur l’Or causés par la 
présence des ligands peptidiques. Cet effet a été déterminé par ECD et c’est dépendent 
de la structure secondaire du peptide et de l’aminoacide dans le ligands le plus proche a 
l’Or.   
III 
On a investigué les raisons de la solubilité en eau de les peptides ci-dessus décrives. On 
a supposé de mécanismes de auto-agrégation en eau. Des mensurations de microscopie 
électronique TEM ont confirmé cette hypothèse. En le cas de l’undeca-peptide Z-Ala3-
(AibAla)4OMe, ces agrégats résultent être sphériques et avec dimensions environs 100 
nm très réguliers. Après, c’en a étudié la capacité de encapsuler des nanoparticules  
d’Or. Ça pourrait étendre les applications des systèmes auto-assemblant dans le champ 
de recherche biomédicale et de les matériaux.                
IV 
On a synthétisé deux nouveaux aminoacides Cα-tetrasubstitués avec deux 
fonctionnalités azo-benzéniques identiques en chaîne latérale. Donc, on a étudié des 
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 processus de photo-isomérisation réversibles. C’a été aussi déterminé la formation de 
intermèdies chiraux dans le processus. On a couplé ces aminoacides à un résidu chiral 
(L-Leu). En ce cas, au cours du processus de isomérisation on a formé des espèces 
diastereoisomériques intermèdies. Après, des nanoparticules métalliques ont été 
synthétisé. En particulaire, le processus de photo-isomérisation a été effectué aussi sur 
le solide directement. Un étude sur le propriétés magnétiques dépendent de la 
isomérisation a été effectué.        
V 
On a synthétisé une série de peptides hélicoïdaux rigides avec des Pyrènes ou 
Ferrocènes à la fin N-terminale. La rigidité a été assuré par l’utilisation de résidus 
alternés de L-Ala et Aib. Ces peptides ont été préparé pour la formation de SAM sur des 
superficies d’Or pour applications en électrochimie. Pour faire ça, les peptides 
contiennent aussi un ou plus résidus de acide 4-amine-1,2-ditiolane-4-carboxylique 
(Adt), un résidu qui peut lier l’Or par des liaisons disulfures. Ce genre de liaison assure 
aussi une disposition parallèle des chaînes peptidiques sur la superficie d’Or. Donc, on a 
synthétisé deux décapeptides avec deux Adt en positions 1 et 8 (deux tours de α-hélice) 
et une séries de esapeptides avec deux Adt en position 1 et 4 (un tour de hélice 310). 
Cette géométrie permit une liaison la plus efficiente à la superficie, parce que le résidus 
de Adt sont à la même côte du peptide. Le produits finals ont été caractérisé 
chimiquement. On a conduit des investigations détaillés sur la conformation de deux 
esapeptides. Pour un esapeptide avec un Fèrrocene, on a conduit des mensurations 
électrochimiques pour tester les propriétés de oxydoréduction du Fèrrocene lié au 
peptide et des mensurations aussi de génération de photo-courant.                            
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 RIASSUNTO 
I 
Al fine di determinare la lunghezza critica per la formazione di eliche peptidiche in 
acqua è stata effettuata un’indagine ECD su una serie completa di oligopeptidi acetilati 
composti da residui alternati di L-Ala ed Aib e terminante come estere metilico. Tali 
peptidi, pur non presentando funzionalità cariche o polari, risultano essere idrosolubili. 
L’indagine è stata effettuata nell’UV da 250 a 190 nm, ovvero nella regione dello 
spettro dicroico sensibile alla conformazione peptidica. Anche l’assenza dell’estere 
metilico (residuo C-terminale come carbossile o carbossilato) e la variazione della 
temperatura sono state studiate per osservare gli effetti sulla confomazione. Le 
lunghezze critiche per la transizione da struttura random ad elica 310 e da elica 310 ad 
elica α risultano essere l’esapeptide e l’ottapeptide rispettivamente. 
II 
Una serie completa di nanoparticelle d’Oro sono state sintetizzate dai peptidi della serie 
alternata Aib/L-Ala descritta, opportunamente funzionalizzati con acido 3-mercapto 
propionico. Lo studio ha stabilito la presenza di effetti chirali indotti sull’oro dalla 
presenza dei leganti peptidici. Tale effetto è stato determinato via indagine ECD ed è 
dipendente dalla struttura secondaria del peptide e dall’amminoacido più prossimo in 
catena nei leganti peptidici. 
III 
Le cause della solubilità in acqua evidenziata dai peptide della serie è stata indagata. 
Sono stati supposti dei meccanismi di auto aggregazione in acqua. Un’ indagine TEM 
ha confermato tale ipotesi. Nel caso dell’undeca-peptide Z-Ala3-(AibAla)4OMe tali 
aggregati risultano sferici e di dimensioni dell’ordine dei 100 nm. Ne è stata inoltre 
studiata la capacità di inglobare nanoaparticelle di Oro. Tali sistemi possono ampliare le 
applicazioni di sistemi auto assemblanti nei campi della biomedicina e dei materiali. 
IV 
Due nuovi ammino acidi Cα tetrasostituiti recanti due unità azobenzeniche identiche in 
catena laterale sono stati sintetizzati. Sono stati studiati processi di foto-isomerizzazione 
reversibili. E’ stata inoltre determinata la formazione di speci intermedie chirali durante 
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 tale processo. Tali amminoacidi sono stati accoppiati a residui chirali (L-Leu). In tal 
caso, durante il processo di isomerizzazione è stata riscontrata la formazione di speci 
diastereoisomeriche. Tali amminoacidi recanti due unità azobenzeniche sono stati 
quindi opportunamente derivatizzati per la formazione di nanoaparticelle metalliche. In 
particolare, il processo di foto-isomerizzazione è stato testato in fase solida su 
nanoparticelle di Oro con tali ammino acidi come leganti. E’ stato quindi svolto uno 
studio sulle proprietà magnetiche di tali nanoparticelle e la sua dipendenza dal processo 
di foto-isomerizzazione delle catene laterali dei leganti. 
V 
Sono stati sintetizzati una serie di peptidi elicoidali rigidi funzionalizzati con unità 
Pireneacetica o Ferrocenica all’estremità N-terminale. La rigidità di tali eliche 
peptidiche è stata ottenuta utilizzando residui alternati di L-Ala ed Aib. Tali peptidi 
sono stati sintetizzati per formare SAM su superfici di Oro per applicazioni in 
elettrochimica. A tale scopo, i peptidi contengono anche uno o più residui di acido 4-
ammino-1,2-ditiolano-4-carbossilico (Adt), un residuo in grado di legare l’Oro grazie al 
legame disolfuro in catena laterale. Tale tipo di legame assicura inoltre una disposizione 
parallela delle catene peptidiche rispetto la superficie. Sono stati sintetizzati due 
decapeptidi recanti due Adt in posizione 1 e 8 (due giri esatti in un’α-elica) ed una serie 
di esapeptidi recanti gli Adt in posizione 1 e 4 (un giro di elica 310). Tale geometria 
consente il legame più efficiente possibile alla superficie, in quanto i residui di Adt si 
trovano dallo stesso lato dell’elica. I prodotti finali sono stati chimicamente 
caratterizzati. Sono state condotte approfondite indagini conformazionali su due 
esapeptidi. Su un esapeptide contenente Ferrocene sono stati inoltre condotti degli 
esperimenti di voltammetria ciclica e di generazione di foto-corrente. 
viii 
 
TABLE OF ABBREVIATIONS 
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Introduction 
 
INTRODUCTION 
Nucleic acids and protein amino acids are two crucial building blocks of living 
organisms. These moieties are chiral molecules, involved in biosynthesis as  precursors 
of two of the most important biopolymers, DNA and proteins. Therefore, this points out 
the important function of handedness in nature. The ability of controlling the folding 
properties of synthetic molecules has been the aim of several, recently developed, 
research fields. Foldamers are sequence-specific synthetic oligomers analogue to 
peptides, proteins and oligonucleotides that fold into well-defined three-dimensional 
structures. They offer to the chemical biologist a broad pallet of building blocks for the 
construction of molecules that test and extend our understanding on protein folding and 
function. Foldamers also provide templates for presenting complex arrays of functional 
groups in virtually unlimited geometrical patterns, thereby presenting attractive 
opportunities for the design of molecules that bind in a sequence- and structure-specific 
manner to oligosaccharides, nucleic acids, membranes and proteins.1 On the base of the 
definitions of foldamers,2 a pool of suitable monomers can be exploited in order to 
access synthetically those abilities that only natural macromolecules displayed. In fact, 
foldamers consist in a wide range of oligomers that adopt in solution a well defined 
structure on the base of intra-molecular interactions (such as hydrogen bonds, constrain, 
repulsion) among non-consecutive residues. Several classifications of foldamers have 
been employed. For instance, foldamers could be classified into two main classes, 
determined by the presence or absence of aromatic units within the monomer unit (Fig. 
1). “Aliphatic” foldamers have saturated carbon chains separating amide or urea groups.  
 
 
Fig. 1  Examples of foldamer frameworks. 
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Examples of this group include the β-,2b,3 γ-,4 and δ-,5 oligoureas,6 azapeptides,7 
pyrrolinones,8 α-aminoxy-peptides,9 and sugar-based peptides.10 The second class 
presents aromatic spacers within the backbone. The poly-pyrrole/imidazole DNA-
binding oligomers,11 provided early examples of heteroaryl oligomers that bind 
biologically relevant targets. In either case, the initial monomer selection is typically 
affected by a variety of factors, including the ease of their synthesis and structural 
characterization. The classes of residues and related oligomers that have been designed 
to exhibit such folding properties are nowadays many, and are still growing, being the 
research on foldamers an open field.12 The secondary structure formed by a given type 
of amide foldamer depends on the planar amide bonds, the number and substitution 
patterns of the methylene units within the backbone, and conformational restraints such 
as the incorporation of cyclic structures within the amino acid. The helices formed by 
foldamers are characterized by their handedness and the number of atoms within 
repeating hydrogen bonding rings of their structures. In conventional peptides, the main 
conformations are 310- and α-helices, with 10 atoms and 13 atoms in the hydrogen 
bonded rings. In Table 1 examples are reported on the effect of insertion of one or more 
methylenes in the peptide back-bone.1,3c,4b,13 
 
 
 
Tab.1 Conformation available to synthetic foldamers: a) Cα corresponds to Cα-substituted α-amino acids (normal substitution 
pattern), or disubstituted amino acids (as in α-amino-isobutyric acid). C2 and C3 correspond to the carbon that bears a substituent in 
β-amino acids. b) The number of atoms in the hydrogen bonded rings corresponds to the number of atoms, including the hydrogen 
of the amide. Note that for some mixed α/β-amino acids, there is more than one ring type that repeats throughout the helix. For 
example, in α2β the hydrogen bonding occurs between each amide carbonyl at position i and an amide at i + 3. If the ring is formed 
between the carbonyl of a β-amino acid (at i), then the ring includes two subsequent α-amino acids (at i + 1 and i + 2) before coming 
to the hydrogen bonded amide proton. Hence there are 10 atoms, as in the 310-helix for this case. The subsequent two hydrogen 
bonded rings will include an α-amino acid and a β-amino acid, resulting in 11-atom rings. c) Direction that the carbonyl group 
points, toward either the C terminus or the N terminus. A ‘mixed’ entry indicates that the carbonyl group points in both directions, at 
different points in the helix. d) This hydrogen bonding pattern is observed when the C2 position is substituted with a hydroxyl 
group, when the C2 position is a part of a cyclopropane ring, or when C2 and C3 are part of an oxo-norbonene ring system.  
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For instance, β-peptides in which the monomer is a trans-2-amino-cyclopentane-
carboxylic acid (or cyclized residues in which the β2 and β3 positions are part of a five-
member ring) adopt a “12-helix” conformation, with the same hydrogen bonding pattern 
as the 310-helix of α-peptides, but with two additional carbon atoms inserted into the 
backbone. Park et al. examined the impact of incorporating acyclic residues into this 
structure using a series of peptides, with one to four β2-substituted residues present in a 
background of cyclized amino acids.14 Although the helical propensity was lower 
because of the incorporation of the β2 residues, the 12-helix previously observed to be 
the predominant form for cyclic residues remained the favored structure. Other 
substitution patterns of β-peptides (including residues constructed from cyclohexane 
rings or β3-substituted residues) favor the 14-helix, which bears both similarities and 
differences to the α-helix. The 14-helix has two intervening amide units within each 
hydrogen bonded ring (as in the α-helix), butthe amide carbonyl groups are directed 
toward the N terminus rather than the C terminus as in the α-helix.  
Among the non-coded α-amino acids, Cα,α-tetra substituted amino acids constitute a 
wide class of molecules with well recognized folding induction abilities.15 They are 
naturally wide spread but do not belong to the coded 20 proteinogenic amino acids. Aib 
(α-amino-iso-butirric acid) is the simplest achiral tetra-substituted amino acid. For 
instance, its omo-peptides have been synthesized up to the undecamer level without 
ceasing to prefer the 310-helical conformation, even though in many analogues with the 
replacement of tri-substitued coded amino acids the α-helix conformation was 
demonstrated to be more stable.16 Conformational energy calculation demonstrated that 
the presence of the two methyl groups (Aib can be seen as a di-methyl glycine) induces 
a restriction in the conformational space available for the chain, that results in a 
propensity to induce an helical folding.17 Moreover, the ability of Aib to induce β-turn 
confomation  has been demonstrated for very short peptides (tripeptide).17b Many 
analogues of Aib have been exploited in order to build sequence with predictable 
lengths and shapes and impart novel functionalities. For examples, cyclic analogues of 
Aib such as Ac5c, TOAC, Api and others exhibited inducing ability for C10 (β-turn).15 
In order to classificate the amino acids on the base of their conformational preference is 
essential to define their geometric features. In 1963, Ramachandran et al. introduced the 
φ and ϕ angles (Figure 2) as a parameterization of the protein backbone.18 The plot of 
these angles, the Ramachandran plot, has become a standard tool used in determining 
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protein structure and in defining secondary structure. Using an analysis of local hard-
sphere repulsions between atoms that are at least third neighbors (1-4 interactions), it 
was constructed a steric map of the Ramachandran plot that predicted the commonly 
allowed regions for peptide secondary structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Representation of a short peptide structure. The torsional angles indicated as suggested by the 
IUPAC-IUB Commission for biochemical nomenclature.19 
 
 
 
 
 
4 
 
 
Peptide torsion angles (dihedral angles; angles between planes). 
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In Table 2 are reported the fundamental parameters that characterize the α-helix and the 
310 helix conformations.   
Parameters Elica 
310 
Elica 
α 
φ −57° −63° 
ψ -30° -42° 
Hydrogen bond angle  
NH•••O=C 
128° 156° 
Rotation  per residue 111° 99° 
Axial traslaction per 
residue 
1.94 
Å 
1.56 
Å 
Residues per turn 3.24 3.63 
Pitch 6.29 
Å 
5.67Å 
Tab.2 Geometric elements for model α- and 310-helices. 
 
The α-helix results in a larger coil than the 310-helix. In fact, the hydrogen bonding in 
α-helix involves the CO of residue i and the NH of residue i+4 whereas in 310-helix the 
interaction is between the COi and NHi+3.  In Figure 3 the description of the hydrogen 
bonding for the most common  turns is reported. 
 
 
Fig.3 Representation of γ- (i→i+2), β- (i→i+3) and α-turn (i→i+4). 
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Many efforts during the past decades have been accomplished in order to design 
conformational constrained  peptides that would be able to overcome the recognized 
problems to design peptides as drug for receptors targeting.20 The contribution of tetra-
substituted amino acids in this field relies on the ability of such residue to preserve or to 
induce a well-defined conformation requirements. 
 
Aims of the present work 
In this PhD work will be presented and discussed a series of supramolecular 
applications which involved a well conformational defined short peptides, based on 
non-coded amino acids. The applications will range from self-assembly, chiro-optical,  
magneto-optical to electrochemistry.            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
Introduction 
 
REFERENCES 
1)  Goodman C.M., Choi S., Shandler S.,DeGrado W.F., Nature Chemical Biology, 
2007, 3 (5), 252-262  
2)  a) Gellman S.H., Accounts of Chemical Research, 1998, 31, 173-160 ; b) Appella 
D.H., Christianson L.A., et al., Journal of American Chemical Society, 1996, 118, 
13071-13072  
3)  a) Cheng R.P., Gellman s.H.,DeGrado W.F., Chemical Reviews, 2001, 101, 3219-
3232 ; b) Seebach D., Gademann J., et al., Helvetica Chimica Acta, 1997, 80 (7), 
2033-2038 ; c) Seebach D., Hook D.F.,Glatti A., Biopolymers, 2006, 84, 23-37 ; 
d) Pilsl L.K.A.,Reiser O., Amino Acids, 2011, 41, 709-718  
4)  a) Sharma G.V.M.,al. e., Angewandte Chemie International Edition, 2006, 45, 
2944-2947 ; b) Baldauf C., Günther R.,Hofmann H.-J., Journal of Organic 
Chemistry, 2006, 71, 1200-1208  
5)  a) Arndt H.D., Ziemer B.,Koert U., Organic Letters, 2004, 6, 3269-3272 ; b) 
Trabocchi A., Guarna F.,Guarna A., Current Organic Chemistry, 2005, 9, 1127-
1153  
6)  a) Violette A.,al. e., Journal of American Chemical Society, 2005, 127, 2156-2164 
; b) Violette A., Averlant-Petit M.C., et al., Journal of American Chemical 
Society, 2005, 127, 2156-2164  
7)  a) Salaun A., Potel M., et al., Journal of Organic Chemistry, 2005, 70, 6499-6502 
; b) Zega A., Current Medicinal Chemistry, 2005, 12, 589-597  
8)  Smith A.B., Knight S.D., Sprengeler P.A.,Hirschmann R., Biorganic Medicinal 
Chemistry, 1996, 4, 1021-1034  
9)  Li X.,Yang D., Chemical Communications, 2006, 3367-3379  
10)  a) Chakraborty T.K., Srinivasu P., Tapadar S.,Mohan B.K., Glycoconjugate 
Journal, 2005, 22, 83-93 ; b) Claridge T.D.W.,al. e., Journal of Organic 
Chemistry, 2005, 70, 2082-2090  
11)  Dervan P.B., Science, 1986, 232, 464-471  
12)  a) Hecht S.,Huc I., Foldamers, 2007. Weinheim, Wiley-VCH; b) Guichard 
G.,Huc I., Chemical Communications, 2011, 47, 5933-5941 ; c) Hill D.J., Mio 
M.J., et al., Chemical Review, 2001, 101, 3893-4011  
13)  Chen Y., Mant C.T., et al., The Journal of Biological Chemistry, 2005, 13, 
12316-12329  
14)  Park J.S., Lee H.S., et al., Journal of American Chemical Society, 2003, 125, 
8539-8545  
15)  Toniolo C., Crisma M., Formaggio F.,Peggion C., Biopolymers (Pept. Sci.), 2001, 
60, 396-419  
16)  Toniolo C., Crisma M., Formaggio F.,Peggion C., Biopolymers (Pept. Sci.), 2001, 
60, 396  
17)  a) Rose G.D., Gierasch L.M.,Smith J.A., Advances in Protein Chemistry, 1985, 
37, 1 ; b) Benedetti E., Bavoso A., et al., Journal of American Chemical Society, 
1982, 104, 2437 ; c) Venkataram P.,Sasisekharan V., Macromolecules, 1979, 12, 
1107 ; d) Paterson Y., Rumsey S.M., et al., Journal of American Chemical 
Society, 1981, 103, 2947  
18)  Ramachandran G.N.,Sasisekharan V., Journal of Molecular Biology, 1963, 7, 95-
99  
19)  Nomenclature I.-I.C.o.B., 1970, 9, 3471,  
20)  Santagada V.,Caliendo G., Peptides and Peptidomimetics, 2003. Padova, Piccin 
Nuova Libraria 
7 
 
Introduction 
 
 
 
 
8 
 
ECD characterization in water of –(Aib-Ala)n- and –(Ala-Aib-Ala)n- oligomers 
 
 
I 
ECD characterization in water of the first totally water-soluble peptide series 
based on –(Aib-Ala)n- and –(Ala-Aib-Ala)n- oligomers 
 
INTRODUCTION 
Constrained  peptides and peptidomimetics have emerged as a powerful tool for the 
design of ligands for proteins, enzymes and receptors targeting.1 In fact, the peptide 
conformation plays a central role in the binding activity to biological targets. Many 
problems are connected with the exploitation of peptides as drugs: i) low metabolic 
stability, in particular at the gastrointestinal stage, ii) low absorption after oral 
assumption due to their high molecular weight or because of lacking of active transport, 
iii) rapid expulsion through liver or kidney, iv) not-selective interactions, v) not-
selective delivering.1 Therefore, the ability of ensuring folding ability along with 
stability in biological environment is a central topic in peptides and peptidomimetics 
research.2 In this field, non-proteinogenic α-amino-acids, and in particular Cα-tetra 
substituted amino acids, represent a powerful tool for designing peptides with controlled 
length and conformation.2c,2e,3 Different classes of Cα-tetra substituted amino acids have 
been tried as inductor of different turns stabilization. For instance, Cα,α-dialchyl amino 
acids possess the ability to induce β-turn structure even in short-length peptides. In the 
Aib omo-peptides this ability has been recognized even for the shortest oligomer 
possible for this conformation, the tri-peptide.4 Nevertheless, the helical conformation 
preference of Aib containing peptide is dependent on the ratio of proteinogenic and 
tetra-substituted amino acid.5 Another factor that influences the conformational 
preference is the length. Twenty years ago was published the first X-ray diffraction 
proof for a 310→α-helix conversion in the crystal state induced by peptide lengthening 
only.5 The -(Aib-Ala)3-  sequential oligomer was found to be fully 310-helical, while the 
-(Aib-Ala)4- octamer, as well as the higher oligomers -(Aib-Ala)5,6-, was essentially α-
helical (when discussing the remarkably short peptides found to be helical in these 
series, one should remind that they are heavily based on the strongly helicogenic, non-
coded Aib residue).3g,6 However, it was subsequently found that the isomeric -(Ala-
Aib)4- octapeptide sequence adopts a C-terminally distorted 310-helix structure in the 
crystal state.7 It is evident that, at a main-chain length near the critical size between 
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these two types of helices, even subtle differences in the chemical structure, terminal 
protecting groups, packing motifs, and co-crystallized solvent molecules, may bias 
significantly the helix preference. In this same paper, it was also reported that the long 
oligomer -(Ala-Aib)8- is in α-helical conformation under the same experimental 
conditions. Moreover, according to an ECD study -(Aib-Ala)3- is right-handed helical in 
the solid state (KBr pellets).78 
FTIR absorption and NMR investigations support the view that in CDCl3 solutions the 
penta- and heptamers -Ala-(Aib-Ala)n- (n = 2 and 3) are in a 310-helical conformation.9 
However, partially conflicting results were reported in this secondary structure-
supporting organic solvent for the longer oligomer -(Aib-Ala)5- in the sense that NMR 
data are consistent with its 310-helicity, while FTIR absorption favors the concomitant 
occurrence of 310- and α-helical conformations. This latter conclusion was also 
proposed for -Ala-(Aib-Ala)5- [in particular, the parameter indicative of the early onset 
of the α-helical conformation (an intense 1659 cm-1 band) is first seen in -(Aib-Ala)5-]. 
The polar, strong hydrogen-bonding acceptor, DMSO seems to destabilize the 310-helial 
conformation of this series favoring the α-helix.9b,10 Furthermore, the results of our 
NMR analysis supported the conclusion the all -(Ala-Aib)n- (n = 4, 6, 8) are folded in 
the α-helix conformation in CD3CN solution.7 Using electronic circular dichroism 
(ECD) spectroscopy it was shown that in the polar hydrogen-bonding donor solvents 
methanol, ethanol, and 2,2,2-trifluoroethanol (TFE) the characteristic features (double 
negative maxima near 222 and 205 nm) of a right-handed helical conformation are first 
seen at the octapeptide -(Aib-Ala)4- or -(Ala-Aib)4-/nonapeptide -Ala-(Aib-Ala)4- 
levels.11 ECD patterns indicative of partially developed 310- and α-helical conformations 
first appear at the 7- and 8-mers, respectively. Heating and increase in peptide 
concentration do not deteriorate dramatically the helix content. However, the ECD of 
the Nα-para-bromobenzoylated short -(Aib-Ala)3- oligomer in TFE is characterized by a 
bisignated pattern centered at 238 nm originated from the exciton split transition of the 
aromatic chromophore interacting with the amido-chromophores of the peptide 
molecules arranged in a right-handed helical array.12 Interestingly, according to the 
authors,when the -(Aib-Ala)5- decapeptide is covalently bound at the C-terminus to a 
strongly water-solubilizing polymer, the corresponding ECD curve is reminiscent of 
that typical of the mainly unordered conformation (however, for a comment see 
below).13 This is the only conformational study reported in the literature to date of a 
10 
 
ECD characterization in water of –(Aib-Ala)n- and –(Ala-Aib-Ala)n- oligomers 
 
 
sequential Aib/Ala peptide in water solution. From the vast amount of results discussed 
above, it is quite clear that the conformations preferentially adopted by the sequential 
Aib/Ala oligomers were extensively investigated in the crystal (solid) state and in a 
variety of organic solvents, but the corresponding studies in water are almost 
completely missing. Conversely, the first example of water soluble 310 helix was 
reported just 12 years ago.14 In that publication, two analogue sequences both 
containing ATANP [(L)-2-amino-3[1-(1,4,7)-triazacyclononane] residues, respectively 
based on (L)-Iva (Isovaline) and Aib, were designed in a way that ensured water 
solubility and helical conformation, leading to 310 helix stabilization. By chance, 
intriguing physic-chemical applications of the -Aib-Ala- series have been performed 
recently by Kimura and co-workers.7,11,15 In this work the extent of the ordered 
secondary structure steadily increases to the 14-mer level in the (Aib-Ala)n series and to 
the 64-mer level in the (Ala-Aib)n series. In particular, these authors reported the 
scientific stimulating ability of their helical structures to transfer electrons to long 
distances (up to 120 Å), through a self-assembled monolayer of peptide on a gold 
surface. Recently, in order to exploit these systems as a molecular-electronics, we 
decided to re-prepare the -(Aib-Ala)n- and -Ala-(Aib-Ala)n- sequential peptide series up 
to the nonamer stage. Serendipitously, during the step-by-step synthesis in solution, we 
discovered that a non-insignificant amount of each peptide went lost during the 
purification procedures, which inter alia involved extraction of the impurities from an 
ethyl acetate (or a methylene chloride) solution with water. The unexpected water 
solubility of this family of peptides, even in the absence of a covalently-bound, strong 
hydrophilic moiety, prompted us to fill the aforementioned gap by exploiting ECD 
spectroscopy in the far-UV region to assess its critical main-chain length for helix 
formation in water for the first time. 
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RESULT AND DISCUSSION 
The physical properties and analytical data for the  -(Aib-Ala)n-  and  -Ala-(Aib-Ala)n-  
peptides synthesized in this work are listed in Table 1. All peptides were prepared by 
classical solution methodology. 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide 
(EDCI) was used in combination with the efficient additive 7-aza-1-hydroxy-1,2,3-
benzotriazole (HOAt) in CH2Cl2 in the presence of N,N-diisopropyl-ethylamine (DIEA) 
for coupling reactions.16 Removal of the benzyloxycarbonyl (Z) Nα-protecting group 
was carried out by catalytic hydrogenation. The Nα-acetylated (Ac) peptide esters were 
obtained  in 70-98% yield by reacting the Nα-deprotected synthetic precursor with acetic 
anhydride in dichloromethane. A 6 mM LiOH solution was used to remove the C-
terminal methyl ester (OMe) functionality (quantitative yield). All peptides were 
chemically characterized by melting point determination, polarimetric measurement, 
thin-layer chromatography (TLC) in three solvent systems, and solid-state IR absorption 
in KBr (Table 1), and by 1H NMR (chemical shift reported in experimental section).  
 
Tab. 1 Chemical chracterization data for the synthesized peptides 
 
 
 
 
 
 
aDetermined on a Leitz model Laborlux apparatus (Wetzlar, Germany). 
bEt2O, diethyl ether; EtOAc, ethyl acetate; PE, petroleum ether. 
cSilica gel plates (60F-254 Merk, Darmstadt, Germany), solvent systems: (I) chloroform/ethanol 9:1, (II) 
butan-1-ol/water/acetic acid 3:1:1, and (III) toluene/ethanol7:1. The compounds were detected on the 
plates with an UV lamp (for Z Na-derivatives only) and/or revealed by oxidation with a potassium 
permanganate solution. 
dDetermined on a Perkin-Elmer 241 polarimeter equipped with a Haake (Karlsruhe, Germany) L 
thermostat; a 10 cm path length cell was used; c =0.1 mg/mL(methanol). 
eDetermined in KBr pellets on a Perkin-Elmer 1720X FT-IR spectrophotometer 
 
 
 
Peptide M.p. (°C)a Rf(I)c Rf(II)c Rf(III) c [α]D20  d IRe, ν (cm-1) 
Z–Aib–Ala–OMe 68–69  0.90  0.95  0.30  -21.1  3311, 1747, 1702, 1691, 1527  
Z–Ala–Aib–Ala–OMe 157–158  0.80  0.85  0.15  -25.0  3377, 1741, 1704, 1680, 1537  
Z–(Aib–Ala)2–OMe 58–60  0.50  0.85  0.10  -28.8  3326, 1740, 1706, 1660, 1529  
Z–Ala–(Aib–Ala)2–OMe 156–158  0.50  0.80  0.10  -21.3  3315, 1741, 1703, 1665, 1531  
Z–(Aib–Ala)3–OMe 151–153  0.45  0.80  0.10  -3.7  3321, 1743, 1704, 1662, 1531  
Z–Ala–(Aib–Ala)3–OMe 96–99  0.35  0.75  0.10  -10.7  3321, 1745, 1705, 1662, 1531  
Z–(Aib–Ala)4–OMe 204–206  0.35  0.75  0.10  -27.4  3321, 1742, 1704, 1660, 1530  
Z–Ala–(Aib–Ala)4–OMe 103–105  0.35  0.75  0.10  -26.8  3321, 1744, 1704, 1662, 1531  
Ac–Aib–Ala–OMe 83–85  0.80  0.85  0.20  -72.4           3329, 1754, 1657, 1534  
Ac–Ala–Aib–Ala–OMe 87–89  0.65  0.75  0.15  -78.8  3310, 1742, 1653, 1535  
Ac–(Aib–Ala)2–OMe 97–99  0.40  0.75  0.10  -26.7  3312, 1743, 1657, 1534  
Ac–Ala–(Aib–Ala)2–OMe 103–105  0.40  0.70  0.10  -73.1  3330, 1741, 1669, 1533  
Ac–(Aib–Ala)3–OMe 107–109  0.35  0.70  0.10  -58.0  3341, 1745, 1657, 1533  
Ac–Ala–(Aib–Ala)3–OMe 110–112  0.25  0.65  0.10  -84.2  3337, 1743, 1660, 1533  
Ac–(Aib–Ala)4–OMe 154–156  0.20  0.65  0.10  -88.4  3317, 1743, 1656, 1534  
Ac–Ala–(Aib–Ala)4–OMe 149–151  0.20  0.60  0.10  -110.3  3353, 1742, 1653, 1538  
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ECD characterization 
 
The ECD spectra  (Figure 1)  in the far-UV region of the oligomers with alternating Aib 
and Ala residues in water solution at neutral pH were recorded. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Far-UV ECD spectra of: (A) Ac–Ala–(Aib–Ala)n–OMe (n=1,2,3,4). (B) Ac–(Aib–Ala)n–OMe (n= 
1,2,3,4). All measurements were recorded in water at 20°C. 
 
In these peptides, in addition to the peptide chromophores, the other chromophores 
possibly contributing to this spectral region are the N-terminal acetamido and the C-
terminal methyl ester.17 However, these contributions are not expected to modify 
significantly the overall patterns. Figure 1A shows the ECD spectra of the odd 
oligomers and Figure 1B  illustrates those of the even oligomers. In the analysis of the 
ECD spectra, one should take into account two contrasting types of contributions:         
(i) our sequential peptides were synthesized beginning from a C-terminal Ala residue. 
Therefore, it is reasonable to assume that all even-number oligomers will exhibit a 
significantly higher helicity than that of their immediately lower (odd) oligomers, not 
only by virtue of their slightly longer main chain but mostly because the newly 
incorporated residue is the strongly helicogenicAib;3c,3g  (ii) on the other hand, an added 
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chiral Ala (from an even to an odd oligomer), although this residue would be 
remarkably less helicogenic than Aib, is expected to contribute to the peptide ellipticity 
values much more than the achiral Aib. It is widely recognized that the ECD spectra 
with a strong negative Cotton effect well below 200 nm (peptide π-π* transition) are 
indicative of an unordered conformation, often with a substantial contribution from the 
extended poly-(L-Pro)n II helix component (especially when the spectra show clear 
evidence for a positive dichroism at 215–220 nm).17On  the other hand, when the 
peptide is folded into a right-handed (310 or α-) helical conformation to a significant 
extent, the interacting peptide chromophores generate a split π-π* transition, the 
(parallel) component of which is observed as a negative band red-shifted to 203–208 
nm. The discrimination between the 310and α-helices (the former is expected to pre-
dominate at main-chain lengths lower than those typical of the latter) is feasible by 
ECD, at least to a first approximation, by calculating the ratio (R) of the ellipticities 
between the negative 222 nm (peptide n-π* transition) Cotton effect and that near 205 
nm.18 More specifically, a value of  0.15–0.35 for R is considered diagnostic for the 310-
helix, while a value close to the unity is typical of the α-helix. On the basis of the 
assumptions and considerations discussed above, from the ECD spectra shown in 
Figure 1, we extracted the following conclusions in terms of the preferred 
conformations of our sequential peptides in water:  
1. The spectra of dimer, trimer, tetramer, and pentamer, with their wide range of 
positive ellipticities between 200 and 235 nm and the absence of any strong negative 
Cotton effect above 190 nm, can be safely assigned to an ensemble of a predominant 
poly-(L-Pro)n II component and a unordered conformation.  
2. The curves of hexamer and heptamer, with a clear negative Cotton effect at about 200 
nm, but with an increasingly negative ellipticity below 195 nm, are consistent with the 
onset of a partially helical conformation. We assign the nature of the helix that is 
formed to be of the310-type, as the calculated R values are 0.15 for the hexamer and 
0.30 for the heptamer (however, it is worth mentioning here that the ECD curves appear 
to contain a significant positive contribution near 220 nm from the poly-(L-Pro)n II 
component that might lower the R value).  
3. The curves of the octamer and nonamer, both showing negative Cotton effects at 225 
and 203 nm, are indicative of well-developed helical structures. The corresponding R 
values, 0.40 for the octamer and 0.70 for the nonamer, strongly support the view that the 
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former peptide begins to fold in the α-helix conformation, while the latter peptide is 
largely α-helical. It is also worth pointing out that the ellipticity of the negative Cotton 
effect near 200 nm increases significantly from the 7-mer to the 8-mer, but it decreases 
from either the 6-mer to the 7-mer or from the 8-mer to the 9-mer. This observation 
seems not only to indicate that the overall peptide helicity is much more influenced by 
the incorporation of an Aib residue, as expected,3c,3g but also that the overall ellipticity 
is poorly sensitive to the addition of an extra, although chiral, Ala residue. Finally, we 
checked the influence of a few chemical and environmental parameters on the ECD 
spectrum of the octapeptide: (i) nature of the C-terminal group, a carboxylic ester (–
COOCH3), a carboxylic acid (-COOH), or an ionized (–COO-) moiety (Figure 2); and 
(ii) heating.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 ECD spectra of Ac–(Aib–Ala)4–OMe in water at 20°C before (A) and after (B) alkaline hydrolysis, 
and after protonation of the C-terminal group to –COOH (C).  
 
The  results suggest that temperature (at least in the range 20-50°C, data not shown) as 
well as alkaline hydrolysis of the ester bond to the -COO- function have only a 
negligible effect on the ECD spectrum (Figure 2). Conversely, protonation of the 
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ionized -COO- moiety to -COOH tends to shift the 310-helix↔α-helix equilibrium 
significantly in favor of the latter secondary structure (R=0.60). Similar results have 
already been reported and discussed by our group on a related peptide octamer.19As 
stated earlier, more than 30 years ago, Oekonomopulos and Jung reported the ECD 
spectrum of the terminally protected decapeptide Boc–(Aib–Ala)5–OPOE [tert-
butoxycarbonyl (Boc), polyethyleneglycol (POE)] in water.20 The curve shows two 
negative Cotton effects, at 202 nm (stronger) and 229 nm (weaker). The R value is 0.35. 
Considering that the ECD spectrum of a 310-helix was not known yet, not unexpectedly 
the authors proposed a “mainly unordered conformation” for that peptide. We tend to 
mainly ascribe the different R values (0.70 versus 0.35) and the related percentages of 
310-versus α-helix conformations in our nonapeptide and Oekonomopulos and Jung’s 
decapeptide to the different N- and C-protecting groups in the two peptides. In 
particular, the role of the highly hydrophilic POE polymer, although known not to alter 
the global helicity in water of the peptide to the C-terminus of which it is covalently 
linked, has not been deeply investigated to date as far as this specific conformational 
transition is concerned.21 
Cα-tetrasubstituted α-amino acids, the prototype of which is Aib, are instrumental in 
remarkably stabilizing turn and helical structures in short peptides.3c,3g Determining the 
main-chain length for the onset of a given helical structure is essential for the study of 
how  peptides and proteins fold. In this connection, it is widely recognized that folding 
initially implies formation of intramolecular C=O···H–N hydrogen bonds of the helical, 
type-III, β-turn conformation. Subsequently, this same H-bonding pattern propagates, 
affording a 310-helix. As the helical stretch elongates further, the less-constrained, but 
structurally related, α-helix tends to become more stable than the 310-helix.3g,5b,22 
Terminally protected Aib homopeptides adopt the type-III (III’) β-turn conformation at 
a stage as low as the trimer in the crystal state. A fully developed 310-helix is first seen 
at the homo-pentamer level.4,23These same conformations were observed in the trimer 
and octamer in solvents of low polarity, e.g. CDCl3.9a,24 ECD spectroscopy showed that 
the terminally blocked (αMe)Val (Cα-methyl Val) homo-hexamer is 310-helical in 
methanol.3f,25A solvent-controlled, reversible 310-/α-helix transition does take place for 
this oligomer on going to highly polar alcohols.3e Crystals of an N-acetylated (αMe)Val 
homo-heptamer alkylamide exhibits 310-/α-helix dimorphism depending on the alcohol 
solution from which they are grown.26 An N-benzyloxycarbonyl/Cαmethoxy protected 
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homo-octamer based on a chiral, Cα↔ Cα cyclized, α-amino acid was found to fold in 
the α-helix structure in the crystalline state.27 None of these homo-oligomers is water 
soluble. As for the extensively investigated, sequential peptides based exclusively on 
Aib and Ala, the terminally protected –Aib-(Ala-Aib)2- and -(Aib-Ala)3- are the shortest 
oligomers reported till date to be folded in the 310-helix structure in the crystal state 
(interestingly, the –Ala–Aib–Ala– tripeptide does form a β-turn, but it is not of the 
helical type).5a,28 Further main-chain elongation to the octapeptide -(Aib-Ala)4-,but not 
to the isomeric -(Ala-Aib)4-, generates an α-helix structure. In CDCl3 solution, a nascent 
310-helix is seen in the -(Aib-Ala)2 tetrapeptide,and a fully developed 310-helix in the      
-Ala-(Aib-Ala)2- pentapeptide.The onset of the α-helix is first observed in the -(Ala-
Aib)5- decapeptide. In alcohol solutions, the ECD signatures typical of the 310- and α-
helices are recognized at the heptamer and octamer levels, 
respectively.5a,7,9,11,13,15c,20,29The present study was intended to fill the gap derived from 
the absence in the literature of any detailed conformational study in the much more 
biologically relevant aqueous solution (at physiological pH and temperature) on a 
complete peptide series rich in helicogenic Cα-tetrasubstituted α-amino acids aimed at 
assessing their critical main-chain length for helix formation. We find that, in the 
sequential series based on Aib and Ala residues only, the “borderline” peptides between 
different (non-helical versus 310-helical, and 310-helical versus α-helical) conformations 
under these experimental conditions are the hexamers and octamers, respectively. 
In summary, we reported the synthesis and conformational electronic CD 
characterization  in water of the whole series of alternating -Aib-Ala- and -Ala-Aib-Ala- 
oligomers up to nonamer. This work represents the first example of a wholly water 
soluble peptide series whose conformation has been fully characterized via ECD 
spectroscopy in water. This investigation allowed to fill the gap in the knowledge on the 
conformational behavior for this peptide series in a so relevant biological solvent. It was 
shown that the conformation is mostly 310 even from the tetramer stage, and is fully 
developed at the hexamer stage. These are the shortest examples ever seen in water for 
such a conformation. Moreover, it was possible to determinate the turn point for the 
310↔α-helix transition. It is indeed well known that Aib-containing peptides, relying on 
the content of the Cα-tetra substituted amino acid, show a 310 preference for shortest 
peptide even in alcohols, whereas α-helix is preferred for the longest ones. In this case, 
the values of R (a parameter calculated on the ratio between molar ellipticies of the two 
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negative maxima in UV-ECD spectra at 203 and 220nm) clearly indicates that the        
α-form contributes significantly at the eptamer stage, whereas the octamer is quite 
completely an α-helix. The helix stability has also been confirmed for different 
ionization form of C-terminus, where nor saponification to carboxylate nor further re-
acidification to free carboxyl can induce a destabilization of the structure. The 
temperature also had only negligible effects on conformation. This property of Aib-
containing peptide has also already been demonstrated in DMSO solution for omo-Aib, 
up to very high temperature.3d,9b,29e In conclusion, the reported work permitted to 
investigate the conformation dependence varying the chain-length only. Further 
investigation will explain the reasons for the solubility properties in water. In fact, none 
structure element in these peptides had been inserted in order to induce hydrophylicity 
as in ATANP-containing peptides, nor the peptide itself presents charge or polar 
moieties.14 
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EXPERIMENTAL SECTION 
 
GENERAL  METHODS 
NMR: 1H spectra were recorded at room temperature on a Bruker AV-200 (200 MHz) 
instrument using deuterated chloroform (98.8% Fluka). The multiplicity of a signal is 
indicated as: s - singlet, d - doublet, t - triplet, q - quartet, m - multiplet. Chemical shifts 
(δ) are expressed in ppm . 
TLC: The products and intermediates have been checked on TLC plate with the 
following eluant systems: 
CHCl3/EtOH 9:1 Rf1 
1-Butanol/AcOH/H2O 3:1:1 Rf2 
toluene/EtOH 7:1 Rf3 
FT   IR: The KBr spectra were recorded on a Perkin-Elmer 580 B equipped with an IR 
data station Perkin-Elmer 3600. For spectra in CDCl3 (98.8% Fluka),  a Perkin-Elmer 
1720X was emploeyd. The instrument operates in FT and is interfaced to a IBM PS/2 
50 Z computer. 0.1 and 1cm  CaF2 pathway cells have been employed. For each 
spectrum have been  collected 50 scans (4cm-1 resolution) under nitrogen. 
Mass Spectrometry: High-resolution mass spectra were obtained by electrospray 
ionization (ESI) on a Perseptive Biosystem Mariner ESI-TOF or a Bruker Microtof-Q 
spectrometer. 
CD: The ECD spectra were obtained on a Jasco (Tokyo, Japan) model J-715 
spectropolarimeter. Cylindrical fused quartz cells (Hellma, Müllheim, Germany) of 
0.1and 0.01 cm pathlength were used. The data are expressed in terms of [ϴ]T, total 
molar ellipticity (degx cm2xdmol
-1
). The solvent used was pH 7 Milli-Q water 
(Millipore Corporation, Billerica, MA). A Haake (Karlsruhe, Germany) model F3 
thermostat was used for the measurements at temperatures >20°C. Values are reported 
in total molar ellipticy (deg x cm2 x dmol-1) : 
 
[Θ]T = (MW ×Θ )/( l × c )  = 3300 ×∆ε = 3300 ×  (εL-εR ) 
Θ = observed ellipticy 
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MW = molecular weight 
l = pathway length (cm) 
c = concentration in gr/l 
∆ε = εL - εR = difference between left- and right-handed component of estinction 
coefficients of polarized light 
 
SYNTHESIS AND CHARACTERIZATION 
HCl·H-L-Ala-OMe 
To 100 mL of anydrous MeOH at -15°C, 25 g ofH-L-Ala-OH [380 mmol] and SOCl2 
(32.68 mL, 450 mmol) were added under stirring. The flask was closed with CaCl2 tube 
and the temperature was left rising up to r.t. Therefore,the system has been refluxed for 
20 hours. The solvent has been removed under reduced pressure, taking many times the 
residue in Et2O. The product precipitated as a white powder from MeOH/Et2O. Yield 
92%.IR (KBr): 3421, 2987, 1740 cm-1. 1H NMR (200 MHz, CDCl3): δ 8.68 [broad s, 
3H, Ala NH3], 4.06-4.31 [q, 1H, Ala α-CH], 3.73 [s, 3H, Ala -OMe], 1.43-1.40 [d, 3H, 
Ala β-CH3]. 
Z-L-Ala-OH 
To 100 mL of H2O/MeCN 1:1 15.6 g of H-L-Ala-OH (170 mmol) were added under 
stirring. The mixture was cooled down to 0°C and then 43.15g (170 mmol) of Z-OSu, 
previously solved in 100 mL of MeCN, were added along with 24.2 mL of TEA (170 
mmol).The mixture temperature was rised up to r.t. and the reaction followed on TLC 
plate. After 24 hours mostly of the MeCN was removed under vacuum, and the aqueous 
solution diluted with 50 mL of 5% NaHCO3(aq.).The solution was washed with 10 mL of 
Et2O, acidified slowly with solid KHSO4 and the extracted with EtOAc (3x100 mL). 
The organic layers were put together and washed with water (6x50 mL) and brine. The 
organic layer was dried on Na2SO4 and the solvent removed under vacuum. The product 
precipitated from EtOAc/PE as a white solid. Yield 95%. IR (KBr): 3388, 1736cm-1.1H 
NMR (200 MHz, CDCl3): δ 10.06 [broad s, 1H, Ala -COOH], 7.36 [s, 5H, Z fenile], 
5.35 [d, 1H, Ala NH], 5.14 [s, 2H, Z CH2], 4.47-4.40 [m, 1H, Alaα-CH], 1.49-1.45 [d, 
3H, Alaβ-CH3]. 
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Z-Aib-OH 
To 100 mL of H2O/MeCN 1:1, 20 g of H-Aib-OH [194 mmol] were added under 
stirring. The mixture was cooled down to 0°C and then 76 g (306 mmol) of Z-OSu, 
previously solved in 100 mL of MeCN, were added along with 40 mL of TEA (306 
mmol). The mixture temperature was rised up to r.t. and the reaction followed on TLC 
plate. Another equivalent of Z-OSu has been added in six times during 3 days. The 
basicity of the solution has been corrected by addition of TEA. Then, mostly of the 
MeCN was removed under vacuum, and the aqueous solution diluted with 50 mL of 5% 
NaHCO3(aq.). The solution was washed with 10 mL of Et2O, acidified slowly with solid 
KHSO4and the extracted with EtOAc (3x100 mL). The organic layers were put together 
and washed with water (6x50 mL) and brine. The organic layer was dried on Na2SO4 
and the solvent removed under vacuum. The product precipitated from EtOAc/PE as a 
white solid. Yield 95%. IR (KBr): 3334, 1714, 1519cm-1. 1H NMR (200 MHz, CDCl3): 
δ: 7.34 (s, 5H, phenyl ring), 5.45 (s, 1H, NH), 5.10 (s, 2H, CH2), 1.56 (s, 6H, β-CH3). 
Synthesis of Z- series 
Z-Aib-L-Ala-OMe 
To a solution of 7g of Z-Aib-OH (30 mmol), 4.5bg of HOAt [33 mmol] and 6.3 g of 
EDC (33 mmol) in dry CH2Cl2 at 0°C, 12.1g of HCl.H-L-Ala-OMe (41mmol) were 
added along with 10mL of NMM (41mmol). The reaction has been kept at r.t. and under 
stirring and closed with CaCl2 tube for 18 hours. The solvent has so been removed at 
low pressure and taken in EtOAc. The solution has been washed with 5% KHSO4, H2O, 
5% NaHCO3and brine.The organic layer was dried on Na2SO4 and the solvent removed 
under vacuum. The product precipitated from EtOAc/PE as a white solid. Yield 95%. 
M.p.: 55-59°C. Rf1: 0.90;  Rf2: 0.95;  Rf3: 0.30. [α]D20: -31.5° (c[g.mL-1] =1.2, MeOH). 
IR (KBr): 3311, 1747, 1691, 1527 cm-1. IR (KBr): 3311, 1747, 1691, 1527 cm-1. 1H 
NMR (200 MHz, CDCl3): δ 7.35 [s, 5H, Z fenile], 6.79-6.77 [d, 1H, Ala NH], 5.29 [s, 
1H, AibΝH], 5.10 [s, 2H, Z CH2], 4.62-4.51 [m, 1H, Alaα-CH], 3.74 [s, 3H, -OMe 
CH3], 1.55-1.53 [m, 6H, Aib 2 β-CH3], 1.38-1.35 [d, 3H, Alaβ-CH3]. 
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Z-L-Ala-Aib-L-Ala-OMe 
7 g of Z-Aib-L-Ala-OMe (22 mmol) were solved into 250 mL of MeOH in a 500 mL 
round bottom  flask. Under stirring, N2 was flushed for 15’. Then, 1.05 g of Pd/C (10%) 
was added and H2 flushed instead of N2. The reaction was followed for 3 hours at r.t. 
The catalyzer was filtered off on celite and the MeOH removed under reduced pressure 
till complete dryness. Then, a freshly prepared 50 mL solution indry CH2Cl2 at 0°C was 
added, containing 7.37 g of Z-L-Ala-OH (33 mmol), 4.9 g of HOAt (33 mmol) and 7.59 
g of EDC (33 mmol) at 0°C. 4.65 mLof NMM (40 mmol) was added, too. The reaction 
has been followed on TLC plate for 18 hours. The solvent was removed under vacuum 
and the residue taken in 200 mL of EtOAc. The organic layer was then washed with 
5%KHSO4(aq.), H2O, 5%NaHCO3(aq.)and brine.The organic layer was then dried over 
Na2SO4and solvent removed under vacuum. The product precipitated from EtOAc/PE 
as a white solid. Yield 70%.M.p.: 159-161°C. Rf1: 0.80;  Rf2: 0.85;  Rf3: 0.15. [α]D20: -
51.0° (c[g.mL-1] =1.2, MeOH). IR (KBr): 3377, 1741, 1680, 1537cm-1. 1H NMR (200 
MHz, CDCl3): δ 7.35 [s, 5H, Z fenile], 6.95-6.92 [d, 1H, Ala NH], 6.50 [s, 1H, AibNH], 
5.27-5.24 [d, 1H, Ala NH], 5.12 [s, 2H, Z CH2], 4.61-4.46 [m, 1H, Alaα-CH], 4.19-4.05 
[m, 1H, Alaα-CH], 3.74 [s, 3H, -OMe CH3], 1.56-1.52 [m, 6H, Aib 2 β-CH3], 1.40-1.37 
[m, 6H, 2 Alaβ-CH3]. 
Z-Aib-L-Ala-Aib-L-Ala-OMe 
This product was obtained from 3.6 g of Z-Aib-OH (16 mmol) and H-L-Ala-Aib-L-Ala-
OMe (15 mmol; obtained via catalytic hydrogenation as seen previously). The 
activation was accomplished with HOAt/EDC coupling reactant in dry DCM. The 
product precipitated from EtOAc/PE as a white solid. Yield 83%.M.p.: 60-63°C. Rf1: 
0.50;  Rf2: 0.85;  Rf3: 0.10. [α]D20: -32.8° (c[g.mL-1] =2.3, MeOH). IR (KBr): 3326, 
1740, 1660, 1529cm-1. 1H NMR (200 MHz, CDCl3): δ 7.36 [s, 5H, Z fenile], 7.22-7.18 
[d, 1H, Ala NH], 7.03 [s, 1H, Aib NH], 6.50-6.47 [d, 1H, Ala NH], 5.19 [s, 1H, Aib 
NH], 5.10 [s, 2H, Z CH2], 4.59-4.45 [m, 1H, Alaα-CH], 4.24-4.14 [m, 1H, Alaα-CH], 
3.72 [s, 3H, -OMe CH3], 1.54-1.52 [m, 12H, 2 Aib 2 β-CH3], 1.38-1.34 [m, 6H, 2 Alaβ-
CH3]. 
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Z-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
This product was obtained from 2.6 g  of Z-L-Ala-OH (12 mmol) and H-Aib-L-Ala-
Aib-L-Ala-OMe [12 mmol; obtained via catalytic hydrogenation as seen previously]. 
The activation was accomplished with HOAt/EDC coupling reactant in dry DCM. The 
product was purified on silica gel chromatographic column (95:5 CHCl3:EtOH) and 
then precipitated from EtOAc/PE as a white solid. Yield 80%.M.p.: 62-65°C. Rf1: 0.50;  
Rf2: 0.80;  Rf3: 0.10. [α]D20: -25.6° (c[g.mL-1] =2.3, MeOH). IR (KBr): 3315, 1741, 
1665, 1531cm-1. 1H NMR (200 MHz, CDCl3): δ 7.35 [s, 5H, Z fenile], 7.20-7.14 [m, 
3H, Ala NH, Aib NH, Ala NH], 6.52 [s, 1H, Aib NH], 5.54-5.52 [d, 1H, Ala NH], 5.13-
4.94 [q, 2H, Z CH2], 4.61-4.50 [m, 1H, Alaα-CH], 4.46-4.01 [2m, 2H, Alaα-CH, Alaα-
CH], 3.67 [s, 3H, -OMe CH3], 1.55-1.03 [m, 21H, 2 Aib 2 β-CH3, 3 Alaβ-CH3]. 
Z-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
This product was obtained from 2.1 g of Z-Aib-OH (9 mmol) and H-L-Ala-Aib-L-Ala-
Aib-L-Ala-OMe (9 mmol; obtained via catalytic hydrogenation as seen previously). The 
activation was accomplished with HOAt/EDC coupling reactant in dry DCM. The 
product was purified on silica gel chromatographic column (90:10 CHCl3:EtOH) and 
then precipitated from EtOAc/PE as a white solid. Yield 99%.M.p.: 65-68°C. Rf1: 0.45;  
Rf2: 0.80;  Rf3: 0.10. [α]D20: -13.3° (c[g.mL-1] =1.7, MeOH). IR (KBr): 3321, 1743, 
1662, 1531cm-1. 1H NMR (200 MHz, CDCl3): δ 7.45-7.15 [5m, 5H, 2 Aib NH, 3 Ala 
NH], 7.35 [s, 5H, Z fenile], 6.56 [s, 1H, Aib NH], 5.19-5.01 [q, 2H, Z CH2], 4.63-4.52 
[m, 1H, Alaα-CH], 4.48-4.30 [m, 1H, Alaα-CH], 4.02-3.97 [m, 1H, Alaα-CH], 3.64 [s, 
3H, -OMe CH3], 1.55-1.32 [m, 27H, 3 Aib 2 β-CH3, 3 Alaβ-CH3].   
Z-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
This product was obtained from 1.8 g of Z-L-Ala-OH (8 mmol) and H-Aib-L-Ala-Aib-
L-Ala-Aib-L-Ala-OMe (8 mmol; obtained via catalytic hydrogenation as seen 
previously). The activation was accomplished with HOAt/EDC coupling reactant in dry 
DCM. The product was purified on silica gel chromatographic column (90:10 
CHCl3:EtOH) and then precipitated from EtOAc/PE as a white solid. Yield 50%. M.p.: 
70-73°C. Rf1: 0.35;  Rf2: 0.75;  Rf3: 0.10. [α]D20: -17.7° (c[g.mL-1] =1.1, MeOH). IR 
(KBr): 3321, 1745, 1662, 1531cm-1. 1H NMR (200 MHz, CDCl3): δ 7.43-7.17 [5m, 5H, 
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2 Aib NH, 3 Ala NH], 7.36 [s, 5H, Z fenile], 6.67 [s, 1H, Aib NH], 5.72-5.71 [d, 1H, 
Ala NH], 5.25-5.05 [q, 2H, Z CH2], 4.63-4.56 [m, 1H, Alaα-CH], 4.42-4.35 [m, 1H, 
Alaα-CH], 4.04-3.94 [m, 2H, 2 Alaα-CH], 3.66 [s, 3H, -OMe CH3], 1.59-1.16 [m, 30H, 
3 Aib 2 β-CH3, 4 Alaβ-CH3]. 
Z-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
This product was obtained from 0.3 g of Z-Aib-OH (1.2 mmol) and H-L-Ala-Aib-L-
Ala-Aib-L-Ala-Aib-L-Ala-OMe (1.2 mmol; obtained via catalytic hydrogenation as 
seen previously). The activation was accomplished with HOAt/EDC coupling reactant 
in dry DCM. The product was directly purified on silica gel chromatographic column 
(90:10 CHCl3:EtOH) without aqueous work-up and then precipitated from EtOAc/PE as 
a white solid. Yield 95%. M.p.: 143-146°C. Rf1: 0.35;  Rf2: 0.75;  Rf3: 0.10. [α]D20: -
77.4° (c[g.mL-1] =0.2, MeOH). IR (KBr): 3321, 1742, 1660, 1530cm-1. 1H NMR (200 
MHz, CDCl3): δ 7.51-7.13 [7m, 7H, 3 Aib NH, 4 Ala NH], 7.36 [s, 5H, Z fenile], 6.38 
[s, 1H, Aib NH], 5.22-5.02 [q, 2H, Z CH2], 4.65-4.50 [m, 1H, Ala α-CH], 4.44-4.33 [m, 
1H, Ala α-CH], 4.05-3.73 [m, 2H, 2 Ala α-CH], 3.65 [s, 3H, -OMe CH3], 1.58-1.25 [m, 
36H, 4 Aib 2 β-CH3, 4 Ala β-CH3]. 
Z-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
This product was obtained from 0.2 g of Z-L-Ala-OH (0.8 mmol) and H-L-Ala-Aib-L-
Ala-Aib-L-Ala-Aib-L-Ala-OMe (0.8 mmol; obtained via catalytic hydrogenation as 
seen previously). The activation was accomplished with HOAt/EDC coupling reactant 
in dry DCM. The product was directly purified on silica gel chromatographic column 
(90:10 CHCl3:EtOH) without  aqueous work-up and then precipitated from EtOAc/PE 
as a white solid. Yield 71%. M.p.: 103-106°C. Rf1: 0.35;  Rf2: 0.75;  Rf3: 0.10. [α]D20: -
26.8° (c[g.mL-1] =0.9, MeOH). IR (KBr): 3321, 1744, 1662, 1531cm-1. 1H NMR (200 
MHz, CDCl3): δ 7.75-7.34 [8m, 8H, 4 Aib NH, 4 Ala NH], 7.35 [s, 5H, Z fenile], 6.86 
[s, 1H, Ala NH], 5.24-5.06 [q, 2H, Z CH2], 4.62-4.32 [2m, 2H, 2 Ala α-CH], 4.06-4.90 
[m, 3H, 3 Ala α-CH], 3.66 [s, 3H, -OMe CH3], 1.90-1.29 [m, 39H, 4 Aib 2 β-CH3, 5 
Ala β-CH3]. 
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Synthesis of Ac- Series 
Each Z- derivatives have been converted in part to its Ac- analogue. The general 
synthetic procedure is further described synthetically for Ac-(Aib-L-Ala)4-OMe. 
50 mg of Z-(Aib-L-Ala)4-OMe (0.7 mmol) were solved into 5 mL of MeOH in a 50 mL 
round bottom flask. Under stirring, N2 was flushed for 15’. Then, 10mg of Pd/C (10%) 
was added and H2 flushed instead of N2. The reaction was followed for 20’ at r.t.. The 
catalyzer was filtered off on celite and the MeOH removed under reduced pressure till 
complete dryness. Then, the residue was taken in 5 mL dry DCM and 1 mL of Ac2O 
straight added to solution. The reaction was followed on TLC plate for 10’. Then the 
solvent was removed under vacuum, taking at least 4 times with acetonitrile. Then, 
distilled water (5 mL) was added to residue and the so-obtained solution was finally 
lyophilized. The product has been purified on silica gel column (CHCl3:EtOH 99:1). 
Yield 90%. ESI-MS (m/z)= 699.4 [M+H+], 721.4 [M+Na+]. IR (KBr):3317, 1743, 
1656, 1534 cm-1.1H NMR (200 MHz, CDCl3): δ7.59-7.32 (m, 8H, 8 NH), 4.54-4.47 (t, 
1H, Ala α-CH), 4.32-4.25 (t, 1H, Ala α-CH), 4.05-3.96 (m, 2H, 2 Ala α-CH), 3.68 (s, 
3H, s, 3H, -OMe CH3), 2.04 (s, 3H, Ac CH3), 1.56-1.42 (m, 36H, 4 Aib 2 β-CH3, 4 Ala 
β-CH3). 
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Peptide-capped gold nanoparticles 
 
II 
Role of amino acid chirality and helical conformation in inducing plasmonicCD 
bands of peptide-capped gold nanoparticles 
 
INTRODUCTION 
Peptide-functionalized gold nanoparticles constitute quite appealing supramolecular 
systems for their ability to mimic properties of natural proteins. Indeed, by confining on 
the surface of a cluster of gold atoms several copies of a peptide, a nanosystem that 
resembles a protein in size (a few nanometers), shape (globular), and possibly, function, 
may be obtained. Peptide-functionalized gold nanoparticles have been used, inter alia, in 
catalysis, selective protein recognition, drug delivery, and gene transfection.1 Whenever 
a protein is considered, chirality is a peculiar property of the biopolymer, both because 
of the presence of the chiral amino acids and, when present, of the helical conformation 
of the sequence. Accordingly, a mimetic system of a protein must take into account in 
its features this relevant property. In spite of this, little attention has been paid so far to 
the chiral properties of peptide-functionalized gold nanoparticles considering the whole 
supramolecular system (gold core and peptide passivating monolayer) and not just the 
easily-addressable peptide units. A number of interesting papers have been reported in 
the last several years after the first observation by Whetten of optical activity of 
glutathione (a tripeptide)-passivated gold nanoparticles.2 It is now well accepted that 
chirality in such nanosystems may derive from: a) the chiral arrangement of the metal 
cluster of the gold core; b) the binding of the thiolates on the gold surface to form 
chirally arranged staples (an unusual bridged binding motif involving gold and sulfur); 
and c)  the chirality of the surrounding monolayer of passivating organic molecules. 
Among the chiral biomolecules reported so far for nanocluster passivation are DNA,3 
peptide nanotubes,4cysteine,5,6 glutathione,7 and peptides.8 
We have recently demonstrated that peptide sequences rich in  Cα-tetra substituted α-
amino acids are endowed of the peculiar property to stabilize the metallic cluster of gold 
(and other noble metals as well) nanoparticles in very polar solvents.9 This was 
attributed to the strong propensity of these sequences to fold into rather robust 310- or α-
helix conformations. Critical parameters, like main-chain length and type of solvent 
used, have been fairly assessed for helix formation of these peptides in solution.10,11 
However, nothing is known concerning their folding behavior when bound to the 
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surface of a gold nanoparticle. Furthermore, no study is available on the role of the 
individual amino acids and secondary structure of the sequence in inducing chiroptical 
properties to the passivated nanoparticles. This paper specifically addresses these 
points.We have already reported on the helical folding properties in water of a series of 
N-terminally acetylated, C-terminally methoxylatedoligopeptides, characterized by a 
sequence with alternating Aib (α-amino isobutyric acid) and L-Ala residues, from the 
dimer to the nonamer.11 We found that the critical main-chain length for 310- and α-helix 
formation in aqueous solution, although not to a full extent, is six residues. These 
structurally robust sequences constituted the bases for our investigation.  
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RESULTS AND DISCUSSION 
The Z-derivated peptide oligomers11 were modified by thiol-functionalization at the 
N-terminus for passivation of the gold nanoclusters. The seven peptides with Aib/L-Ala 
alternating residues and N-mercaptopropionyl (mpr-) N-termination (2-8, see Figure 1) 
were synthesized by conventional solution protocols. Even sequences are characterized 
by an Aib amino acid at the N-terminus while odd ones are characterized by a L-Ala 
amino acid because our optimized synthetic protocol  uses L-Ala as  C-terminus starting 
peptide. 
 
 
Fig. 1.Chemical structure for: 2, mpr-Aib-Ala-OMe;  3, mpr-Ala-Aib-Ala-OMe; 4, mpr-(Aib-Ala)2-
OMe; 5, mpr-Ala-(Aib-Ala)2-OMe; 6, mpr-(Aib-Ala)3-OMe; 7, mpr-Ala-(Aib-Ala)3-OMe; 8, mpr-(Aib-
Ala)4-OMe. 
All the seven peptides were chemically characterized in full and, because of their good 
solubility in water, we were able to record their ECD spectra in the far-UV region in 
this solvent at neutral pH. In spite of the presence of potentially interfering 
chromophores (the N-terminal mercapto-propionamide and the C-terminal methyl 
ester)12–14 the spectra didn’t show marked modification of the dichroic signature. This 
resembles that found for the parent oligomers devoid of the thiolated unit. Figure 2A 
shows the ECD spectra of all oligomers. Noteworthy, there is an increase in folding 
propensity and associated chiroptical properties in the series, but such a trend is not 
linear due to two contrasting effects at play as the sequence elongates. In fact, on one 
side all even-number oligomers should exhibit a significantly higher helicity than that of 
their immediately lower (odd) oligomer, not only by virtue of their slightly longer main 
chain but also because the newly incorporated residue is the strongly helicogenic Aib.15–
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17 On the other side, the chiral L-Ala added to form each odd oligomer, although 
remarkably less helicogenic than Aib, should contribute to the observed ellipticity much 
more than the achiral Aib. The data show, in line with our previous results that, in the 
sequential series 2-8, a helical conformation starts to form with the hexamer while a 
complete helix is observed only with the octamer. 
 
Fig. 2 A: Far-UV ECD spectra of 2-8 series recorded in water at 20°C. Concentration 1 mM. B: FTIR 
absorption spectra of 2-8 series recorded in deuterated water at 20°C. Concentration 10 mM. C: proposed 
folding process for the 2-8 series. 
The analysis of the ellipticity ratios (R) between the negative 222 nm (peptide n → π* 
transition, Cotton effect) and that near 205 nm allows the discrimination between the 
310- and α-helix structure.18 It is well accepted that a value of 0.15-0.35 for R is 
considered diagnostic for a 310-helix, while a value close to the unity is typical of a α-
helix. In our case R is ca. 0.3 for 8 supporting the assignment of a 310-helix 
conformation. Information obtained from ECD experiments were confirmed by FTIR 
absorption spectra in the C=O stretching region, which were recorded for the sequential 
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series 2-8 in deuterated water (Figure 2B). The ester C=O band is located at 1728 cm-1, 
while the amide I C=O band spans from 1633 (2) to 1638 (8) cm-1 (amide II  band is 
located in the 1460 cm-1 region). The peptide chain elongation results into an increasing 
molar absorption in going from peptide 2 to 8, as the result of the larger number of 
chromophores in the longer peptides. The concomitant shift of the absorption maxima to 
slightly higher wavenumbers confirms the formation of consecutive C=O···H-N 
intramolecular H-bonds of the β-turn type, that finally results in a  stabilized helical 
structure from the hexamer to the octamer. The overall folding process is reported in 
Figure 2C.These oligopeptides where then used as passivating agents for the synthesis 
of the gold nanoparticles AuNp2-8. The nanoparticles were prepared by one phase 
NaBH4 reduction of HAuCl4 in water/methanol and in the presence of a two-fold molar 
excess of the peptides. After purification via gel filtration, the nanoparticles were 
characterized by TEM and TGA analysis, as previously reported,9a to obtain the relevant 
characterization data summarized in Table 1. Inspection of Table 1 shows that 
diameters of the obtained nanoparticles are fairly constant in the 2.0-2.4 nm range.  
Tab. 1 Chemical structures data for all peptide-capped AuNp2-8 reported in this work. 
Entry Core 
d 
(nm) 
Au atoms 
forAuNp[b] 
Pep. 
chain 
for 
AuNp[c] 
Footprint 
(nm2) 
AuNp2 2.0 247 126 0.10 
AuNp3 
AuNp4 
AuNp5 
AuNp6 
AuNp7 
AuNp8 
2.2 
2.3 
2.0 
2.3 
2.4 
2.4 
329 
376 
247 
376 
427 
427 
138 
119 
55 
54 
33 
27 
0.11 
0.14 
0.23 
0.31 
0.45 
0.68 
[a] d = diameter. Calculated by averaging the size of at least 200 nanoparticles;[b] Calculated assuming a 
spherical model. 
On the contrary, there is a huge decrease in the number of peptides necessary to fully 
passivate the gold cluster surface as the sequence elongates. In fact with AuNp8 the 
number of peptides reduces to ca. one fifth with respect to that required for shorter 
peptides. This implies a larger surface coverage exerted by each peptide (footprint 
increases from ca. 0.1 nm2 to 0.2 nm2 and eventually to ca. 0.7 nm2). Footprint values 
obtained for AuNp1-3 are similar to those reported for gold nanoparticles passivated by 
alkylthiols or poly(Aib) short peptides, and indicate a dense packing of the coating 
molecules on the particles surface. On the other hand, footprints observed for AuNp8 
are similar to the ones we previously reports for gold nanoparticles coated with helical 
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peptides.8 This quite interesting behavior of the peptides when bound to the gold 
nanocluster will be discussed in detail below. Figure 3A reporting the results of the 
ECD analysis of AuNp2-8 evidences the different behavior observed with respect to the 
peptides in solutions. In fact, AuNp2, 4, 6 display a Cotton effect below 200 nm with 
concomitant weak positive dichroism at 215-220 nm suggesting an un-ordered 
conformation. On the other hand, AuNp3 and 5 have a negative band at ca. 235 nm 
providing evidence of β-sheet formation. As in solution, the formation of a significant 
amount of helical conformation requires at least a 6mer sequence. 
 
 
Fig. 3 A: Far-UV ECD spectra of 2-8 AuNpsseries recorded in water at 20°C. Concentration 1 mM. B: 
FTIR absorption spectra of 2-8 AuNpsseries recorded in D2O at 20°C. 
However, when compared to the spectra of the free, unbound peptides reported in 
Figure 2A, the ones of the AuNps indicate that the helical content is decreased for 
identical sequences when bound to the nanocluster surface. The spectra of Figure 3A 
and the structural information they provide suggest also a plausible explanation for the 
observation we have made above concerning the number of peptides required for the 
passivation of the gold cluster. Peptides 2-4 are likely un-ordered. They may form weak 
intermolecular H-bonds or may interact with the gold surface. On the contrary peptides 
6-8 are more ordered as they start developing a helical conformation (that of a 310-helix 
for 8). They are hence involved in the formation of intramolecular H-bonds. Because of 
the lack of an helical conformation, shorter sequences may be more tightly packed on 
the surface as compared to the longer ones. A simple calculation reveals that a 310-helix 
displays an (circular) axial backbone footprint close to 0.55 nm2 [considering a d (side 
chain)i→(side chain)i+1, of ca. 8.3 Å], while that of an extended conformation 
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(elliptical) is close to 0.12 nm2 (considering two section, C=Oi→ C=Oi +1, of ca. 3.8 Å 
and d (side chain)i→ (side chain)i +1, of ca. 4.3 Å).This is fully consistent with the data 
of Table 1. FTIR absorption spectra in the C=O stretching region were recorded as well 
for the sequential series AuNp2-8 in deuterated water (Figure 3B). Although the 
overall spectra profiles are similar to the above discussed 2-8 ligands series,  one 
additional bandlocated at 1558 cm-1, exceptionally intense for AuNp2 (1558 cm-1), 
emerged. Recently, Hamm and co-workers reported an FTIR surface enhancement 
effect on the amide group when conjugated to AuNps.19 We might attributed this band 
to a gold-amide interaction that take place extremely only for the shortest peptide ligand 
(2). Apart to this peculiar behavior, the peptide chain elongation results again into an 
increasing molar absorption from peptide-capped nanoparticles 2-8. The UV-Vis spectra 
of AuNp2-8 in neutral water solution (Figure 4A) are fully consistent with their size as 
they show only a very weak, if any, plasmon resonance band above 500 nm.  
 
Figure 4.UV-Vis spectra (A) and ECD spectra (B) of the AuNps(2-8) series synthesized in this work. 
Solvent: water. 
It is known that this band becomes relevant only for gold nanoparticles larger than 3 
nm. In addition, all the absorption spectra exhibit little resolved fine structure below 400 
nm, similar to that we have reported for Aib-based short peptide AuNps, but not as well 
resolved as those reported for smaller (0.7-1.3 nm) gold particles passivated by L-
glutathione, penicillamine and N-isobutyryl-L-cysteine. Remarkably, the ECD spectra 
of AuNp5-8 in the 300-650 nm region (Figure 4B) reveal quite interesting patterns. In 
fact, dicroic bands are observed also in this region. The behavior of these bands with the 
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elongation of the peptides sequence is intriguing. First of all, the intensity of the bands 
is larger for shorter sequences than for longer ones. As a matter of fact the spectrum of 
AuNp8, i.e. of the most helical peptide is almost flat. Second, the spectra show a 
peculiar pattern related to the presence of an achiral amino acid (Aib) or a chiral one (L-
Ala) close to the gold surface. Dichroic bands are roughly inverted for the two series of 
peptides (AuNp2, AuNp4, AuNp6 and AuNp3, AuNp5 and AuNp7). The best 
comparison can be done for AuNp2 and AuNp3 that show the strongest signals. The 
ECD spectrum  of AuNp2 (for which Aib is the amino acid close to the surface)presents 
two positive bands located at 505 and 560 nm and, in the 300-450 nm region, a set of 
alternating, intense bands. The spectrum of AuNp3 (for which L-Ala is the amino acid 
close to the surface) shows, on the contrary, a large negative band located at 550 nm in 
addition to a positive band at 440 nm and a strong negative one at 340 nm. Thus the odd 
and even peptide sequences behave like pseudo enantiomers in their ECD spectrum. 
This alternating pattern continues along the series although the intensity of the bands 
progressively decreases as the ordered structure of the sequences increases. Interestingly 
enough, a 1.8 nm-diameter nanoparticles coated with peptide 4 and prepared by a 
different synthetic procedure (thiol exchange on nanoparticles coated with secondary 
amines) revealed the same chiroptical properties. The similarity of these patterns with 
those recently reported by Bürgi and co-workers for the two enantiomers of 
Au40(SCH2CH2Ph)24 is striking and could suggest that, depending on the Aib-Ala order 
in the peptide sequence (likely the amino acid that is closest to the Au surface), one of 
the two possible nanoparticles is preferentially formed.15 Although with the present data 
it is not possible to provide a clear explanation for this behavior a number of 
observations can be made. First, the formation of a helical conformation kills ellipticity 
as shown in Figure 4. This means that intramolecular H-bonding prevents a critical 
interaction for the formation of stereogenic units. Second, at least two independent 
chiral sources appear to contribute to the observed chiroptical signal. One could be 
related to the formation of chiral staples (of the type (RSAu)nSR with n=1 or 2), the 
second to the chiral α carbon of L-Ala when it is the closest amino acid to the gold 
surface.In both case, as aforementioned, the stereogenic selection could be associated i) 
with inter-peptide H-bonds formation (similar to a β-sheet) or ii) with a very week but 
relevant coordination of a nitrogen or oxygen of an amide bond toone of the gold atoms. 
Of course, both could operate at the same time to provide a three-point contact, a key 
concept in stereo-selection, as reported for the interaction of cysteine on a Au (110) 
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surface. This suggestion is supported by the observation of β-sheet-like bands in the 
ECD spectra only for the particles coated with peptides 3 and 5 and not in the case of 
those coated with 2 and 4. Additional evidence for different inter-ligand interactions 
depending on the amino acid positions in the chain is provided by FTIR second order 
derivative deconvolution of the absorption spectra signals (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All the nanoparticles have very broad amide I bands, likely corresponding to the overlap 
of different band arising for different secondary structures. However, second order 
derivative deconvolution of the signals evidences a relevant difference between odd and 
even peptide coated nanoparticles. In fact, the latter (AuNp2, 4 and 6) show only two 
bands at 1630 and 1645 cm-1 respectively, which could arise from random and turn 
structures; on the other hand, nanoparticles coated with odd peptides 3, 5 and 7 display 
also shoulder at 1665 cm-1 not observed in the related free peptides. The presence of an 
IR absorption band at this wavenumber has been recently attributed to the formation of 
anti-parallel β-sheet structures. Next, we decide to investigate the ECD behavior at 
different temperatures (Figure 6).  
 
Fig.5 FTIR absorption spectra second order derivative deconvolution of 2-8 AuNps series recorded in 
deuterated water at 20°C. 
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Fig.6  ECD spectra of the AuNps(2-6) recorded at different temperatures. Solvent: water. 
 
In the case of AuNp2 the ECD spectra recorded at 20 and 60 °C did not display any 
significant difference. For the AuNp3-6 series the ECD spectra were run at 20, 60 and 
again at 20 °C. Surprising enough, at 60 °C the ECD signals in the Vis region were 
suppressed for all the series members. After a cooling time aim to restore the initial 20 
°C condition, the ECD signals were reestablished at almost the original intensities. This 
is to our knowledge the first example of a temperature dependent ECD-memory effect 
on gold nanoparticles. From all of the above experimental data we might propose an 
hypothetical folding process of peptides2-8 when conjugated to AuNp (Figure 7). 
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Fig. 7 Hypothetical folding process for the peptide-conjugated AuNps series discussed in this work. 
By assuming an AuNp staple model, in the odd AuNp3, AuNp5 and AuNp7 the first Ala (the 
closest amino acid respect to the gold surface) is able, at least in part, to drive a parallel β-sheet type 
intermolecular H-bonds thus to generate a preferred sin-conformation between paired peptides 
anchored on the matching staple. Alongside the backbone elongation the parallel β-sheet motif is 
still conserved (in part) on the N-terminus, although the rest of the amino acid sequence is able to 
fold in a pronounced β-turn type motif along the remained backbone. In case of AuNp4, AuNp6 
andAuNp8 thefirst Aib close to the gold surface act as β-sheet breaker and as a β-turn promoter. 
Along with the backbone elongation the β-turn motif turn out to be the main folding motif, thus to 
generate an extended helical structure for the longest peptides. This peculiarity should drive, for 
steric reason, the peptide ligands in an anti-conformation respect to the matching staple. In the case 
of AuNp2 we might assume an anti-conformation orientation arising from a strong gold-amide 
interaction and Aib (close to gold surfice) sterical repulsion. Anyway, we cannot exclude for all the 
AuNps families members theoccurrence of of weak amide-Au surface interaction whichseems be 
the responsible of the above mentioned  ECD memory effect. 
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CONCLUSIONS 
In conclusion, our studies established the occurrance of chiroptical properties in peptide-
coated 2 nm diameter gold nanoparticles. These properties were detected for the first time in 
nanoparticles of such a size showing moderately strong ECD signals in the range of 300-650 nm, 
corresponding to the gold nanoparticle’s quantized electronic structure. The peptides, although their 
only chiral amino acid is L-Ala, behave like pseudo enantiomers according to the number of amino 
acids in the sequence (odd or even) or, more likely, in accordance with the type of amino acid 
closest to the gold surface (Aib or L-Ala). Such a behavior appears to be strongly influenced by the 
secondary structure assumed by the peptides whenpassivating the nanoparticles and vanishes when 
the sequence is long enough to assume a 310-helix conformation. 
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EXPERIMENTAL SECTION 
GENERAL METHODS 
FTIR: The KBr spectra were recorded on a Perkin-Elmer 580 B equipped with an IR 
data station Perkin-Elmer 3600. For spectra in D2O  a Perkin-Elmer 1720X was 
employed. The instrument operates in FT and is interfaced to a IBM PS/2 50 Z 
computer. 50µm  CaF2 pathway cells have been employed. For each spectrum have 
been  collected 50 scans (4cm-1 resolution) under nitrogen. 
UV-Vis Absorption: The electronic absorption spectra were recorded using a Shimadzu 
model UV-2501 PC spectrophotometer. A 1 cm path length quartz cell was used. 
CD: The ECD measurements have been collected on a J-715 Jascospectropolarimeter, 
with quartz cells Hellma (0.02cm pathway length). Values are reported in total molar 
ellipticy (deg x cm2 x dmol-1) : 
[Θ]T = (MW ×Θ )/( l × c )  = 3300 ×∆ε = 3300 ×  (εL-εR ) 
Θ = observed ellipticy 
MW = molecular weight 
l = pathway length (cm) 
c = concentration in gr/l 
∆ε = εL - εR = difference between left- and right-handed component of estinction 
coefficients of polarized light 
TEM: Samples were analyzed on a Jeol 300PX instrument. Samples were prepared 
before used, by 100 times dilution of a 2mg/ml MeOH solution of AuNp-3, AgNp-3, or 
PtNp-3. A glow discharged carbon coated grid was floated on a small drop of gel 
solution and excess was removed by #50 hardened Whatman filter paper. 
TGA: TGA measurements have been collected by solid state on a Platinum-HT pan, 
heating the sample from 100°C to 900°C under nitrogen atmosphere, therefore treating 
from 900°C to 1000°C under oxygen at the same scanning rate. 
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SYNTHESIS AND CHARACTERIZATION 
Trt-S-CH2-CH2-CO-Aib-L-Ala-OMe 
Triphenylmethyl (Trt)-S-(CH2)2-COOH (0.65 g, 1.18 mmol) was dissolved in 
anhydrous CH2Cl2 and kept at 0°C. Then, HOAt (0.25 g, 1.85 mmol), EDC.HCl (0.36 g, 
1.85 mmol), H-Aib-L-Ala-OMe (obtained by catalytic hydrogenation of the 
corresponding N-protected Z-Aib-L-Ala-OMe (Z, benzyloxycarbonyl) in methanol 
solution (0.5g, 1.55 mmol)( and TEA (0.52 mL,  3.78 mmol) were added to the solution. 
After stirring the solution at room temperature for 24 hours, CH2Cl2 was evaporated 
under  reduced pressure. The oily residue was dissolved in EtOAc and washed with 
10% KHSO4, H2O, 5% NaHCO3, and H2O, dried over anhydrous Na2SO4, and 
evaporated to dryness under reduced pressure. The crude product was purified by flash 
chromatography. The product was crystallized from EtOAc/petroleum ether.Yield 
87%.IR (KBr): 3329, 3272, 3056, 2983, 2936, 1754, 1744, 1657 cm-1. 1H NMR (200 
MHz, CDCl3): δ 7.45-7.17 [m, 15H, Trt aromatic rings], 6.90-6.86 [d, 1H, Ala NH], 
5.72 [s, 1H, AibNH], 4.53-4.46 [dt, 1H, Alaα-CH], 3.69 [s, 3H, -CH3], 2.60-2.49 [m, 
2H, -CH2-], 2.04-1.94 [m, 2H, -CH2-], 1.36-1.32 [d, 6H, Aibβ-CH3], 1.24-1.21 [d, 3H, 
Alaβ-CH3]. 
Trt-S-CH2-CH2-CO-L-Ala-Aib-L-Ala-OMe 
Triphenylmethyl (Trt)-S-(CH2)2-COOH (0.56 g, 1.6 mmol) was dissolved in anhydrous 
CH2Cl2 and kept at 0 °C. Then, HOAt (0.22 g, 1.6 mmol), EDC•HCl (0.33 g, 1.7  
mmol), H-L-Ala-Aib-L-Ala-OMe (obtained by catalytic hydrogenation of the 
corresponding N-protected Z-L-Ala-Aib-L-Ala-OMe (Z, benzyloxycarbonyl) in 
methanol solution (0.5 g, 1.3 mmol)) and triethylamine TEA (0.45 mL,  3.50 mmol) 
were added to the solution. After stirring the solution at room temperature for 24 hours, 
CH2Cl2 was evaporated under  reduced pressure. The oily residue was dissolved in 
EtOAc and washed with 10% KHSO4, H2O, 5% NaHCO3, and H2O, dried over 
anhydrous Na2SO4, and evaporated to dryness under reduced pressure. The crude 
product was purified by flash chromatography. The product was crystallized from 
EtOAc/petroleum ether.Yield 93%.IR (KBr): 3310, 3056, 2983, 2936, 1742, 1653, 
1535 cm-1.1H NMR (200 MHz, CDCl3): δ 7.40-7.17 [m, 15H, Trt aromatic rings], 6.95-
6.91 [d, 1H, Ala NH], 6.52 [s, 1H, AibNH], 5.75-5.72 [d, 1H, Ala NH], 4.53-4.46 [dt, 
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1H, Alaα-CH], 4.27-4.10 [m, 1H, Alaα-CH], 3.71 [s, 3H, OMeCH3], 2.56-2.51 [m, 2H, 
-CH2-], 2.49-1.95 [m, 2H, -CH2-], 1.58-1.21 [m, 12H, Aibβ-CH3, 2Ala β-CH3]. 
Trt-S-CH2-CH2-CO-Aib-L-Ala-Aib-L-Ala-OMe 
Triphenylmethyl (Trt)-S-(CH2)2-COOH (0.42 g, 1.2 mmol) was dissolved in anhydrous 
CH2Cl2 and kept at 0 °C. Then, HOAt (0.17 g, 1.2 mmol), EDC.HCl (0.23 g, 1.2 mmol), 
H-Aib-L-Ala-Aib-L-Ala-OMe (obtained by catalytic hydrogenation of the 
corresponding N-protected Z-Aib-L-Ala-Aib-L-Ala-OMe (Z, benzyloxycarbonyl) in 
methanol solution (0.6 g, 1.1 mmol)) and triethylamine TEA (0.33 mL,2.4 mmol) were 
added to the solution. After stirring the solution at room temperature for 24 hours, 
CH2Cl2 was evaporated under  reduced pressure. The oily residue was dissolved in 
EtOAc and washed with 10% KHSO4, H2O, 5% NaHCO3, and H2O, dried over 
anhydrous Na2SO4, and evaporated to dryness under reduced pressure. The crude 
product was purified by flash chromatography. The product was crystallized from 
EtOAc/petroleum ether.Yield 83%. IR (KBr): 3312, 3056, 2984, 2936, 2871, 1743, 
1657, 1534 cm-1.1H NMR (200 MHz, CDCl3): δ 7.42-7.24 [m, 15H, Trt aromatic rings], 
7.21 [d, 1H, Ala NH] 7.13 [s, 1H, Aib NH], 6.69-6.67 [d, 1H, Ala NH], 6.58 [s, 1H, 
AibNH], 4.55-4.48 [m, 1H, Alaα-CH], 4.10-4.00 [m, 1H, Alaα-CH], 3.70 [s, 3H, 
OMeCH3], 2.80-2.75 [m, 2H, -CH2-], 2.55-2.49 [m, 2H, -CH2-], 1.58-1.17 [m, 18H, 
2Aib β-CH3, 2Ala β-CH3]. 
Trt-S-CH2-CH2-CO-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
Triphenylmethyl (Trt)-S-(CH2)2-COOH (0.21 g, 0.6 mmol) was dissolved in anhydrous 
CH2Cl2 and kept at 0 °C. Then, HOAt (0.08 g, 0.6 mmol), EDC.HCl (0.12 g, 0.6 mmol), 
H-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (obtained by catalytic hydrogenation of the 
corresponding N-protected Z-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (Z, 
benzyloxycarbonyl) in methanol solution (0.6 g, 1.1 mmol)) and triethylamine TEA 
(0.17mL,1.2 mmol) were added to the solution. After stirring the solution at room 
temperature for 24 hours, CH2Cl2 was evaporated under  reduced pressure. The oily 
residue was dissolved in EtOAc and washed with 10% KHSO4, H2O, 5% NaHCO3, and 
H2O, dried over anhydrous Na2SO4, and evaporated to dryness under reduced pressure. 
The crude product was purified by flash chromatography. The product was crystallized 
from EtOAc/petroleum ether.Yield 80%. IR (KBr): 3352, 3330, 3310, 3053, 3029, 
2984, 2937, 1741, 1715, 1669, 1533 cm-1.1H NMR (200 MHz, CDCl3): δ 7.42-7.08 [m, 
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18H, Trt aromatic rings, Aib+2Ala NH], 6.45 [s, 1H, Aib NH], 6.02 [d, 1H, Ala NH], 
4.58-4.47 [m, 1H, Alaα-CH], 4.38-4.27 [m, 1H, Alaα-CH], 4.14-4.10 [m, 1H, Alaα-
CH] 3.63 [s, 3H, OMeCH3], 2.87-2.77 [m, 2H, -CH2-], 2.45-2.11 [2m, 2H, -CH2-], 1.62-
1.24 [m, 21H, 2Aib β-CH3, 3Ala β-CH3]. 
Trt-S-CH2-CH2-CO-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
Triphenylmethyl (Trt)-S-(CH2)2-COOH (0.32 g, 0.7 mmol) was dissolved in anhydrous 
CH2Cl2 and kept at 0 °C. Then, HOAt (0.17 g, 0.7 mmol), EDC.HCl (0.25 g, 0.7 mmol), 
H-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (obtained by catalytic hydrogenation of the 
corresponding N-protected Z-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (Z, 
benzyloxycarbonyl) in methanol solution (0.5 g, 0.6 mmol)) and triethylamine TEA 
(0.38 mL, 1.4 mmol) were added to the solution. After stirring the solution at room 
temperature for 24 hours, CH2Cl2 was evaporated under  reduced pressure. The oily 
residue was dissolved in EtOAc and washed with 10% KHSO4, H2O, 5% NaHCO3, and 
H2O, dried over anhydrous Na2SO4, and evaporated to dryness under reduced pressure. 
The crude product was purified by flash chromatography. The product was crystallized 
from EtOAc/petroleum ether.Yield 75%. IR (KBr): 3341, 3056, 2984, 2935, 2873, 
1745, 1857, 1533 cm-1.1H NMR (200 MHz, CDCl3): δ 7.22-7.19 [m, 18H, Trt aromatic 
rings, Aib+2Ala NH], 6.99-6.91 [d, 1H, Ala NH], 6.71 [d, 1H, Ala NH], 5.70 [s, 1H, 
Aib NH], 4.65-4.57 [m, 1H, Alaα-CH], 4.38-4.35 [m, 1H, Alaα-CH], 4.10-3.90 [m, 1H, 
Alaα-CH] 3.66 [s, 3H,OMeCH3], 3.01-2.90 [m, 2H, -CH2-], 2.50-2.05 [2m, 2H, -CH2-], 
1.62-1.24 [m, 27H, 3Aib β-CH3, 3Ala β-CH3]. 
Trt-S-CH2-CH2-CO-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
Triphenylmethyl (Trt)-S-(CH2)2-COOH (0.32 g, 0.7 mmol) was dissolved in anhydrous 
CH2Cl2 and kept at 0 °C. Then, HOAt (0.17 g, 0.7 mmol), EDC.HCl (0.25 g, 0.7 mmol), 
H-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (obtained by catalytic hydrogenation of the 
corresponding N-protected Z-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (Z, 
benzyloxycarbonyl) in methanol solution (0.4 g, 0.6 mmol)) and triethylamine TEA 
(0.38 mL,  1.4 mmol) were added to the solution. After stirring the solution at room 
temperature for 24 hours, CH2Cl2 was evaporated under  reduced pressure. The oily 
residue was dissolved in EtOAc and washed with 10% KHSO4, H2O, 5% NaHCO3, and 
H2O, dried over anhydrous Na2SO4, and evaporated to dryness under reduced pressure. 
The crude product was purified by flash chromatography. The product was crystallized 
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from EtOAc/petroleum ether.Yield 75%. IR (KBr): 3337, 3060, 3031, 2932, 2912, 
2647, 2568, 1703, 1662, 1533 cm-1.1H NMR (200 MHz, CDCl3): δ 7.41-7.27 [m, 21H, 
Trt aromatic rings, 3Aib+3Ala NH], 6.25 [s, 1H, Aib NH], 4.56-4.49 [m, 1H, Alaα-
CH], 4.36-4.29 [m, 1H, Alaα-CH], 4.10-3.90 [m, 1H, Alaα-CH] 3.66 [s, 3H, OMeCH3], 
3.01-2.90 [m, 2H, -CH2-], 2.50-2.05 [2m, 2H, -CH2-], 1.62-1.24 [m, 27H, 3Aib β-CH3, 
3Ala β-CH3]. 
General synthesis and purification of gold nanoparticles peptide conjugate 
Trt-S-(CH2)2-CO-derivated ofthe peptide and HAuCl4 (0.3 eq.) were combined in 10 ml 
of a 1:1 methanol/water solvent mixture. The resulting solution was allowed to stand for 
1 h under stirring. Then, NaBH4 (10 eq.) in water were rapidly added and the solution 
was stirred at room temperature for additional 10 minutes. The solvent was removed 
under reduced pressure and the residue solved in water. The so-obtained solution was 
straight charged in a gel-filtration column. The Nps were obtained by liophylization.  
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Supramolecular self-assemblied aggregates 
 
III 
 
Hydrophobic Aib/Ala peptides solubilize in water through formation of 
supramolecular assemblies 
 
 
INTRODUCTION 
Our interest in self-assembly arose from the rationalization of the evidence for water 
solubility property of a peptides series containing alternating Ala and Aib (α-
aminoisobutyric acid).1 During the solution syntheses of peptides containing alternating 
Ala and Aib (α-aminoisobutyric acid) stretches, we observed unusually low yields. 
After a careful inspection of all synthetic steps, we discovered that much of the product 
was lost in the purification procedures as, unexpectedly, these peptides are soluble in 
water.1,2 To the best of our knowledge, this is the first example of a class of  N- and C-
terminal protected, hydrophobic peptides able to dissolve in water. This finding is even 
more surprising in view of the absence of any residue having a charged (e.g.Lys, Asp) 
or a polar (e.g. Ser, Thr) side chain. The explanation of such a behavior is not 
straightforward. Therefore, we started a series of experiments aimed at explaining the 
observed hydrosolubility. The preliminary results of our efforts, reported in this 
work,focus on the undecapeptide Z-(L-Ala)3-(Aib-L-Ala)4-OMe,2 where Z is 
benzyloxycarbonyl and OMe is methoxy.  
Interestingly, these Ala/Aib peptides maintain in water2 the same helical 
conformations they display in organic solvents.3-7 Thus, one cannot ascribe their 
solubility in water to a conformational change, according to which, for instance, the 
polar peptide moieties would be exposed to the solvent and not any longer engaged in 
intramolecular H-bonds. A different mechanism has definitely to be involved. In a 310- 
or α-helical peptide two or three, respectively, amide carbonyls at the C-terminus are 
not part of the intramolecular H-bonding network. The same situation applies to the first 
two or three amide NHs at the N-terminus. Taking into account these observations, we 
hypothesized that aggregates of helical peptides would form, in which the N- and/or C-
terminal segments are located on the external surface, in contact with water molecules, 
whereas the hydrophobic sections the peptides are embedded in the aggregate. 
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RESULTS AND DISCUSSION 
 
PEPTIDE CONFORMATION 
The ECD spectra in water of Z-(L-Ala)3-(Aib-L-Ala)4-OMe and its C-terminal free 
analog Z-(L-Ala)3-(Aib-L-Ala)4-OH are reported in Figure 1. Although slightly 
diverging, the two spectra are indicative of α-helical structures, as the ratios of the 
ellipticities between the two negative Cotton effects at about 222 nm and 205 nm are 
0.74 for Z-(L-Ala)3-(Aib-L-Ala)4-OMe and 0.91 for Z-(L-Ala)3-(Aib-L-Ala)4-OH.8,9 
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Fig. 1 Far-UV ECD spectra of Z-(L-Ala)3-(Aib-L-Ala)4-OMe (o) and Z-(L-Ala)3-(Aib-L-Ala)4-OH 
(●) in water at 20 °C. Peptide concentration: 1 mM. 
 
To get a closer look into conformational features possibly responsible for the water 
solubility of our Ala/Aib peptides, we tried to grow single crystals of Z-(L-Ala)3-(Aib-
L-Ala)4-OMe. Our attempts were successful only for its closely related analog Z-(L-
Ala)3-(Aib-L-Ala)4-OH. Its molecular conformation, as determined by single-crystal X-
ray diffraction, is illustrated in Figure 2.  
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Fig. 2 X-ray diffraction structure of Z-(Ala)3-(Aib-L-Ala)4-OH crystallized from 2-propanol solution. 
Only one of the three co-crystallized water molecules in shown. The intramolecular H-bonds are 
represented by dashed lines. 
 
Relevant torsion angles are reported in Table 1, while intra- and intermolecular H-bond  
parameters are listed in Table 2. 
 
 
 
 
 
Tab. 1 Selected torsion angles [°] for Z-(L-Ala)3-(Aib-L-Ala)4-OH trihydrate. 
C02-C01-C07-OU 148.6(3) CA5-C5-N6-CA6 177.27(19) 
C06-C01-C07-OU -32.1(5) C5-N6-CA6-C6 -55.5(3) 
C01-C07-OU-C0 171.1(3) N6-CA6-C6-N7 -45.0(3) 
C07-OU-C0-N1 -174.5(3) CA6-C6-N7-CA7 -176.1(2) 
OU-C0-N1-CA1 -172.4(2) C6-N7-CA7-C7 -61.0(3) 
C0-N1-CA1-C1 -64.7(3) N7-CA7-C7-N8 -41.0(3) 
N1-CA1-C1-N2 -38.8(3) CA7-C7-N8-CA8 -175.7(2) 
CA1-C1-N2-CA2 -179.2(2) C7-N8-CA8-C8 -60.8(3) 
C1-N2-CA2-C2 -67.9(3) N8-CA8-C8-N9 -24.4(3) 
N2-CA2-C2-N3 -42.2(4) CA8-C8-N9-CA9 179.5(3) 
CA2-C2-N3-CA3 179.4(2) C8-N9-CA9-C9 -72.6(4) 
C2-N3-CA3-C3 -61.1(3) N9-CA9-C9-N10 -19.3(4) 
N3-CA3-C3-N4 -44.8(3) CA9-C9-N10-CA10 177.9(3) 
CA3-C3-N4-CA4 -179.0(2) C9-N10-CA10-C10 53.4(4) 
C3-N4-CA4-C4 -54.1(3) N10-CA10-C10-N11 52.2(4) 
N4-CA4-C4-N5 -48.5(3) CA10-C10-N11-CA11 -175.5(3) 
CA4-C4-N5-CA5 -176.0(2) C10-N11-CA11-C11 -151.6(3) 
C4-N5-CA5-C5 -70.7(3) N11-CA11-C11-O11T 50.0(3) 
N5-CA5-C5-N6 -43.3(3)   
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Tab. 2 Hydrogen bonds for Z-(L-Ala)3-(Aib-L-Ala)4-OH trihydrate [Å and °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 N4-H04...O01 0.86 2.28 3.118(3) 164.7 
 N5-H05...O1 0.86 2.44 3.260(3) 159.8 
 N6-H06...O2 0.86 2.03 2.876(3) 169.7 
 N7-H07...O3 0.86 2.09 2.918(2) 160.9 
 N8-H08...O4 0.86 2.52 3.289(3) 149.7 
 N8-H08...O5 0.86 2.62 3.156(3) 121.9 
 N9-H09...O6 0.86 2.42 3.163(3) 145.3 
 N10-H010...O7 0.86 2.21 3.026(3) 157.7 
 N11-H011...O3W 0.86 2.03 2.863(3) 161.2 
 O3W-H3WA...O6 0.83 1.99 2.780(3) 159.8 
 O11T-H11T...O9#1 0.82 1.83 2.634(3) 166.0 
 N1-H01...O10#2 0.86 2.23 3.052(3) 159.9 
 N2-H02...O1W#2 0.86 2.17 3.011(3) 167.2 
 N3-H03...O2W#2 0.86 2.29 3.043(3) 146.1 
 O1W-H1WA...O10 0.80 1.98 2.767(3) 167.6 
 O1W-H1WB...O11#3 0.88 2.01 2.833(4) 154.9 
 O2W-H2WA...O1#4 0.85 2.24 3.006(4) 149.0 
 O2W-H2WB...O1W101 0.86 2.05 2.857(4) 156.6 
 O3W-H3WB...O8#1 0.90 2.05 2.930(4) 165.3 
Symmetry transformations used to generate equivalent atoms: 
#1 x,y+1,z;   #2 x-1/2,y+1/2,z-1;   #3 -x+5/2,y-1/2,-z+2;  #4 x+1/2,y+1/2,z+1 
 
 
The conformation adopted  by the undecapeptide is right-handed α-helical for most of 
its length. Indeed, starting from the N-terminus, five consecutive, N-H…O=C 
intramolecularly H-bonded C13 structures (α-turns) are observed (Table 3).10 The H-
bond donors are the NH groups of residues 4 to 8, and the acceptors the Z-urethane 
carbonyl oxygen O0 and the carbonyls of residues 1 to 4, respectively. The average 
values of the backbone torsion angles for residues 1-7 are φ = -62.1°, ψ = -43.4°, very 
close to those obtained from a statistical analysis of high resolution crystal structures of 
α-helical peptides (φ = -63°, ψ = -42°).11 The N8-H group, in addition to being H-
bonded to O4 in a C13 structure, is also H-bonded to O5, thus forming a C10 structure (β-
turn) as well. 12 In this three-center H-bond arrangement, the N8-H. . .O4 interaction is 
rather elongated and distorted (Table 3).13,14 Then, the backbone folding continues as 
310-helical, in that two consecutive C10 structures are found, the H-bond donors of 
which are the N9-H and N10-H groups, and the acceptors the carbonyl oxygens of 
residues 6 and 7, respectively. The first of these two latter C10 structure is of type-III 
whereas the second is close to type-I, as the backbone torsion angles of Ala(9), which 
occupies its i+1 corner position, lie in the “bridge” region of the φ,ψ space (Table 
2).12,15 The following Aib(10) residue adopts torsion angles belonging to the left-handed 
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helical region of the conformational map. As a result of the screw sense inversion of 
Aib(10) relative to the preceding residues, the N11-H moiety, that would have been a 
donor to O8 if the backbone had continued a helical path, is located outside the helix 
now. The N11-H group is H-bonded to the cocrystallized water molecule O3W which, 
in turn, is H-bonded as the donor to the O6 carbonyl oxygen, thus forming a water-
mediated Schellman motif.18 The occurrence of such helix C-capping motif in peptides 
carrying an Aib residue at the penultimate position has been crystallographically 
documented in a number of cases,16 including a few examples in which the i+5 →i        
N-H…O=C intramolecular H-bond (C16 structure) is mediated by the insertion of a 
cocrystallized solvent (methanol) molecule.17,18 The C-terminal Ala(11) residue, with 
φ,ψ = -151.6(3)°, 50.0(3)°, adopts a quasi-extended conformation. 
The largely α-helical folding of Z-(L-Ala)3-(Aib-L-Ala)4-OH, described above, is 
closely mirrored by the structures of two peptides of comparable length based on 
alternating Aib-L-Ala  residues. Specifically, in the structure of the dodecapeptide 
pBrBz-(Aib-L-Ala)6-OMe a C10 structure at the N-terminus is encompassed within a C13 
structure that is followed by seven additional C13 structures. Then, a C10 and a C16 
structure constitute the Schellman motif that acts as the C-cap of the α-helix, with 
screw-sense inversion at the level of the penultimate Aib(11) residue.19 Similarly, both 
the dihydrate19 and the bis-DMSO solvate20 of the decapeptide pBrBz-(Aib-L-Ala)5-
OMe display five consecutive C13 structures, followed by two C10 structures and a C16 
structure, thus terminating again with a Schellman motif. It is worth noting that the 
corresponding backbone torsion angles of the four (i+1 ÷ i+4) residues encompassed 
within the H-bonded C16 structure are identical (within 6°) in the three (Aib-Ala)n 
structures, whereas in our undecapeptide much larger deviations (19° ÷ 31°) are 
observed for both φ,ψ values of residue i+3 and the ψ value of the screw-sense inverting 
residue i+4, in all probability to allow the replacement of the direct i+5 → i N-H … O=C 
intramolecular H-bond by the water-mediated C16 structure. In the packing mode, the 
N1-H group is H-bonded to the O10 carbonyl oxygen of a (-1/2+x, ½+y, -1+z) 
symmetry related molecule, while the N2-H group is connected to the same acceptor 
through the insertion of the O1W water molecule. O1W is also H-bonded, as the 
acceptor, to O2W which, in turn, is H-bonded to the N3-H group. These either direct or 
water-mediated interaction link peptide molecules, head to tail, along the abc direction. 
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In addition, one direct and one water-mediated H-bonds laterally connect peptide 
molecules along the b direction. Specifically, the C-terminal (carboxylic) O11T-H 
group is H-bonded to the O9 carbonyl oxygen of a (x, 1+y, z) molecule, and the O3W 
water molecule (inserted between the N11-H and the O6 carbonyl in the Schellman 
motif) is H-bonded to O8 (symmetry: x, 1+y, z). The remaining H-bonding donor 
capability of O1W is satisfied by a (5/2-x, -1/2+y, 2-z) symmetry equivalent of O11, 
thus indirectly connecting molecules along the ac direction,  whereas O2W donates a H-
bond to O1 (symmetry equivalence: ½+x, ½+y, 1+z). 
 
MORPHOLOGY OF THE AGGREGATE PEPTIDES IN WATER 
To assess the presence of molecular aggregates, DLS is a fast and reliable technique. 
According to our measurements (data not shown), all water-soluble Aib/Ala peptides 
previously investigated do form in water large aggregates [above to the critical 
aggregate concentration (CAC) of 15 mM], with average dimensions of which range 
from 20 to 100 nm.1,2 In this preliminary report we decided to focus on Z-(L-Ala)3-(Aib-
L-Ala)4-OMe in view of its relevant size and applications.2 DLS measurements of this 
peptide in water solution (Figure 3) clearly indicate the presence of large aggregates, of 
up to 100 nm hydrodynamic radius. These measurements, repeated several times on 
newly prepared peptide solutions, were completely reproducible. Interestingly, when 
our undecapeptide was dissolved in methanol, the DLS analysis detected structures 
about ten times smaller (2-10 nm in hydrodynamic radius), consistent with the presence 
of isolated peptide molecules and small aggregates. It is worth reminding here that the 
N-to-C length of an α-helical peptide of 11 residues does not exceed 2 nm. Therefore, 
these data clearly indicate that large, self-assembled, peptide bodies do form in water.  
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Fig. 3 DLS patterns of a 15mM Z-(Ala)3-(Aib-L-Ala)4-OMe in water 
To further evaluate the size and shape of our aggregates, aqueous solutions of Z-(L-
Ala)3-(Aib-L-Ala)4-OMe were investigated also by means of the TEM technique with 
uranyl acetate as staining agent. Spherical assemblies were observed (Figure 4), 
comparable in size to those revealed by DLS (Figure 3). Smaller spherical aggregates 
(about 10 nm) are also present (Figure 4A). They possibly represent the initial steps of 
a pathway leading to the larger aggregates.  
 
Fig. 4 TEM images of Z-(Ala)3-(Aib-L-Ala)4-OMe from an aqueous solution. The sample was stained 
negatively with uranylacetate. The scale bars represent 1000 (A),100 (B) and 50 (C) nm, respectively 
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The AFM analysis of the same peptide sample, deposited on a mica substrate, confirms 
the size (about 100 nm, Figure 5A) and, most importantly, the spherical nature (Figure 
5B) of these peptide aggregates. 
      A                                     B       
 
Fig. 5 AFM images of the Z-(Ala)3-(Aib-L-Ala)4-OMe aggregates formed in aqueous solution. The x 
axis of panel Aspansabout 0.6µm. In panel B the 3D-structure of an aggregate is reported. 
 
 
The CAC was investigated by TEM. A set of different solution of Z-(Ala)3-(Aib-L-
Ala)4-OMe at concentration of  5, 10, 15 and 20 mM in were submitted to TEM analysis 
and the results are shown in Figure 6. From the TEM results that  is clearly visible only 
from concentrations above 15 mM. 
 
 
Fig. 6 TEM images of Z-(Ala)3-(Aib-L-Ala)4-OMe at different concentrations from 
an aqueous solution. The sample was stained negatively with uranyl acetate. 
 
One possible explanation for the origin of the spherical microstructure from Z-(Ala)3-
(Aib-L-Ala)4-OMe in water solution is depicted in Figure 7. We assume that above the 
CAC the single monomers (Fig. 7/1) could “dimerized” (Fig. 7/2) as consequence of the 
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π-π stacking (non-covalent) interactions generate from the Z-group in aqueous media. 
These interaction could be extended to several dimers that induced self-assembly to 
generate fibrillar type network (Fig. 7/3). These fibrillar network are able to generate 
spherical aggregate to minimize the overall solvation energy. 
 
 
Fig. 7 Proposed mechanism of spherical micro-aggregate formation  from Z-(Ala)3-(Aib-L-Ala)4-
OMe in water solution. 
 
 
Encapsulation experiments 
We also checked the ability of the Z-(Ala)3-(Aib-L-Ala)4-OMe aggregates to 
encapsulate other molecules. As guest, we chose the water soluble, peptide-coated Au 
nanoparticles AuNps11,2 characterized by an average diameter of 6 nm (2 nm the Au 
core, 2+2 nm the helical peptide capping layer). A dark, red colored, water solution of 
AuNps11 was added to a clear and colorless water solution of Z-(Ala)3-(Aib-L-Ala)4-
OMe. To remove the free, not encapsulated, AuNps11the mixture was applied to a size-
exclusion Superdex 75 preparative column (3000-70000 Dalton, GE Healthcare Life 
Sciences). At the expected retention time, one major peak was observed, isolated and 
subsequently analyzed by means of DLS and TEM. Interestingly, the solution 
corresponding to this peak was colored, which indicates the presence of AuNps11. DLS 
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analysis of this fraction  revealed the presence of aggregates with hydrodynamic radius 
of about 100 nm (Figure 8A). As a control,the same technique gave an one order of 
magnitude smaller size for AuNps11 alone (Figure 8B). 
 
 
 
A 
B 
 
Fig. 8 DLS patterns for Z-(Ala)3-(Aib-L-Ala)4-OMe/AuNps11 aggregates (A) and AuNps11 alone 
(B) in water. 
 
 
The TEM images of the same samples (Figure 9) are in agreement with the DLS 
analysis (Figure 8). In these TEM experiments,the uranyl acetate staining was not 
needed, as the Au atoms of the encapsulated AuNps11 allowed  an easy detection. 
Figure 9A shows a TEM image of the Z-(Ala)3-(Aib-L-Ala)4-OMe/AuNps11 mixture, 
before the size-exclusion chromatography separation. It is quite clear that several 
AuNps11 have been incorporated into our undecapeptide aggregates, thus permitting 
their detection. The size (about 100 nm) of the two large bodies of  Figure 9A is in 
agreement with the values obtained from the DLS measurements (Figure 8A). On the 
58 
 
other hand, the numerous small dark spots, enlarged in the inset of Figure 9A, are 
ascribed to free, not encapsulated AuNps11, as their size (2 nm) matches that of the 
AuNps11 metal core. After size-exclusion chromatography, the small spots of free 
AuNps11 disappear (Figure 9B) as clearly seen in the expansion (Figure 9C). Under 
these conditions, only the large peptide aggregates, with the AuNps11 encapsulated, are 
observed. 
 
A                          B              C 
 
 
Fig. 9 TEM images fromaqueous solutions containing Z-(Ala)3-(Aib-L-Ala)4-OMe 
and AuNps11 before (A) with the inset of smaller spots (free AuNps11) and after (B 
and C) size-exclusion chromatography. No staining with uranyl acetate was performed. 
Thescale bars represent 100 (A), 10 (A, inset), 1000(B) and 50 (C) nm. 
       
Aggregate constituents 
Given for granted the formation  in water of large, spherical, self-assembled aggregates 
for Z-(L-Ala)3-(Aib-L-Ala)4-OMe,2 and related shorter peptides,1  the main question to 
be answered is what these aggregates are made of: only peptides or peptides and solvent 
(water)? Micelles and vesicles are two well known spherical assemblies occurring in 
Nature. For their formation, amphiphilic molecules are required. Our Aib/Ala peptides 
do not possess charges or highly polar groups, with the exception of amide N-H and 
C=O groups not intramolecularly H-bonded at the N- and C-terminus, respectively. 
Interestingly, in the undecapeptide crystal structure discussed above, the Shellman motif 
allows the occurrence of four free carbonyl oxygens, rather than three as found in a 
regular α-helix. In addition, the Shellman motif induces a kink on the peptide helix. 
These two features might be relevant for the formation of the supramolecular, self-
assembled structures observed by TEM and DLS, although at the present stage of our 
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studies we cannot formulate a precise model. In any case, micellar aggregates of Z-(L-
Ala)3-(Aib-L-Ala)4-OMe would have a diameter not larger than 5 nm, i.e. 
approximately twice the length of the peptide helix (about 2 nm). Conversely, the 
aggregates observed by DLS and TEM possess a diameter about ten times larger. Then, 
the likely formation of vesicles should be taken  into account. In this event, our 
aggregates could contain water in the inner part. To assess this possibility, we are 
planning the incorporation of appropriate spectroscopic probes into our self-assembled 
aggregates. 21,22 
 
CONCLUSIONS 
Recent reviews comprehensively explored the up-to-date research on peptide-
amphiphiles (amphiphilic peptides that can give supra-molecular aggregates in 
solution).23,24 In a review, Hamley includes the PA in two groups: (i) designed purely 
peptidic systems with amphiphilic properties arising from sequences of hydrophobic 
and hydrophilic (charged) residues, and (ii) peptides modified by attachment of 
hydrophobic lipid chains these are termed peptide amphiphiles (PAs). Peptides are 
intriguingly useful precursors for self-assembled structure design even due to the high 
number of exploitable amino acid building blocks. This free-energy driven mechanism 
of aggregation organizes molecules in a high ordered structure at multiple lenght scale. 
The tuning of self-assembly can also be ruled by controlling several environment 
parameters such as pH,25,26 solvent,27,28 metal  ions,29 and temperature.30 Peptides have 
been recognized as very useful building blocks for self-assembly nano-structures. Their 
ability to fold into a specific secondary structure provides an unique platform for the 
design of molecular nano-structure. Furthermore, the secondary structure in peptides is 
strongly controlled by the amino-acid content, even in conjugation with tailored higlhy 
hydrophilic sub-units.27  
The main contribution of this work consists in the discovery that a series of 
Aib/Ala peptides, lacking any charge or polar group, dissolve in water through the 
formation of self-assembled bodies. These aggregates are larger than a typical micelle, 
although it is not clear yet if they form vesicles or a different type of supramolecular 
structure. Our contention, supported by X-ray diffraction data, is that a hydrophilic side 
(the N- and/or the C-terminus and/or a face of the helix) of the peptide has to be located 
on the outer layer of these aggregates. Additional syntheses and experiments are 
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currently in progress in our laboratory to understand the chemical composition of these 
large, spherical structures. We are confident that our efforts will add a new tool to the 
number of possible applications envisaged for peptide self-assembled 
aggregates.21,23,24,31-33  
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EXPERIMENTAL SECTION 
 
GENERAL METHODS 
SYNTHESIS: The undecapeptide Z-(L-Ala)3-(Aib-L-Ala)4-OMe, its C-unprotected 
analogue (free COOH) and the Au nanoparticle (AuNp11) used for the encapsulation 
experiments were prepared by solution procedures as previously reported.1,2AuNp11 is 
an Au nanoparticle coated with the same peptide segment, -(L-Ala)3-(Aib-L-Ala)4-, 
responsible for the formation in water of the large aggregates described in this work.  
 
TLC: The products and intermediates have been checked on TLC plate with the following 
eluant systems: 
CHCl3/EtOH 9:1 Rf1 
1-Butanol/AcOH/H2O 3:1:1 Rf2 
toluene/EtOH 7:1 Rf3 
CD: The ECD spectra were obtained on a Jasco (Tokyo, Japan) model J-715 
spectropolarimeter. Cylindrical fused quartz cells (Hellma, Müllheim, Germany) of 0.1 
mm path length were employed. The data are expressed in terms of [θ]T, the total molar 
ellipticity (deg x cm2 x dmol-1). The solvent used was MilliQ (Millipore Corporation, 
Billerica, MA) pH 7 water.  
DLS: Dynamic Light Scattering (DLS) measurements were performed with a Malvern 
Zetasizer NanoS instrument equipped with a thermostated cell holder and Ar laser 
operating at 633 nm. Hydrodynamic particle diameters were obtained from cumulant or 
distribution fit of the autocorrelation functions collected at 178° scattering angle. Size 
measurements were performed at 25° C in water. 
TEM: The samples, prepared immediately before use by dilution of the peptide 
aggregates solution (100 times) with water and vortex, analyzed on a Jeol 300PX 
instrument. A glow discharged carbon coated grid was floated on a small drop of gel 
solution and excess was removed by #50 hardened Whatman filter paper. The grid was 
then floated on 2% uranyl acetate solution for 10 seconds, and the excess was removed 
by #50 hardened Whatman filter paper.   
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AFM: AFM images were taken using a Park Autoprobe CP instrument operating in 
contact mode in air. Samples were prepared immediately before analysis, by dilution of 
the peptide aggregates solution with water and vortex.  The topographies were acquired 
under environment conditions. The scan rate was 1.0 Hz and the force set point was the 
lowest to improve resolution at the same time minimizing damage to the samples. 
Surface morphological  investigations were performed on as-prepared samples (ca. 2×2 
cm2) obtained by drop casting the aggregate solutions at different concentrations on 
mica substrate.  
X-RAYS DIFFRACTION: Single crystals of Z-(L-Ala)3-(Aib-L-Ala)4-OH were 
grown by slow evaporation from a 2-propanol solution. X-ray diffraction data were 
collected with an Agilent Technologies Gemini E four-circle kappa diffractometer 
equipped with a 92 mm EOS CCD detector, using graphite monochromated Cu Kα 
radiation (λ = 1.54178 Å). Data collection and reduction were performed with the 
CrysAlisPro software (version 1.171.35.11, Agilent Technologies). A semi-empirical 
absorption correction based on the multi-scan technique using spherical harmonics, 
implemented in SCALE3 ABSPACK scaling algorithm, was applied. The 
measurements were accomplished by Dr. Marco Crisma, CNR-ICB, Padova. 
The structure was solved by direct methods of the SIR 2002 program.34 The 
asymmetric unit is composed of one peptide molecule and three cocrystallized water 
molecules. Refinement was carried out by full-matrix least-squares procedures on F2, 
using all data, by application of the SHELXL-97 program,35 with all non-H-atoms 
anisotropic. H-atoms of the peptide molecule were calculated at idealized positions and 
refined using a riding model. The positions of the H-atoms of the cocrystallized water 
molecules were recovered from a difference Fourier map and they were not refined. 
Relevant crystal data and structure refinement parameters are listed in Table 3. CCDC 
908157contains the supplementary crystallographic data for this paper. These data can 
be obtained from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif 
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Tab. 3  Crystal data and structure refinement for Z-(L-Ala)3-(Aib-L-Ala)4-OH trihydrate 
 
Empirical formula  C45 H77 N11 O17 
Formula weight  1044.18 
Temperature  293(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  C2 
Unit cell dimensions a = 33.2617(13) Å      α= 90° 
b = 8.4156(2) Å     β= 
124.813(6)° 
c = 24.4073(10) Å   γ = 90° 
Volume 5609.2(3) Å3 
Z 4 
Density (calculated) 1.236 Mg/m3 
Absorption coefficient 0.796 mm-1 
F(000) 2240 
Crystal size 0.50 × 0.28 × 0.04 mm3 
Theta range for data collection 2.68 to 61.02°. 
Index ranges -37 ≤ h ≤ 37, -9 ≤ k ≤ 8, -27 ≤ 
l ≤ 27 
Reflections collected 22711 
Independent reflections 7604 [R(int) = 0.0342] 
Completeness to theta = 
61.02° 
99.4 %  
Absorption correction Semi-empirical from 
equivalents 
Max. and min. transmission 1.00000 and 0.60880 
Refinement method Full-matrix least-squares on 
F2 
Data / restraints / parameters 7604 / 1 / 658 
Goodness-of-fit on F2 0.993 
Final R indices [I>2sigma(I)] R1 = 0.0413, wR2 = 0.1057 
R indices (all data) R1 = 0.0465, wR2 = 0.1102 
Absolute structure parameter -0.12(17) 
Largest diff. peak and hole 0.166 and -0.159 e.Å-3 
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SYNTHESIS AND CHARACTERIZATION 
The synthesis of shorter intermediates refer to Chapter 1.1 Here below are reported the 
sytheses of the intermediate 10-mer and the 11-mer as they were prepared. 
Z-L-Ala-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
This compound was prepared from Z-L-Ala-OH (0.16 g, 7.0·10-4 moli) and H-L-Ala-
Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (5.8·10-4 mol; obtained via cathalytic 
hydrogenation in MeOH of the Z-derivative) as previously described for Z-L-Ala-Aib-
L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe. The product precipitated from 
EtOAc/PE. Yield 98%. m.p.: 159-163°C. Rf1: 0.25;  Rf2: 0.75;  Rf3: 0.10. [α]D20: -
36.7° (c[gmL-1] =0.6, MeOH). IR (KBr): 3320, 1743, 1661, 1531 cm-1.   1H NMR (200 
MHz, CDCl3): δ 7.79-7.18 (9m, 9H, 4 Aib NH, 5 Ala NH), 7.36 (s, 5H, Z fenile), 6.97 
(d, 1H, Ala NH), 5.13 (s, 2H, Z CH2), 4.56-4.29 (2m, 2H, 2 Ala α-CH), 4.01-3.99 (m, 
4H, 4 Ala α-CH), 3.67 (s, 3H, -OMe CH3), 1.61-1.20 (m, 42H, 4 Aib 2 β-CH3, 6 Ala β-
CH3). 
Z-L-Ala-L-Ala-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe 
This compound was prepared from Z-L-Ala-OH (8.8·10-2 g, 3.4·10-4 mol) and H- L-
Ala-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe (3.3·10-4 mol; obtained 
via cathalytic hydrogenation in MeOH of the Z-derivative) as previously described for 
Z-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-Aib-L-Ala-OMe. The product precipitated 
from EtOAc/PE. Yield 70%. m.p.: 134-138°C. Rf1: 0.15;  Rf2: 0.75;  Rf3: 0.10. [α]D20: 
-10.1° (c(gmL-1) =0.4, MeOH). IR (KBr) 3230, 1740, 1662, 1531 cm-1.  1H NMR (200 
MHz, CDCl3): δ 8.10-7.20 (10m, 10H, 4 Aib NH, 6 Ala NH), 7.36 (s, 5H, Z fenile), 
7.16 (d, 1H, Ala NH), 5.18 (s, 2H, Z CH2), 4.54-4.26 (2m, 4H, 4 Ala α-CH), 4.10-3.95 
(m, 5H, 5 Ala α-CH), 3.68 (s, 3H, -OMe CH3), 1.61-1.20 (m, 45H, 4 Aib 2 β-CH3, 7 
Ala β−CH3). 
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IV 
Bis-azobenzene photoswitchable, prochiral, Cα-tetrasubstituted α-amino acids for 
nanomaterial applications 
 
INTRODUCTION 
Great interest is currently devoted to molecular or supramolecular entities that have 
access to two or more forms, the interconversion of which can be triggered by an 
external stimulus.1 Several switching systems have been reported which are based on 
photochromic behaviour, resulting in optical control of chirality, fluorescence, 
intersystem crossing, electrochemically and photochemically induced changes in liquid 
crystals, thin films and membranes.2 The design of molecular compounds that exhibit 
photoinduced magnetization and magnetic transitions is one of the main challenges in 
the field of materials science because of their possible application to future optical 
memory and switching devices.3 Hence, the construction of a new class of optically 
switchable magnetic compounds that exhibit both large magnetization changes and 
ferromagnetic order even at room temperature is nowadays an issue of great potential.3a-
c, 4 Particularly interesting are photoactive molecules formed on the surface of gold, 
silver, and platinum nanoparticles. Due to the high surface-to-volume ratio, the 
concentration of photoactive compounds compared to the number of gold atoms allows 
for standard characterization techniques such, as UV/Vis or FTIR absorption 
spectroscopy, to be employed to detect photochromic switching.3b Azobenzenes were 
among the first photochromic switches used and are still subject of extensive 
investigation.5 Their cis- and trans (hereafter termed c and t)-isomers have a different 
spatial arrangement of the aromatic moieties, and consequently show significantly 
different physical and chemical properties, including dipole moments. We are currently 
expanding this field by developing a novel family of Cα-tetrasubstituted α-amino acids, 
characterized by two azobenzene moieties covalently linked to their α-carbon atom, to 
be exploited as photo-responsive building-blocks able to drive conformational and other 
stereochemical changes even if conjugated with other molecules. These compounds are 
based on the symmetrical di[4-(phenylazo)benzyl]glycine (pDazbg), and its 3-
(phenylazo)benzyl analogue (mDazbg).  
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RESULTS AND DISCUSSION 
As a first step, we synthesized  the two Cα-tetrasubstituted α-amino ethylesters, H2- 
pDazbg-OEt (1) and H2-mDazbg-OEt (2), as illustrated for the former compound in 
Scheme 1 (for synthetic details, see experimental section). The key step (iv), the double 
alkylation of ethyl isocyanoacetate with (E)-1-[4-(bromomethyl)phenyl]-2-
phenyldiazene, was performed in excellent yield and the product was easily isolated. 
Next, treatment of the ethyl 2-isocyano derivative with concentrated HCl in ethanol 
gave 1 as the ammonium salt, which, in turn, by acidic hydrolysis, quantitatively 
afforded the related pDazbg free Cα-tetrasubstituted α-amino acid. The synthesis of (2) 
was performed in a similar way, starting from 3-aminobenzoic acid and nitrosobenzene 
(for synthetic details, see SI). By slow evaporation of a CH2Cl2/TFA (trifluoroacetic 
acid) solution of 1 we were able to grow single crystals, suitable for X-ray diffraction 
analysis (Figure 1). The backbone of the α-amino ethyl ester adopts an extended 
conformation [N1-C1A-C1-OT (ψT) torsion angle -179.8(3)°], which allows the 
presence of an intra-residue H-bond (C5 form) between the N1-H1B group and the O1 
carbonyl oxygen.  
 
 
Fig. 1 A) Synthesis of 1. Reagents and conditions: (i) AcOH, nitosobenzene, rt, 24 h, 80 %; (ii) THF, 
LiAlH4, rt, 24 h, 93%; (iii) triphenylphosphine, N-bromosuccinimide, CH2Cl2, rt, 12 h, 91%; (iv) ethyl 
isocyanoacetate, tetrabutylammonium bisulfate, K2CO3, 50 ºC, 24 h, 96%; (v) HCl, EtOH, rt, 2 h, 100 %. 
B) X-ray diffraction structure of the “albatross-like“ compound 1. 
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The occurrence of the fully-extended conformation has been crystallographically 
documented for other Cα,α-symmetrically disubstituted glycines, including Dbg, in 
simple derivatives and peptides.[6] The χ1 torsion angles about the C1A–C1B1 (pro-S 
side-chain) and C1A–C1B2 (pro-R side chain) bonds are in the g+ [62.9(3)°] and the g- 
[-62.7(3)°] disposition, respectively. The two azobenze mojetis are in that conformation. 
The two side chain extend essentially flat, the angle between normals to the benzyl and 
phenyl ring being 10.3° and 2.6° for the pro-S and the pro-R chain, respectively. 
Interestingly, the distance between the carbon atoms, terminal to the two side chains, is 
20.29 Å. In the second part of our study, we investigated the switch properties induced 
by light on the two thiol-containing compounds [trityl (Trt)-protected 
mercaptopropionic acid] Trt-S-(CH2)2-CO-pDazbg-OH (3) (Figure 2) and Trt-S-
(CH2)2-CO-mDazbg-OH (4) (for synthetic details, see SI). We choose this thiol for 
subsequent studies that take advantage of these compounds as capping layer for metallic 
nanoparticles. These compounds were characterized by UV-Vis spectroscopy, NMR 
and reverse-phase HPLC. We found that both 3 and 4 undergo multiple, reversible 
isomerizations (Figure 2) in a variety of solvents by irradiation with Vis light (450 nm 
to t) or UV light (350 nm to c).  However, when both compounds are dispersed in a 
paraffin medium, their photoswitch processes are blocked. Interestingly, using HPLC 
and NMR, we were also able to detect an intermediate state in the interconversion 
pathway (in which only one of the two azobenzene undergoes isomerization), namely 
the racemate of the t/c and t/c conformations (Figure 2). Specifically, two 0.1 mM 
solutions in MeOH (as well in several different solvents, data not shown) one containing 
3 and the other 4 were separately irradiated under multiple cycles at two different 
wavelengths, 350 and 450 nm. Under Uv irradiation at 350 nm, we observed in both 
samples  that the strong absorption maximum at 356 nm, typical for the trans form of 
azobenzene moieties, rapidly decreases in intensity, while the weak absorption band at 
450 nm concomitantly increases (figure 2 II). The opposite phenomenon takes place 
when the samples were subsequently illuminated with visible light. 
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Fig.2. (I) Mechanism of light driven isomerization for 3 (same mechanism, not shown for 4). (II) Uv-vis 
absorption  spectra of the multiple, reversible, c/t isomerization of 3, in a 0.1 mM in MeOH solution, and 
(inset) HPLC profile of the 2-min irradiated (at 350 nm) solution. (III) The 2D-NMR spectrum run after 
2-min irradiation at 350 nm (HPLC profiles B), shows the concomitant presences of three isomeric 
species. 
 
As detected by HPLC, the conversion from the t form to the c form and vice versa, goes 
through an intermediate (Figure 2 II, inset). We associate this intermediate to the 
isomerization of only one of the two azobenzene side chains. As a consequence of this 
limited photoswitch, the Cα-atom becomes chiral, and therefore a mixture of two 
enantiomers is generated. To confirm our hypothesis of “mono” isomerization, we 
carried out (DQF) COSY NMR experiments on the all-t compound, its all- c isomer, 
and on a 1:1:1 mixture of all-t, t/c, and c/t isomers genarated by 2-min irradiation with 
UV light. In this latter case (Figure 2 III), the NMR spectrum provides clear evidence 
for the occurrence of three independent species in a photo-stationary equilibrium.  This 
phenomenon was further, albeit indirectly, demonstrated by investigating the 
photoisomerization of the chiral dipeptide containing one bis-azobenzeneresidue 
(pDazbg) coupled with H-L-Leu-OMe, namely H-pDazbg-L-Leu-OMe (5). In this case, 
due to the presence of L-Leu, the intermediate species generated upon isomerization of 
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a single azobenzene unit are diastereomers, H-(R)-pazoDbg-L-Leu-OMe and H-(S)-
pazoDbg-L-Leu-OMe (Figure 3), and should therefore be distinguishable in the HPLC 
and NMR experiments.  
 
Fig. 3 (I) Mechanism of light-driven isomerization for 5.  (II) The 2D-NMR spectrum run after 3-min of irradiation at 
350 nm (HPLC profile shown in the inst) highlights the concomitant presence of four isomeric species. 
A solution of compound 5 in MeOH in the all-t conformation was prepared and the 
isomerization process under irradiation with UV light was followed by HPLC (Figure 3 
II). Beside the two peaks corresponding to the all-t and all-c forms, two additional 
peaks of similar intensity were detected and assigned to the diastereomeric dipeptides 
exhibiting each azobenzene group of the pazoDbg residue in a different isomeric state, 
that is, the t/c and c/t species in Figure 3 I. This “mono” isomerization step was also 
analyzed by DQF-COSY experiments on a ≈ 1:1:1:1 mixture of all four isomers (Figure 
3 II). This study demonstrated that the remote L-Leu stereocenter affects all of the 
diastereotopic -CβH2- protons, which resulted in a further splitting of the DQF COSY 
cross-peak patterns as compared to those in Figure 2 III. Indeed, these experiments 
provide evidence for the presence of four independent species in a photo-stationary 
equilibrium.  
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The behavior of different metal nanoparticles conjugated with 3 was next investigated. 
Au, Ag and Pt nanoparticles (Figure 4 I) were prepared by chemical reduction (with 
NaBH4) of HAuCl4, AgNO3 and H2PtCl6, respectively, in a CHCl3/methanol/water 
mixture in the presence of 3.8 According to our TEM analysis (Figure 4 II) spherical 
Ag, Au and Pt nanoparticles (1.5–4 nm diameter) were obtained. Formation of the 3-
conjugated nanoparticles was confirmed by the UV-Vis absorption spectra, where weak  
Fig.4 Light-driven isomerization of the 3-conjugated metal nanoparticles. (I) Representations of 
AuNp-3 (left), AgNp-3 (center) and PtNp-3 (right). (II) Representative TEM micrographs. (III) UV-
Vis absorption spectra of the c↔t isomerization of Ag, Au, Pt nanoparticles capped with 3 in MeOH. 
Colors of the curves match those of the corresponding nanoparticle-conjugates in part (I). (IV) UV-
Vis absorption spectra for the c↔t isomerization of AuNp-3 in a paraffin medium (solid state). (V) 
1H-NMR spectra of AuNp-3 run after different times of irradiation: (a) 0 min, all-t; (b) 6-min 
irradiation at 350 nm; (c) 10-min irradiation at 350 nm, all-c; and (d) 20-min irradiation at 450 nm. 
(VI) 1H-NMR spectra of PtNp-3 run after different times of irradiation: (a) 0 min, all-t; (b) 6-min 
irradiation at 350 nm; (c) 10-min irradiation at 350 nm, all-c; and (d) 20-min irradiation at 450 nm. 
 
72 
 
Bis-Azobenzene Photoswitchable, Prochiral, Cα-Tetrasubstituted α-Amino Acids 
 
(due to the small nanoparticle size and the large absorption coefficient of the 
azobenzene moieties) metal-dependent plasmonic bands were observed. The 
photoswitch behavior of the conjugates was initially investigated by UV-Vis 
spectroscopy in solution (Figure 4 III), which allowed us to follow the reversible 
isomerization process. Then, the Au nanoparticles (AuNp-3) were examined in the solid 
state (dispersed in a paraffin medium; Figure 4 IV), where the photoinduced molecular 
switch was clearly seen over several cycles of irradiation. For the AuNp-3 and Pt 
nanoparticles (PtNp-3) the c↔t isomerization was also studied by NMR (Figures 4V 
and 4 VI) and HPLC (Figure 5).  
In the NMR experiments, part of the complex envelope of broad peaks, corresponding 
to the aromatic protons of both metallic nanoparticles, showed a significant upfield shift 
during the irradiation process at 350 nm. The irradiation was stopped after 10 min, when 
the NMR spectra did not change anymore. Then, the NMR tube was irradiated with Vis 
light for 20 min. At this point, the new NMR signals were almost superimposable to 
those in the initial spectra recorded before UV irradiation. Monitoring the isomerization 
process by HPLC (Figura 5), it was found that the peak corresponding to the all-t form 
of AuNp-3 (and PtNp-3 as well) changed its retention time under UV irradiation.  
 
Fig. 5 HPLC profiles for AuNP-3 (left: function of time exposure at 350nm) and PtNp-3 (right), for the 
light-driven trans to cis isomerization process. 
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As recently reported by Einaga and co-workers,3a-c azobenzene passivated gold 
nanoparticles show a “controlled” ferromagnetism.9 They demonstrated that this 
property can be selectively modulated by alternating photoillumination with UV and 
Vis light (that is, by exploiting c↔t isomerization) in the solid state. Based on this 
result, we investigated the magnetic susceptibility χ of AuNp-3 by solution-state NMR 
at room temperature.10 The method is based on the fact that the resonance frequency for 
a given nucleus depends, among other factors, upon the volume susceptibility of the 
medium. We used tert-butanol as the inert indicator compound and CD3OH as the 
solvent, and focused our attention on AuNp-3. This conjugate was subjected to 
sequential irradiation at 350 nm (5 time points), 450 nm (3 time points) and again 350 
nm (3 time points). The resulting chemical shifts for the tert-butanol CH3 protons (inner 
and outer NMR tubes) are reported in Figure 5. The modulation of χ as a consequence 
of irradiation is proportional to the relative difference (in Hz) between the two signals. 
It is clear from the graph that the behavior of χ is strongly correlated to the 
isomerization of 3 (as a grafted ligand). In detail, starting from the all-t conformation for 
AuNp-3, upon irradiation at 350 nm the value of χ increased to a maximum 
corresponding to the all-c conformation (this value did not change under prolonged 
photoillumination). Then, upon irradiation at 450 nm, the χ value reversibly decreased, 
down to almost its initial value. This behavior was reproducible for several switches (2 
cycles are shown in Figure 6) between the UV and Vis irradiation wavelengths. 
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Fig. 6 Modulation of the magnetic susceptibility of AuNp-3. Outer compartment (tube A): 4% tert-
butanol in CD3OH. Inner compartment (tube B): 4% tert-butanol and 2.5 mg/ml AuNp-3 in CD3OH (the 
resonance signals of CD3OH are not shown). Spectrum 1, all-t conformation for AuNp-3. From spectrum 
2 to spectrum 5, four different periods of irradiation with UV light. Spectra 6 and 7 were recorded after 
two different times of irradiation with Vis light. Spectra 8 and 9 were recorded after two different times of 
irradiation with UV light. 
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EXPERIMENTAL SECTION 
 
 
GENERAL METHODS 
NMR: 1H spectra were recorded at room temperature on a Bruker AV-400 (400 MHz) 
or a Bruker AC-300 (300 MHz) instrument using the partially deuterated solvent or 
TMS as internal references. The multiplicity of a signal is indicated as: s - singlet, d - 
doublet, t - triplet, q - quartet, m - multiplet (br stands for broad). Chemical shifts (δ) are 
expressed in ppm and coupling constants (J) in Hertz. 
FT-IR: FT-IR spectra were recorded with a Perkin-Elmer 1720X or a Nicolet Avatar 
360 FTIR spectrophotometer; ν max is given for the main absorption bands. 
Mass Spectrometry: High-resolution mass spectra were obtained by electrospray 
ionization (ESI) on a Perseptive Biosystem Mariner ESI-TOF or a Bruker Microtof-Q 
spectrometer. 
HPLC: The HPLC measurements were performed using an Agilent 1200 series 
apparatus, equipped with a UV detector at variable wavelengths. For compounds 3, 4, 
and 5 HPLC conditions: Phenomenex C18 (100 Å) (stationary phase), 10–70% B, 25 
min, 1 ml/min (eluents: A = water/acetonitrile 9/1, 0.05% TFA; B = water/acetonitrile 
1/9, 0.05% TFA). For compounds AuNp-3 and PtNp-3 HPLC conditions: Phenomenex 
Onyx Monolithic C18 (stationary phase), 15–75% B, 25 min, 1 ml/min. (eluents: A = 
water/isopropanol 9/1, 0.1% TFA; B = water/isopropanol 1/9, 0.1% TFA). 
UV-Vis Absorption: The electronic absorption spectra were recorded using a Shimadzu 
model UV-2501 PC spectrophotometer. A 1 cm path length quartz cell was used. 
TEM: Samples were analyzed on a Jeol 300PX instrument. Samples were prepared 
before used, by 100 times dilution of a 2mg/ml MeOH solution of AuNp-3, AgNp-3, or 
PtNp-3. A glow discharged carbon coated grid was floated on a small drop of gel 
solution and excess was removed by #50 hardened Whatman filter paper.  
X-RAY DIFFRACTION: X-ray diffraction data were collected with an Oxford 
Diffraction Gemini E four-circle kappa diffractometer equipped with a 92 mm EOS 
CCD detector, using graphite monochromated Cu Kα radiation (λ = 1.54178 Å). The 
sample to detector distance was 50 mm. A total of 1344 frames were collected by 1.0° 
omega oscillation with exposure times of 1.5, 4, or 70 s, depending on the theta values, 
in the 4.11°–68.46° theta range. Data collection and reduction were performed with the 
CrysAlisPro software (version 1.171.33.52; Oxford Diffraction). A semi-empirical 
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absorption correction based on the multi-scan technique using spherical harmonics, 
implemented in SCALE3 ABSPACK scaling algorithm, was applied. The structure was 
solved by ab initio procedures of the SIR 2002 program,11 and refined by full matrix 
least squares on F2, using all data, by application of the SHELXL 97 program,12with all 
non-H atoms anisotropic. All phenyl rings were constrained to the idealized geometry. 
The positions of the H-atoms of the N-terminal free amino group were estimated by 
performing a rotational search of the electron density in the expected cone on the N 
atom and were not refined. All of the remaining H-atoms were calculated at idealized 
positions and refined using a riding model. Relevant crystallographic data and 
diffraction parameters are reported in Table 2. CCDC 832775 contains the 
supplementary crystallographic data for this paper. These data can be obtained from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif 
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SYNTHESIS AND CHARACTERIZATION 
All reagents from commercial suppliers were used without further purification. Thin-
layer chromatography (TLC) was performed on Macherey-Nagel Polygram syl G/UV 
precoated silica gel polyester plates. The products were visualized by exposure to UV 
light (254 nm), iodine vapour or submersion in ninhydrin or cerium molybdate stain 
[aqueous solution of phosphomolybdic acid (2%), CeSO4·4H2O (1%) and H2SO4 (6%)]. 
Column chromatography was performed using Macherey-Nagel 60Å silica gel. 
 
SYNTHESIS OF H-pazoDbg-OEt (1) 
 
p-(Phenylazo)benzoic acid (6) 
A solution of nitrosobenzene (2.00 g, 18.69 mmol) in glacial acetic acid (20 mL) was 
added to a suspension of p-aminobenzoic acid (3.07 g, 22.43 mmol) in glacial acetic 
acid (15 mL) and the mixture was stirred at room temperature for 24 h. The solvent was 
evaporated to dryness and the residue was suspended in water and lyophilized. 
Recrystallization from ethyl acetate afforded pure 6 as an orange solid (3.37 g, 14.91 
mmol, 80% yield). M.p. 247 ºC. IR (KBr) ν 3200–2300, 1678, 1429, 1289 cm–1. 1H 
NMR (DMSO-d6, 400 MHz) δ 7.56–7.65 (m, 3H); 7.88–7.99 (m, 4H); 8.10–8.17 (m, 
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2H); 13.13 (brs, 1H). HRMS (ESI) C13H9N2O2 [M–H]–: calcd. 225.0670, found 
225.0661. 
p-(Phenylazo)benzyl alcohol (7) 
A solution of 6 (3.05 g, 13.50 mmol) in anhydrous THF (60 mL) was added in small 
portions to a suspension of LiAlH4 (616mg, 16.20 mmol) in anhydrous THF (40 mL) 
kept at 0 ºC under an argon atmosphere. The reaction mixture was allowed to warm to 
room temperature and stirred for 24 h. The system was then cooled to 0 ºC and water 
(0.6 mL) was added slowly, followed by 10% aqueous NaOH (1.2 mL) and additional 
water (2 mL). The salts were eliminated by filtration through Celite and the resulting 
solution was dried over MgSO4. The crude product obtained by evaporation of the 
solvent was chromatographed (eluent: hexanes/ethyl acetate 6/4) to give pure 7 as an 
orange solid (2.65 g, 12.52 mmol, 93% yield). M.p. 142 ºC. IR (KBr) ν 3303, 1441, 
1023 cm–1. 1H NMR (CDCl3, 400 MHz) δ 1.85 (brs, 1H); 4.78 (s, 2H); 7.44–7.55 (m, 
5H); 7.90–7.94 (m, 4H). HRMS (ESI) C13H13N2O [M+H]+: calcd. 213.1022, found 
213.1017. 
p-(Phenylazo)benzyl bromide (8) 
To a solution of 7 (2.63 g, 12.40 mmol) in anhydrous THF (60 mL) kept at 0 ºC, 
triphenylphosphine (4.87 g, 18.60 mmol) and N-bromosuccinimide (3.31 g, 18.60 
mmol) were added in small alternate portions and the reaction system was stirred at 
room temperature overnight. The insoluble material was eliminated by filtration through 
a small pad of silica gel and washed thoroughly with THF. The filtrates were evaporated 
and the residue obtained was purified by column cromatography (eluent: hexanes/ethyl 
acetate 8/2) to afford pure 8 as an orange solid (3.11 g, 11.32 mmol, 91% yield). M.p. 
121 ºC. IR (KBr) ν 1577, 1482, 1438, 687 cm–1. 1H NMR (CDCl3, 400 MHz) δ 4.56 
(s, 2H); 7.48–7.56 (m, 5H); 7.88–7.94 (m, 4H). HRMS (ESI) C13H12BrN2 [M+H]+: 
calcd. 275.0178, found 275.0168. 
Ethyl bis[p-(phenylazo)benzyl]isocyanoacetate (9) 
A solution of ethyl isocyanoacetate (600 mg, 5.31 mmol) in acetonitrile (70 mL) was 
treated with finely powdered K2CO3 (4.40 g, 31.86 mmol), tetrabutylammonium 
bisulfate (541 mg, 1.59 mmol) and 8 (3.65 g, 13.27 mmol). The resulting heterogeneous 
mixture was heated at 50 ºC with vigorous stirring for 24 h. The solvent was evaporated 
to dryness and the residue was partitioned between dichloromethane (80 mL) and water 
(60 mL). The aqueous layer was discarded and the organic phase was dried and filtered. 
Removal of the solvent followed by column cromatography (eluent: hexanes/ethyl 
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acetate 8/2) afforded pure 9 as an orange solid (2.55 g, 5.09 mmol, 96% yield). M.p. 
157 ºC. IR (KBr) ν 2133, 1728, 1439, 1238, 1107 cm–1. 1H NMR (CDCl3, 400 MHz) δ 
1.09 (t, 3H, J = 7.1 Hz); 3.19 (d, 2H, J = 13.5 Hz); 3.48 (d, 2H, J = 13.5 Hz); 4.10 (q, 
2H, J = 7.1 Hz); 7.44–7.55 (m, 10H); 7.88–7.95 (m, 8H). HRMS (ESI) C31H28N5O2 
[M+H]+: calcd. 502.2238, found 502.2222. 
Ethyl bis[p-(phenylazo)benzyl]glycinate (H-pazoDbg-OEt, 1) 
Concentrated HCl (8 mL) was added dropwise to a suspension of 9 (2.40 g, 4.80 mmol) 
in ethanol (80 mL) kept at 0 ºC and the reaction mixture was stirred at room temperature 
for 2 h. The solvent was evaporated and the residue was taken up in water and 
lyophilized to afford 1 as a solid (2.53 g, 4.80 mmol, 100% yield). M.p. 120 ºC. IR 
(KBr) ν 3434, 1740, 1444, 1220, 1108 cm–1. 1H NMR (DMSO-d6, 400 MHz) δ 1.27 (t, 
3H, J = 7.1 Hz); 3.40 (d, 2H, J = 13.9 Hz); 3.48 (d, 2H, J = 13.9 Hz); 4.26 (q, 2H, J = 
7.1 Hz); 7.52–7.64 (m, 10H); 7.85–7.91 (m, 8H); 8.80 (brs, 3H). HRMS (ESI) 
C30H30N5O2 [M+H]+: calcd. 492.2394, found 492.2391. 
 
SYNTHESIS OF H-mazoDbg-OEt (2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
Bis-Azobenzene Photoswitchable, Prochiral, Cα-Tetrasubstituted α-Amino Acids 
 
m-(Phenylazo)benzoic acid (10) 
A solution of nitrosobenzene (4.00 g, 37.38 mmol) in glacial acetic acid (45 mL) was 
added to a suspension of maminobenzoic acid (6.15 g, 44.86 mmol) in glacial acetic 
acid (30 mL) and the mixture was stirred at room temperature for 48h. The solvent was 
evaporated to dryness and the residue was suspended in water and lyophilized. 
Recrystallization from ethyl acetate afforded pure 10 as a brown solid (6.33 g, 28.01 
mmol, 75% yield). M.p. 168 ºC. IR (KBr) ν 3300–2100, 1681, 1419, 1311 cm–1. 1H 
NMR (CDCl3, 400 MHz) δ 7.48–7.58 (m, 3H); 7.62–7.68 (m, 1H); 7.94–8.00 (m, 2H); 
8.15–8.26 (m, 2H); 8.67 (m, 1H). HRMS (ESI) C13H9N2O2 [M–H]–: calcd. 225.0670, 
found 225.0666. 
m-(Phenylazo)benzyl alcohol (11) 
A solution of 10 (2.96 g, 13.11 mmol) in anhydrous THF (60 mL) was added in small 
portions to a suspension of LiAlH4 (598mg, 15.73 mmol) in anhydrous THF (40 mL) 
kept at 0 ºC under an argon atmosphere. The reaction mixture was allowed to warm to 
room temperature and then heated at 40 ºC for 72 h. The system was cooled to 0 ºC and 
water (0.6 mL) was added slowly, followed by 10% aqueous NaOH (1.2 mL) and 
additional water (2 mL). The salts were eliminated by filtration through Celite and the 
resulting solution was dried over MgSO4. The crude product obtained by evaporation of 
the solvent was chromatographed (eluent: hexanes/ethyl acetate 8/2) to give pure 11 as 
an orange solid (1.75 g, 8.25 mmol, 63% yield). M.p. 45 ºC. IR (KBr) ν 3356, 1446, 
1087 cm–1. 1H NMR (CDCl3, 400 MHz) δ 1.77–1.93 (m, 1H); 4.70–4.75 (m, 2H); 
7.37–7.49 (m, 5H); 7.76–7.88 (m, 4H). HRMS (ESI) C13H12N2NaO [M+Na]+: calcd. 
235.0842, found 235.0840. 
m-(Phenylazo)benzyl bromide (12) 
To a solution of 11 (1.74 g, 8.20 mmol) in anhydrous THF (60 mL) kept at 0 ºC, 
triphenylphosphine (3.22 g, 12.30 mmol) and N-bromosuccinimide (2.19 g, 12.30 
mmol) were added in small alternate portions and the reaction system was stirred at 45 
ºC overnight. The insoluble material was eliminated by filtration through a small pad of 
silica gel and washed thoroughly with THF. The filtrates were evaporated and the 
residue obtained was purified by column cromatography (eluent: hexanes/ethyl acetate 
9/1) to afford pure 12 as an orange solid (2.02 g, 7.33 mmol, 89% yield). M.p. 39 ºC. 
IR (KBr) ν 1630, 1460, 1441, 690 cm–1. 1H NMR (CDCl3, 400 MHz) δ 4.59 (s, 2H); 
7.47–7.56 (m, 5H); 7.85–7.96 (m, 4H). HRMS (ESI) C13H12BrN2 [M+H]+: calcd. 
275.0178, found 275.0178. 
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Ethyl bis[m-(phenylazo)benzyl]isocyanoacetate (13) 
A solution of ethyl isocyanoacetate (300 mg, 2.65 mmol) in acetonitrile (50 ml) was 
treated with finely powdered K2CO3 (2.19 g, 15.90 mmol), tetrabutylammonium 
bisulfate (270 mg, 0.80 mmol), and 12 (1.53 g, 5.57 mmol). The resulting 
heterogeneous mixture was heated at 50 ºC with vigorous stirring for 48 h. The solvent 
was evaporated to dryness and the residue was partitioned between dichloromethane (60 
mL) and water (40 mL). The aqueous layer was discarded and the organic phase was 
dried and filtered. Removal of the solvent followed by column chromatography (eluent: 
hexanes/ethyl acetate 8/2) afforded pure 13 as an orange solid (1.16 g, 2.31 mmol, 87% 
yield). M.p. 80 ºC. IR (KBr) ν 2134, 1752, 1445, 1195, 1089 cm–1. 1H NMR (CDCl3, 
400 MHz) δ 1.10 (t, 3H, J = 7.1 Hz ); 3.23 (d, 2H, J = 13.6 Hz); 3.53 (d, 2H, J = 13.6 
Hz); 4.11 (q, 2H, J = 7.1 Hz); 7.42–7.55 (m, 10H); 7.81–7.92 (m, 8H). HRMS (ESI) 
C31H28N5O2 [M+H]+: calcd. 502.2238, found 502.2237. 
Ethyl bis[m-(phenylazo)benzyl]glycinate (H-mazoDbg-OEt, 2) 
Concentrated HCl (4 mL) was added dropwise to a suspension of 13 (1.12 g, 2.24 
mmol) in ethanol (40 mL) kept at 0 ºC and the reaction mixture was stirred at room 
temperature for 2 h. The solvent was evaporated and the residue was taken up in water 
and lyophilized to afford 2 as a solid (1.18 g, 2.24 mmol, 100% yield). M.p. 100 ºC. IR 
(KBr) ν 3451, 1744, 1447, 1094 cm–1. 1H NMR (DMSO-d6, 400 MHz) δ 1.30 (t, 3H, J 
= 7.1 Hz); 3.43 (d, 2H, J = 14.0 Hz); 3.52 (d, 2H, J = 14.0 Hz); 4.26 (q, 2H, J= 7.1 Hz); 
7.50–7.64 (m, 10H); 7.82–7.90 (m, 8H); 8.80 (brs, 3H). HRMS (ESI) C30H30N5O2 
[M+H]+: calcd. 492.2394, found 492.2398. 
 
SYNTHESIS OF Trt-S-(CH2)2-CO-pazoDbg-OH (3) 
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A 2N solution of KOH in ethanol (2 mL) and water (1 mL) were added to a suspension 
of 1 (639mg, 1.21 mmol) in ethanol (30 mL) and the reaction mixture was stirred at 40 
ºC for 48 h. The  solvent was evaporated and the residue was suspended in water (30 
mL), neutralized with 2N HCl and extracted with dichloromethane (3 × 20 mL). The 
combined organic layers were dried over MgSO4 and filtered. The yellow solid (400 
mg, 0.86 mmol) isolated by evaporation of the solvent was dissolved in dry DMF (5 
mL). N,N-Diisopropylethylamine (300 μl, 1.72 mmol) was added and the solution 
obtained was kept for the next step. Separately, S-(Trityl)-3-mercaptopropionic acid 
(440 mg, 1.30 mmol) and cyanuric chloride (380 mg, 2.01 mmol) were dissolved in dry 
dichloromethane (15 ml) at 0 oC. Pyridine (101 μl, 1.3 mmol) was added dropwise to 
this solution at room temperature and the resulting suspension was vigorously stirred for 
30 min. Then, the DMF solution previously prepared from 1 was slowly added to this 
suspension and the mixture was stirred at room temperature for 48 h. After removal of 
the solvent, the residue was dissolved in ethyl acetate and washed successively with 
10% KHSO4, water, 5% NaHCO3, 0.5N HCl and water, dried over Na2SO4, and 
evaporated to dryness. Purification by column chromatography (eluent: 
chloroform/ethanol 95/5) afforded pure 3 (430 mg, 0.54 mmol, 63% yield). M.p. 220 
°C. IR (KBr): ν 3341, 1674, 1665, 1521, 1442 cm-1. 1H NMR (CDCl3, 300 MHz) δ 
1.85 (t, 2H, J = 8.6 Hz); 2.59 (t, 2H, J = 8.6 Hz); 3.33 (d, 2H, J = 15.9 Hz); 4.10 (d, 2H, 
J = 15.9 Hz); 5.95 (s, 1H); 7.17–7.29 (m, 10H); 7.40–7.47 (m, 15H); 7.72–7.88 (m, 8H). 
HRMS (ESI) C50H44N5O3S [M+H]+: calcd. 794.3086, found 794.3078. 
 
SYNTHESIS OF Trt-S-(CH2)2-CO-mazoDbg-OH (4) 
 
Trt-S-(CH2)2-CO-mazoDbg-OH (4) 
A 2N solution of KOH in ethanol (1 mL) and water (1mL) were added to a solution of 2 
(294 mg, 0.56 mmol) in ethanol (20 mL) and the reaction mixture was stirred at 40 ºC 
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for 48 h. The solvent was evaporated and the residue was suspended in water (30 mL), 
neutralized with 2N HCl and extracted with dichloromethane (3 × 15 mL). The 
combined organic layers were dried over MgSO4 and filtered. The yellow solid (260 mg, 
0.39 mmol) isolated by evaporation of the solvent was dissolved in dry DMF (5 mL). 
N,N-Diisopropylethylamine (140 μl, 0.8 mmol) was added and the solution obtained 
was kept for the next step. Separately, S-(Trityl)-3-mercaptopropionic acid (200 mg, 
5.78 mmol) and cyanuric chloride (171 mg, 0.92 mmol) were dissolved in dry 
dichloromethane (10 ml) at 0 oC. Pyridine (44 μl, 5.78 mmol) was added dropwise to 
this solution at room temperature and the resulting suspension was vigorously stirred for 
30 min. Then, the DMF solution previously prepared from 2 was slowly added to this 
suspension and the mixture was stirred at room temperature for 4 days. After removal of 
the solvent, the residue was dissolved in ethyl acetate and washed successively with 
10% KHSO4, water, 5% NaHCO3, 0.5N HCl and water, dried over Na2SO4, and 
evaporated to dryness. Purification by column chromatography (eluent: 
chloroform/ethanol 95/5) afforded pure 4 (177 mg, 0.22 mmol, 57% yield). M.p. 180 
°C. IR (KBr): ν 3335, 1672, 1661, 1526, 1444 cm-1. 1H NMR (CDCl3, 600 MHz) δ 
1.79 (t, 2H, J = 9.0 Hz); 2.15 (t, 2H, J = 9.0 Hz); 3.33 (d, 2H, J = 12.0 Hz); 3.58 (d, 2H, 
J = 12.0 Hz); 6.99 (s, 1H); 7.16–7.33 (m, 19H); 7.52–7.65 (m, 10H); 7.80–7.83 (m, 4H). 
HRMS (ESI) C50H44N5O3S [M+H]+: calcd. 794.3086, found 794.3076. 
 
SYNTHESIS OF H-pazoDbg-L-Leu-OMe (5) 
A 2N solution of KOH in ethanol (2 mL) and water (1 mL) were added to a suspension 
of 1 (483 mg, 0.92 mmol) in ethanol (30 mL) and the reaction mixture was stirred at 40 
ºC for 48 h. The solvent was evaporated and the residue was suspended in water (30 
mL), neutralized with 2N HCl and extracted with dichloromethane (3 × 20 mL). The 
combined organic layers were dried over MgSO4 and filtered. After evaporation of the 
solvent, the solid obtained (300 mg, 0.65 mmol) was dissolved in dry DMF (5 mL) at 0 
oC and HATU (230 mg, 0.61 mmol), HOAt (82 mg, 0.61 mmol) and N,N-
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diisopropylethylamine (250 μl, 1.30 mmol) were added. Then, a solution of H-L-Leu-
OMe hydrochloride (550 mg, 3.25 mmol) and N,N-diisopropylethylamine (610 μl, 3.3 
mmol) in dry DMF (10 mL) was slowly added and the mixture was stirred at room 
temperature for 24 h. After removal of the solvent, the oily residue was dissolved in 
ethyl acetate and washed successively with 10% KHSO4, water, 5% NaHCO3, 0.5N 
HCl and water, dried over Na2SO4, and evaporated to dryness. Purification by column 
chromatography (eluent: chloroform/methanol 95/5) afforded pure 5 (351 mg, 0.59 
mmol, 91% yield). M.p. 138 °C. IR (KBr) ν 3387, 1729, 1672, 1663, 1522, 1441 cm-1. 
1H NMR (CDCl3, 300 MHz) δ 0.76 (d, 3H, J = 7.8 Hz); 0.83 (d, 3H, J = 7.5 Hz); 1.20–
1.46 (m, 3H); 2.79 (d, 1H, J = 15.9 Hz); 2.92 (d, 1H, J = 15.9 Hz); 3.53 (d, 1H, J = 15.9 
Hz); 3.60 (d, 1H, J = 15.9 
Hz) overlapped with 3.61 (s, 3H); 4.44–4.50 (m, 1H); 7.33–7.54 (m, 11H); 7.81–7.92 
(m, 8H). HRMS (ESI) C35H39N6O3 [M+H]+: calcd. 591.3005, found 591.2997. 
 
SYNTHESIS AND PURIFICATION OF AuNp-3, PtNp-3, AgNp-3 
 
AuNp-3 
Trt-S-(CH2)2-CO-pazoDbg-OH (3) (150 mg, 0.19 mmol) was treated with a 1/1 
TFA/dichloromethane solution containing 1% triisopropylsilane for 10 min to eliminate 
the trityl protecting group. The solvent was evaporated and the residue was dissolved in 
a 1/1/1 chloroform/methanol/water mixture (10 mL). HAuCl4·3H2O (24 mg, 0.063 
mmol) was added and the resulting solution was allowed to stand for 1 h under stirring. 
Then, 10 equivalents of NaBH4 (1.65 mL of a 600 mM solution in water) were added 
and the solution was stirred at room temperature for additional 6 h. The product was 
precipitated by adding an excess of acetonitrile, pelleted for 8 min at top speed in a 
centrifuge, resuspended in a 7/3 diethyl ether/ethanol mixture, pelleted again, and dried 
overnight at room temperature. IR (KBr) ν 3336, 1665, 1445 cm-1. 
 
PtNp-3 
Trt-S-(CH2)2-CO-pazoDbg-OH (3) (150 mg, 0.19 mmol) was treated with a 1/1 
TFA/dichloromethane solution containing 1% triisopropylsilane for 10 min to eliminate 
the trityl protecting group. The solvent was evaporated and the residue was dissolved in 
a 1/1/1 chloroform/methanol/water mixture (10 mL). H2PtCl6·6H2O (36 mg, 0.063 
mmol) was added and the resulting solution was allowed to stand for 1 h under stirring. 
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Then, 10 equivalents of NaBH4 (2.2 mL of a 300 mM solution in water) were added and 
the suspension was stirred at room temperature for additional 6 h. The product was 
precipitated by adding an excess of acetonitrile, pelleted for 8 min at top speed in a 
centrifuge, resuspended in a 7/3 diethyl ether/ethanol mixture, pelleted again, and dried 
overnight at room temperature. IR (KBr) ν 3339, 1668, 1441 cm-1. 
 
AgNp-3 
Trt-S-(CH2)2-CO-pazoDbg-OH (3) (150 mg, 0.19 mmol) was treated with a 1/1 
TFA/dichloromethane solution containing 1% triisopropylsilane for 10 min to eliminate 
the trityl protecting group. The solvent was evaporated and the residue was dissolved in 
a 1/1/1 chloroform/methanol/water mixture (10 mL). AgNO3 (12 mg, 0.063 mmol) was 
added and the resulting solution was allowed to stand for 1 h under stirring. Then, 10 
equivalents of NaBH4 (2.2 mL of a 300 mM solution in water) were added and the 
suspension was stirred at room temperature for additional 6 h. The product was 
precipitated by adding an excess of acetonitrile, pelleted for 8 min at top speed in a 
centrifuge, resuspended in a 7/3 diethyl ether/ethanol mixture, pelleted again, and dried 
overnight at room temperature. IR (KBr) ν 3329, 1664, 1449 cm-1. 
 
X-RAY DIFFRACTION ANALYSIS OF H-pazoDbg-OEt (1) 
Orange crystals in the shape of thin rods were grown by slow evaporation from a 
mixture of dichloromethane and methanol. X-ray diffraction data were collected with an 
Oxford Diffraction Gemini E four-circle kappa diffractometer equipped with a 92 mm 
EOS CCD detector, using graphite monochromated Cu Kα radiation (λ = 1.54178 Å). 
The sample to detector distance was 50 mm. A total of 1344 frames were collected by 
1.0° omega oscillation with exposure times of 1.5, 4, or 70 s, depending on the theta 
values, in the 4.11°–68.46° theta range. Data collection and reduction were performed 
with the CrysAlisPro software (version 1.171.33.52; Oxford Diffraction). A semi-
empirical absorption correction based on the multi-scan technique using spherical 
harmonics, implemented in SCALE3 ABSPACK scaling algorithm, was applied. The 
structure was solved by ab initio procedures of the SIR 2002 program,11 and refined by 
full matrix least squares on F2, using all data, by application of the SHELXL 97 
program,12with all non-H atoms anisotropic. All phenyl rings were constrained to the 
idealized geometry. The positions of the H-atoms of the N-terminal free amino group 
were estimated by performing a rotational search of the electron density in the expected 
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cone on the N atom and were not refined. All of the remaining H-atoms were calculated 
at idealized positions and refined using a riding model. Relevant crystallographic data 
and diffraction parameters are reported in Table 2. CCDC 832775 contains the 
supplementary crystallographic data for this paper. These data can be obtained from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif 
 
 
Tab. 2 Crystal data and structure refinement for H-pazoDbg-OEt (1). 
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Synthesis of peptides containing 4-amino-1,2-dithiolane-4-carboxylic acid (Adt) 
residues 
 
INTRODUCTION 
Self-assembly has become one of the most useful strategy in the bottom-up fabrication  
technologies due to the easiness by which highly ordered thin films of organic material 
over layers and surfaces can be built. This kind of supra-molecular aggregation is 
exploited for biological and spectroscopic investigations, nano-engineering, sensing, 
bio-materials and electro-chemical applications.1 In particular, peptide self-assembled 
monolayers are of current interest to study physicochemical properties of modified 
metal (e.g. Au) surfaces.1e,2 The possibility to produce peptide SAMs over gold surface 
opens the road to the development of new nano-electronic devices for (i) monitoring the 
interaction between peptide or proteins layer and substrates, (ii) electron transfer 
occurring through a peptide chains and (iii) photocurrent generation.1d,3Thiol-gold 
linkage is by far the most extensively employed self-assembly method to get an ordered 
monolayers of organic molecules over gold surfaces.4The functionalization of C- or N-
terminus of peptides with thiol linkers has been utilized, as well by side-chains (as 
cysteine or methionine). Among the several linkers toward gold, dithiolane (disulfur 
bridge) have been exploited for its ability to give a bidentate ligation.5 Lipoic acid is an 
example of this kind of linkage. The presence of a carboxyl moiety allows also for the 
functionalization of molecules, as peptide chains, for binding over gold by means of the 
S-S dithiolane bridge. 
At the beginning of the ‘70s a family of new dithiolane containing cyclic structures was 
firstly synthesized. The 4-amino-1,2-dithiolane-4-carboxylic acid (herein called Adt, 
see Figure 1) was firstly synthesized as building block for organic synthesis.6 In the last 
years Adt has also been discovered in natural compounds (Kottamides A-E; the 
structure of E is reported in Figure 2) produced by the New Zealand ascidian 
Pycnoclavella kottae.7 More recently, Prof. Lucente group prepared Adt-containing 
derivatives and other constructs, as for example a complex with iron that found 
application in catalytic hydrogenation.8 
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Belonging to the class of Cα-tetrasubstituted amino acids whose prototype is the  α-
amino isobutiric acid (Aib), Adt shows a tendency to stabilize helical structures even in 
medium length or short peptides. The Thorpe-Ingold effect promotes β-turn 
conformations, experimentally found in some tri-peptides. From the conformational 
point of view, Adt showed the same behavior of its  analogue Ac5c.8b,8d,8e,9 Moreover, 
beside such conformational property, the presence of a dithiolane S-S on the Cα side 
chain ring makes this moiety an extremely interesting candidate for  functionalization of 
gold surfaces. Nevertheless, the short separation of the S-S linker from the peptide 
backbone allows to design much closer SAM layers to the metal surface as compared to 
the use of lipoic acid as linker. On the other hands, the bidentate ligation should permit 
an higher SAM rigidity in comparison with flexible linkers such as Cysteine (Figure 3).  
 
 
 
 
 
In any case, the possibility to introduce a linker such as Adt on the selected rigid 
peptide, could provide a differently packed SAM. In fact, the electron transfer (ET) 
phenomena involving the peptide helices  has been already studied and the geometry of 
the SAM is not uninfluent over the ET mechanism.10 Usually, the applications of 
peptide scaffold ET studies involve peptides structure able to link peptide helices in a 
one-site binding fashion. A parallel disposition of the peptide to a surface is therefore 
quite uncommon and might open new possibilities for the study of ET phenomena 
Fig.1 4-amino-1,2-dithiolane-4-carboxylic 
acid (Adt) residue. Information on the 
synthesis in the experimental section. Fig.2  Kottamide E: a natural product containing Adt, found in the New Zealand ascidian Pycnoclavellakottae.  
Figure 3. Comparison between differen linkage models. Adt linkage (on the left) should be more rigid 
than cysteine one (in the middle) and permit a  closer placing of peptides than lipoic acid linkage (on 
the right). 
 
S
HN CO
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CONH2
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Au
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mediated by peptides.11 Thus, we designed and synthetized a series of constrained Adt-
containing helical peptides based on Ala or alternating Ala-Aibhost functionalizedwith 
one or more Adt moieties. All of these family members were functionalized with a 
specific probe that finds application in electro-chemistry techniques. As probes we 
selected Pyrene acetic acid (PyrAc) and the Ferrocene carboxylic acid (Fc), on virtue of 
their well-known optical and redox properties.1e,12 The choice of both peptide length and 
position of the Adt moiety was guided by our knowledge about conformationsof Cα-
tetrasubstituted containing peptides. In particular, sequences alternating Cα-
tetrasubstituted and Cα-trisubstituted amino acids are known to promote 310-helical 
structures till the number of residues in lower that 7, otherwise longer sequences 
promote α-helix structure.13 So, as we wanted to ensure a distance of two turns between 
the Adt residues we hypothesized a sequence containing 10 residues, with Adt located at 
positions 1 and 8. Otherwise, we also designed an esapeptidethat would adopt  a 310-
helical structure as shown by ESR measurements on TOAC (an analogue of Aib with a 
nitroxide moiety) containing peptides.14  
Finally we selected: 
 
1) Y-Adt-Ala-Aib-Gly-Aib-Ala-Aib-Adt-Ala-Aib-OMe (α-helix),  
2) Y-Adt-Ala-Aib-Adt-Ala-Aib-OMe (310 helix)  
3) Y-Adt-Ala-Ala-Adt-Ala-Ala-OMe (an analogue of the former).  
Y corresponding toPyrAc or Fc respectively 
 
We decided to synthetize, for comparison, a peptide containing only one Adt in the 
sequence, by replacing the position 1 with an Aib residue (see Figure 4 in Results and 
Discussion).  
Noteworthy, the opportunity to obtain more rigid scaffolds and more ordered SAM is a 
challenge in the research field of ET processes.1e Ferrocenederivated mono-layers show 
many intriguing properties: Fc undergoes to fast reversible electron transfer, is easily 
functionalized and is stable in non-oxidizing environments and evidences showed that 
the charge of the complex and oxidation state of the Iron atom do not affect the peptide 
conformation. Moreover, its insertion into peptide systems does not modify 
substantially the structure, because it is lipophilic and small sized. For these reasons, 
Ferrocene is widely exploited as a redox tag for the characterization of nucleic acids, 
proteins, and peptides.12d Nevertheless, it is still not well-know how peptide back-bone 
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can contribute in the ET process, and different main mechanisms are 
supposed.1c,3b,10a,10c,15 Within 2nm, the process would take place through an electron 
tunneling mechanism (superexchange) through the peptides bon.  Otherwise, above 
2nm, two mechanisms are supposed: i) the hydrogen bonds act as a short-cut for the 
tunneling process, or ii) an hopping mechanism take place involving each single amide 
bond. Otherwise, for the most current theories, both these mechanisms could contribute 
to the overall ET process. Therefore, a short distance of redox tag (under 2nm) that is 
ensured by a parallel linkage of peptide scaffold to gold can improve the knowledge on 
these ET processes.11a,15a,15b,15f 
Beside Ferrocene, also Pyrene has been taken into account, due to its propensity to 
promote photo-current generation phonomena.8e,11b,15f In the presence of an electron 
donor in solution (for example, triethanolamine) the irradiation of the Pyrene label (and 
even seen for Ferrocene) induces the generation of a catodic current detectable with the 
gold electrodes. This could be viewed as example of self-assembly device able to 
convert light to photo-generated current.  
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1 
RESULTS AND DISCUSSION 
 
Synthesis 
This part of the project describes the synthesis of Adt containing peptides.  Figure 4 
reports the chemical structure of the final products. 
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The syntheses of the peptides have been accomplished in the Laboratories the prof. 
François Couty at the Versailles Saint-Quentin-en-Yvelines (France), in collaboration 
Dr. Karen Wright (CNRS, University of Versailles Saint-Quentin-en-Yvelines). Adt has 
been also synthesized as it is not commercially available (see Figure 5 for synthetic 
pathway).8e 
Fig. 4 Peptide chemical structures for: 10mers (1), esamers -Ala-Aib- (2), esamers -Ala-Ala- (3) 
and an esamer containing only one Adt residue. 
 
2 
3 
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The syntheses of the peptides were performed via a step-by-step approach with classical 
methodologies in solution. As aforementioned in the introduction, for the (1) 10-mers 
we considered to insert Adt at positions 1 and 8 (two helical turns apart in an α-helix) 
wanting the dithiolated side-chains to stay on the same side of the helical structure. In 
fact, 3,6 residue per turn are needed for an α-helix.  The choice of a distance of two 
turns was dictated by the willingness to exploit the length of the 10mers to ensure a 
higher rigidity in respect with the surface. Therefore, to get the two dithiolated side 
chains on the same side of the tri-dimensional structure six residues are need to be 
located between two Adt residues. Regarding (2) and (3) (6mers) the Adt should be 
located at positions 1 and 4, exactly at the distance of one turn of a 310 helical structure. 
In this case, the number of residue per turn is 3,2. Therefore in order to achieve a tri-
dimensional structure pointing two Adt on the same side, two residues are need to be 
located between two Adt.  
Regarding the synthetic pathway, a series of different methods of –COOH activation 
and different protection group for N-terminus have been employed. In particular, Fmoc- 
protection has been exploited for Adt residue whereas Boc chemistry has been widely 
used for the others (Aib, Ala and Gly). By consideration that the global yield over 
10mers synthesis would not have been high (due to the low reactivity of coupling over 
Fig. 5 Synthetic protocol for  Fmoc-Adt-OH . 
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Adt and the high amount of tetra-substitute amino acids in the sequence), we decided to 
modify the synthetic protocol for the 10mer in a segment-condensation fashion. To 
ensure a free racemization process the positions 4 and 5 in the 10mers should not be 
occupied by an alanine. For this reason we projected to insert an achiral glycine, in 
order to avoid possible racemization occurring during the further segment condensation 
(both Aib and Gly are achiral indeed).  Thus, the 4mer Boc-Ala-Aib-Gly-Aib-OH has 
been coupled to H-Ala-Aib-Adt-Ala-Aib-OMe in order to achieve the Boc-protected 
9mer precursor. In order to increase the overall yield of the probe-labelled derivatives, 
PyrAcAdtOH and FcAdtOH were prepared aside and successively conjugated to 9mer 
precursor BocAlaAibGlyAibAlaAibAdtAlaAibOMe. This strategy was preferred in 
order to reduce the number of coupling steps. For the same reason, a single coupling on 
the intermediate H-Ala-Aib-Adt-Ala-Aib-OMe with each labelled Adt and Aib 
derivative yielded the (2) group of final products (-[AdtAlaAib]2-OMe and                                         
-AibAlaAibAdtAlaAibOMe). Noteworthy, the very low reactivity of coupling over Adt 
residue imposed another strategy in respect to usual activation with common coupling 
reagents (HATU or OXYMA/EDC), especially for the reaction between 4Aib and 3Adt 
in which an activation via acyl fluoride was preferred. Each intermediate has been 
purified, isolated and characterized (FTIR, 1H NMR, 13C NMR and mass spectra). The 
synthetic scheme of the for Fc-10mer and Fc-(AdtAlaAla)2OMe are reported in Figure 
6 as example. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Synthetic procedure for Fc-10mer  
AibAlaAdtAibAlaAibGlyAibAlaAdt
H OMe
Boc OMe
Fmoc OMe
Boc OMe
Boc OMe
OMeH
OMeBoc
OMeBoc
OMeBoc
OHBoc
OMeBocFc OH
Fc OMe
H OMe
Fc OMe
a) deprotection with TFA/DCM 1:1 b) deprotection with DEA/DCM 30%
c) coupling via OXYMA/EDC d) coupling via HATU
e) coupling via fluoride derivative (prepared with cyanuric fluoride, then 1 week)
g) saponification wih NaOH(aq.)/MeOH
f) coupling via oxazolone (prepared with EDC then 1 week in MeCN at reflux)
Fmoc OMe
b, e
a, dg
b
c
c
a, ca, c
a, c
a, c
h
g
c
a, c
Fmoc OH
h) esterification with SOCl2 in MeOH
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Conformational characterization 
 
FTIR 
The FTIR spectra in CDCl3 of each final product have been recoded. Spectra were 
collected on a Perkin-Elmer 580 B with a IR data station Perkin-Elmer 3600. Data are 
resumed  in Table 1.  
 
 
Compound IR frequencies (cm-1) 
Fc(AdtAlaAla)2OMe 3693, 3605, 3431, 3332, 2987, 2927, 1736, 1665, 1535 
Fc(AdtAlaAib)2OMe 
3699, 3609, 3431, 3325, 2987, 
2931, 1734, 1670, 1524 
FcAibAlaAibAdtAlaAibOMe 3691, 3607, 3431, 3327, 2989, 2934, 1734, 1668, 1524 
FcAdtAlaAibGlyAibAlaAibAdtAlaAibOMe 3691, 3605, 3319, 2987, 2927, 
2855, 1724, 1654, 1534 
PyrAc(AdtAlaAla)2OMe 
3690, 3613, 3424, 3331, 2989, 
2929, 1734, 1668, 1523 
PyrAc(AdtAlaAib)2OMe 
3691, 3612, 3423, 3333, 2989, 
2929, 1734, 1670, 1524 
PyrAcAdtAlaAibGlyAibAlaAibAdtAlaAibOMe 3689, 3607, 3423, 3321, 2989, 
2927, 1734, 1658, 1534 
 
The bands of N-H stretching lay between 3200-3500cm-1 (amide A): the N-H  groups 
which are involved in H-bonds below 3400cm-1 and N-H  groups not involved in H-
bonds pattern and more exposed to solvent above 3400cm-1. The carbonyl is also 
involved in vibrational modes that gives contributions between 1800 and 1500cm-1 
(~1700cm-1 ester, ~1660cm-1 amide I, ~1500cm-1 amide II). For an helix conformation, 
the amide I signal lays between 1650-1665cm-1. From Table 1, the wavenumbers for 
6mers and 10mers are located in the range of 1650 and 1668 cm-1. As reported in the 
literature, values below 1660 cm-1are indicative of an α-helix prevalent conformation, 
whereas above 1660 cm-1is an indication of a prevalent 310 helix.16 The experimental  
amide I data for both the 10mers mode are located at 1650-1660cm-1, whereas all the 
6mers show a concordance between 1665 and 1670cm-1. These parameters are in good 
agreement with those expected (α helix and 310 respectively). More investigations are 
required anyway for assessing the actual conformation in solution, especially by NMR.  
Comparing the FTIR spectra in the amide A region, acquired at 10-3 M and 10-4 M 
concentrations in CDCl3 solution, we can conclude that the H-bonded N-Hs are all 
intramolecularly bound as no dilution effect is observed (as it would be in the case of 
aggregation).  
Table 1 FTIR signals of the final products. All spectra were recorded at CDCl3, 10-3M concentration. Underlined 
values refer to strong peak. 
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2D NMR 
Brief description of the utilized techniques 
The high potential of the 2D NMR is due to the spread of signals from a mono-
dimensional to a bi-dimensional spectrum, that reduces the overlaps between peaks. The 
experiments employed during this Thesis were COSY,17 TOCSY,18 NOESY,19 and 
ROESY.20 COSY (COrrelation Spectroscopy) permits to evaluate scalar correlations 
between three bond distant protons. The experiment reveals the direct spin-spin 
couplings. COSY experiment is primarily used in order to obtain structural information 
via spin-spin connectivity. TOCSY (Total Correlation Spectroscopy) permits to evaluate 
spin correlations along a so called “spin system”: in a tri-substituted amino acid as, for 
istance, Leucine, magnetization is transferred and detected through each α−β−γ−δ 
proton, mutually at a three bonds distance, and each proton couples with each other of 
the same system. This technique allows to recognize the tri-substitute amino acids in a 
sequence and assess their chemical shifts. NOESY (Nuclear Overhauser Effect 
Spectroscopy) allows to evaluate dipolar correlations between the protons through the 
space. Still NOESY is dependent on the size of the molecule another technique is 
applied in some cases. ROESY (Rotating-frame nuclear Overhauser Effect 
Spectroscopy) permits to get the same information of NOESY and is useful for systems 
for which NOE effects are zero.  
 
Secondary  structure  determination 
To assess the 3D structure of a molecule in solution by means of a NMR experiment we 
firstly need to assess the chemical shifts in the 1D spectrum to the proton resonances. In 
this case, COSY and TOCSY are very useful to distinguish each residue from each 
other, because the correlation between proton is present only inside the same residue. If 
the sequence is known, as in this case, these techniques allow to assess chemical shifts 
(except if two or more identical residues are present). However these experiments do 
not give any information on the sequence. In fact, in order to define the qorder of 
residue in the sequence and determinate the conformation in solution another 
experiment is needed. NOE effect is dependent on the dipolar interaction between 
protons and give information on the proximity of protons in space. Therefore, NOESY 
spectra is utilized for assessing the conformation. Typical cross-peaks can be recognized 
for helix structures.21  
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PyrAc(AdtAlaAib)2OMe 
In table 2 are reported the chemical shifts evaluated for this compounds in CD3CN with 
30% CD3Cl at 298K. COSY, TOCSY and NOESY experiments have been employed. 
. 
 NH αH βH Others 
Pyr-CH2-    CH2 4.38-4.53 (dd) 
aromat. 8.39-8.03 
Adt1 7.93  3.36-4.13 
3.54-3.30 
 
Ala2 7.55 3.84 1.25  
Aib3 7.00  0.81-0.51  
Adt4 7.16  3.84-3.40  
Ala5 7.62 4.11 1.33  
Aib6 7.10  1.34  
-OCH3    3.58 
Tab. 2 Chemical shifts for PyrAc(AdtAlaAib)2OMe 
 
TOCSY and COSY cross-peaks were useful to assess the resonance of Alanine protons 
(see TOCSY spectrum in the interest region in Experimental section, Figure 20). The 
assessment of NHs chemical shifts to their own residue has been achieved by analysis of 
the NOESY spectrum in NH→NH coupling region (Figure 21 in the Experimental 
Section). All the spectra have been recorded in CD3CN with a 30% CDCl3 at 298 K. 
The presence of all the expected cross-peaks for NHi→NHi+1 couplings in NOESY 
spectrum is a proof for the presence of an helix structure.21 In order to determinate the 
contributions of 310-helix and α-helix of it, the most indicating zone in the NOESY 
spectrum is the so-called “finger print” region. This section of the spectrum includes all 
the cross-couplings between α-CH  or β-CH2 (usually below 5ppm) and NHs (see 
Figure 22 in Experimental Section). In our case, the presence of only two tri-substituted 
amino acids imposes necessaritly to check also the region of coupling of NH with β-
CH3 (Ala and Aib CH3 - see Figure 23 in Experimental Section).  
The presence of the correlations Adt1CH2→Adt4NH, Ala2CH→Ala5NH (Fig. 20) and 
Aib3CH3→Aib6NH (Fig. 21) of the type CHi→NHi+3 is an evidence of an helical 
folding.21 The preference for the 310-helix versus an α-helix arrangement is usually 
assessed on observing the presence of i → i+2 or i → i+4 cross-peaks. An high number 
of the formers in the spectra (Adt1CH2→Aib3NH, Ala2CH→Adt4NH, 
Aib3CH3→Ala5NH, Adt4CH2→Aib6NH) is a confirm that the peptide adopts a prevalent 
310-helix conformation, in agreement with the expectations for this sequence.14 
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Nevertheless, the cross peak Ala2CH→Aib6NH is an hint of the presence of a mixed 
conformation 310/α.  
 
Fc(AdtAlaAib)2OMe 
In Table 3 are reported the chemical shifts evaluated for this compounds in CD3CN 
with 30% CD3Cl at 298K. COSY, TOCSY and ROESY experiments have been 
employed (TOCSY spectra in the regions of interest for assessing Ala2 and Ala5 
chemical shifts is reported in the Experimental Section, Figure 24). 
 
 
 
Tab. 3 Chemical shifts for Fc (AdtAlaAib)2OMe  
 
The assessment of NHs chemical shifts has been achieved by analysis of the ROESY 
spectrum in NHi →NHi+1 coupling region (Figure 25 in experimental section). All the 
spectra have been collected in CD3CN with a 30% CDCl3. In Table 4 all the cross-peaks 
found in ROESY spectrum are reported.  The presence of most of the expected cross-
peaks for NHi→NHi+1 couplings in ROESY spectrum is a proof for the presence of an 
helix structure.21 Actually, the croo-peak between Aib3NH and Ala2NH has not been 
found due, probably, to the overlap of diagonal signals.  
In order to determinate the contributions of 310-helix and α-helix of it, the most 
indicating zone in the ROESY spectrum is the so-called “finger print” region. This 
section of the spectrum includes all the cross-couplings between α-CH  or β-CH2 
(usually below 5ppm) and NHs. In our case, the presence of only two tri-substituted 
amino acids imposes necessaritly to check also the region of coupling of NH with β-
CH3 (Ala and Aib CH3). The two spectra are reported below in Experimental Section in 
Figure 26 and 27 respectively. In these two last regions only one useful cross-peak is 
 NH αH βH Others 
Fc-    Cp rings: 4.89-
4.84-4.78-4.48-
4.42-4.30-2.29 
Adt1 7.20  3.59-3.72 
3.60-3.98 
 
Ala2 7.59 4.00 1.34  
Aib3 7.63  1.54  
Adt4 7.55  4.01-3.62 
3.27-3.79 
 
Ala5 7.77 4.16 1.38  
Aib6 7.25  1.47  
-OCH3    3.62 
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present in order to assess the conformation. Adt1 CH2 resonace at 3.66ppm couples with 
Aib3 NH. So, this could be a confirm for the presence of a 310-helix prevalent structure. 
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UV-Vis, ECD AND FLUORESCENCE 
The presence in the final products of the chromophores (PyrAc and Fc) makes these 
compounds suitable to be investigated in the nearUV-Vis range. No intrinsic dichroism 
effects should be expected for Pyrene acetic acid and Ferrocene carboxylic acid, indeed. 
However, we recoded for both the PyrAc and the Fc labeled peptides the ECD spectra 
above 250nm. In fact, the presence of a chiral element could induce some chiroptical 
effect to these functional groups.  The most useful region for assessing the peptide 
conformations (from 200 to 250nm) is hardly investigable because of an overlapping 
with the UV absorption bands of the chromophores. So, only the spectra in the Vis 
region have been recorded. The ECD spectra for PyrAc10OMe overlapped to 
PyrAc6OMe (left) and Fc10OMe overlapped to Fc6OMe (right) are reported in Figure 
13 and compared to UV-Vis absorption spectra in the same region. The ECD spectra of 
each final product have been recorded in CDCl3 (10-4 M solutions). As results, dichroic 
effects are present in the range of absorption for both the chromophores. In this region 
(above 250nm) the peptides cannot give any contribution to the spectra. So the 
dichroism signals appearing in the spectra could only come from the achiral 
chromophores and is due to the bound chiral peptide chain that induce a rigid chiral 
environment for the bound label.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13 EDC (above) and related 
UV-Vis absorption spectra (below) 
of PyrAc-10mer (dashed line) 
overlapped on PyrAc-6mer (2) 
(straight line) (left) and
Fc(AdtAlaAib)2OMe (right). All 
the spectra have been recorded for 
10-4M solutions in CDCl3, with a 
1cm cell length. ECD specra are 
normalized respect the concentration. 
Absorption spectra are reported as 
Abs vs wavelength.  
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For comparison, the ECD spectra were recorded at the same conditions (solvent and 
concentration) for a sequence that do not possess any definite secondary structure in 
solution. To this aim, we decided to synthesize the Pyr and Fc derivatives of the 
dipeptide Boc-Ile-Leu-OMe (Figure 14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is worth to note that: i) the profile of the ECD signals for this sequence in the region 
under investigation is definitively different from formers and ii) the intensity is 
extremely lower for dipeptides (one hundred times smaller for Pyrene derivative). Even 
though the content of chiral amino acids between  -(AdtAlaAib)2OMe  and -IleLeuOMe 
is the same, the chiral effect on chromophores is different out of any doubt. Moreover, 
the intrinsic chiral contribution coming from the first residue bound to the chromophore 
is zero for Adt, being achiral, whereas Ile is intrinsically chiral. So, the chiral effect 
should be due to the different conformation of the two different sequences, instead of 
coming from the proximity of the nearest amino acid or from the simple sum of effects 
of single chiral contribution of each amino acid. In fact, this would not explain the 
change in sign of the ellipticity for the two different spectra.  
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Figure 14. EDC of FcIleLeuOMe (above) and PyrAcIleLeuOMe (below). All the spectra have been 
recorded for ~10-4 M solutions in CDCl3, with a 1cm cell length. ECD specra are normalized respect the 
concentration. 
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The comparison between 10-mers and 6-mers shows small differences, in particular a 
different ratio of the two main bands at 290 and 340 nm for ferrocene containing 
peptides, whereas both the shape and the form of the spectrum of Fc-Ile-Leu-OMe is 
rather weaker and does not show any appreciable chiral effect under 300nm. 
Noteworthy, for PyrAc-Ile-Leu-OMe the band at 290 nm is even opposite to which of 
longer ones. This effect seems to be related only to the different conformations of the 
peptides in solution. However, many examples are reported in literature about exciton 
splitting due to excimer couple formation (inducing exciton splitting) that could induce 
a dichroic effect for Pyrene.22 In order to better investigate whether any contribution 
could have come from such a mechanism, the fluorescence spectra for PyrAc10mer and 
for PyrAcIleLeuOMe have been recordedin CDCl3.23 The spectra are reported in Figure 
15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The emission bands in the spectra are due only to the fluorescence of the monomer. For 
excimer the emission band would appear as a broad and more intense band between 
470-550 nm, and is clearly absent in the shown spectra. Therefore, it is possible to state 
that the chiral effect cannot get any contribution from such a mechanism and is due only 
to the presence of the peptide bound to the pyrene. Whether or not the Pyrene is 
sensitive to the whole conformational constained sequence or to the first turn angle will 
be explained by further investigations. 
Fig. 15 fluorescence spectra in CDCl3  for PyrAc10OMe and PyrAcIleLeuOMe. λex=345 nm, recorded 
∆λem=355-600 nm 
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ELECTROCHEMICAL CHARACTERIZATIONS 
The electrochemical experiments have been carried out on modified Adt-peptide gold-
electrodes (SAMs). The experiments and data elaboration were accomplished by prof. 
Venanzi’s research group at the University of Tor-Vergata, Roma. The reported results 
are only briefly summarized here. 
 
Preliminary coating test on Fmoc intermediates 
Cyclic voltammetry measurements of the discharge of [Fe(CN)6]3- on a bare gold 
electrode and in presence of  peptides coating have been compared each other.3e To 
optimize the coating through by a Adt dithiolane bridge to Au surfaces it was performed 
a series of preliminary binding experiments. Panel A in Figure 16 shows that the 
tripeptide FmocAdtAlaAlaOMe does bind to an Au-coated electrode of teflon. Indeed, 
the cyclic voltammetry of the bare Au electrode (red line) is markedly reduced in 
intensity when the peptide links to the electrode (blu line). Interestingly, when the 
intermediate 6mer Fmoc(AdtAlaAla)2OMe was used, the electrode surface (Au-coated 
teflon electrode) was covered much more efficiently (higher reduction of intensity, 
panel B) and evaluated coverage is 3,1·10-14mol/cm2. This event supports the contention 
that the two Adt residues may act cooperatively. Finally, when using a flat Au surface 
(panel C) even the tripeptide (containing only one Adt residue) binds to the electrode 
surface very efficiently.  
 
 
 
 
 
 
 
Cyclic Voltammetry on Fc(AdtAlaAib)2OMe 
The sample has been prepared by solving the Fc containing-compound in a suitable 
amount of chloroform. A concentration of 0.5mM and 0.05mM have been tested. The 
Fig.16 Cyclic voltammetry on bare gold electrodes (red lines). Comparison between 
FmocAdtAlaAlaOMe (A, blue line) and Fmoc(AdtAlaAla)2OMe (B, blue line) 
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concentrations have been determined by means of the absorption of Ferrocene 
chromophore in the SAM at 450nm (ε=400) where no overlap with other absorption 
take place. A gold thin plate (A=0,505cm2) was treated with piranha solution (H2SO4 
96%, H2O2 30% 2:1 v/v) for 15 minutes, washed twice with bidistilled water, dried over 
Argon then left into the sample solution for 18 hours. 
In Figure 17 (left and centre) a comparison between the CV of K3[Fe(CN)6] (Eox=0.27 
mV, Ered=0.4 mV) for the bare electrode and the coated one respectively is reported. 
Besides, in Figure 17 (right) the CV for Ferrocene-coating SAM is reported (0.1M 
NaClO4 in acetonytrile). 
Fig. 17  Left: Fe(III) CV of bare gold electrode in K3[Fe(CN)6]/KCl solution; centre: Fe(III) 
CV of coated electrode in K3[Fe(CN)6]/KCl solution; right: CV of ferrocene SAM (supporting 
electrolyte: 0.1M NaClO4/MeCN). Scan rate: 300mV/s. 
 
From the comparison between Figure 17/left and 17/centre is possible to say the the 
presence of the coating SAM doesn’t inhibite completelly the reduction of Fe(III) 
complex, that indicate a low degree of SAM packaging. In Figure 17/right the CV 
curves for Ferrocene redox process are reported. The evaluated E° in is 0.56 mV and 
this value is due to the linkage via amide bond to the peptide (0.55 mV for Ferrocene 
carboxylic acid).24 The ∆E is close to 0 mV in our case, indicating a good reversibility 
at this scan rate. Moreover, this evidence indicate also that there are not contributions 
from ET processes mediated by Ferrocene diffusion onto the gold surface.25 The peaks 
are also broader and weaker than bare electrode CV. This effect has been associated to a 
rigid coating of the SAM. An analysis of CV curves depending on scan rate (Figure 
28/left in Experimental Section)  indicates that the ∆E between reduction and oxidation 
peaks are linearly dependent on scan rate (Figure 28/right in Experimental Section). 
This also is a confirm of the formation of the SAM. In fact, a free Ferrocene in solution 
should have displayed a square root dependence of ∆E on the scan rate instead of linear 
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one. Moreover, the evauated concentration of peptide on the surface is 3.128.10-11 
mol.cm-2. By assuming the maximun packaging available, a theoretical number of 
2.17.10-10 mol.cm-2 was proposed.1e The former value has been evaluated for the most 
packed helical peptide SAM (tilt angle=0°). So, the quite small surface coverage 
evaluated for Fc-6mer could be due to the 180° packaging on the surface (parallel 
disposition) induced by the two binding Adt in sequence.  
 
 Photocurrent generation 
A photo-current generation experiment was carried out. The result suggests that 
Ferrocene induces the generation of wavelenght-dependent current (Figure 18). In 
Experimental Section the experiment set up is explained. 
 
Fig. 18 Comparison of the UV-Vis absortion spectrum for Ferrocene in the 600-250nm range 
(blue) and the intensity of photo-generated current for Fc(AdtAibAla)2OMe on gold surface. 
 
The process is stronger in the wavelenght region of higher absortpion of Ferrocene. 
Noteworthy, the higher current intensity peak between 300 and 350 nm is due to the 
photo-current generated by the gold electrode itself. 
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X-RAYS ANALYSIS 
Single crystal of Adt-containing pentapeptide Boc-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
were obtained from slow evaporation of a MeOH solution. The molecular structure was 
determined by X-ray diffraction analysis (structure solved by Dr. Marco Crisma, CNR-
ICB, Padova). The pentapeptide is folded into a right-handed 310-helix, stabilized by 
three intramolecular H-bonds, as expected for a short, Aib-containing peptides (Figure 
19).  
 
 
As seen for the longer and more stabilized PyrAc(AdtAlaAib)2OMe by analysis of  
NOESY cross-peaks, this result is in agreement with the supposed conformation.  
 
 
 
 
 
 
 
 
 
 
Figure 19.  X-rays structure for BocAlaAibAdtAlaAibOMe. Crystals obtained by precipitation from 
MeOH solution 
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CONCLUSIONS 
A series of Ferrocene and Pyrene labelled helical peptides containing one or more 4-
amino-1,2-dithiolane-4-carboxylic acid (Adt) residues have been synthetized and fully 
chemically characterized. Such peptides have been designed to be employed in the 
formation of SAMs over gold surface (by means of linkage with the dithiolaneAdt side 
chains) for electrochemical applications. A detailed conformational study on a hexamers 
series and electrochemical characterization have been performed. In particular, 2D 
NMR experiment indicated a prevalent 310 conformation, even if hints of the 
incoming α-structure have been detected. In fact, for longer peptides α-structure is 
known to be more stable in Ala/Aib containing peptides.26 X-rays structure was 
resolved for a 5-mer intermediate, evidencing a 310 helix conformation at that length 
stage. Therefore, electrochemical investigation on a Ferrocene containing 6-mer have 
been performed. In particular, the redox properties of the Ferrocene has been sampled 
by CV experiments on SAM. As result, the analises of the result suggets that the Adt 
residues in the sequence impose a parallel displacement (respect to the peptide axle) of 
the peptides over the gold, leading to a lower coverage of the surface in respect to a 
perpendicular displacement. Therefore, preliminary experiments aimed to generate 
photo-current have been investigated for the Ferrocene containing peptide. These last 
results indicated that these peptides are suitable to be good candidatefor thelight-current 
conversion process. 
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EXPERIMENTAL SECTION 
GENERAL  METHODS 
SYNTHESIS: The sntheses were accomplished in the Laboratories of prof. François 
Couty in Versailles (France). In solution methodology has been employed for all the 
intermediates and amino acids derivatives. 
NMR: 1H spectra were recorded at room temperature on a Bruker AV-400 (400 MHz) 
and a Bruker AV-3400 (300 MHz) instruments using deuterated solvents (chloroform, 
pyridine, DMSO or acetonytrile) with or without TMS. In absence of TMS, residual 
peaks of solvents have been used as reference for assessing chemical shifts. The 
multiplicity of a signal is indicated as: s - singlet, d - doublet, t - triplet, q - quartet, m - 
multiplet. Chemical shifts (δ) are expressed in ppm. 
FT-IR: The KBr spectra were recorded on a Perkin-Elmer 580 B equipped with an IR 
data station Perkin-Elmer 3600. For spectra in CDCl3 (98.8% Fluka),  a Perkin-Elmer 
1720X was emploeyd. The instrument operates in FT and is interfaced to a IBM PS/2 
50 Z computer. 0.1 and 1cm  CaF2 pathway cells have been employed. For each 
spectrum have been  collected 50 scans (4cm-1 resolution) under nitrogen. 
Mass Spectrometry: High-resolution mass spectra were obtained by electrospray 
ionization (ESI) on a Perseptive Biosystem Mariner ESI-TOF or a Bruker Microtof-Q 
spectrometer. 
HPLC: The HPLC measurements were performed using an Agilent 1200 series 
apparatus, equipped with a UV detector at variable wavelengths. For compounds 3, 4, 
and 5 HPLC conditions: Phenomenex C18 (100 Å) (stationary phase), 40–70% B, 30 
min. 
UV-Vis Absorption: The electronic absorption spectra were recorded using a Shimadzu 
model UV-2501 PC spectrophotometer. A 1 cm path length quartz cell was used. 
 
CD: The ECD measurements have been collected on a J-715 Jasco spectropolarimeter, 
with quartz cells Hellma (0.02cm pathway length). Values are reported in total molar 
ellipticy (deg x cm2 x dmol-1) : [Θ]T = (MW × Θ )/( l × c )  = 3300 ×  ∆ε = 3300 ×  (εL-εR ) 
Θ = observed ellipticy 
MW = molecular weight 
l = pathway length (cm) 
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c = concentration in gr/l 
∆ε = εL - εR = difference between left- and right-handed component of estinction 
coefficients of polarized light 
Fluorescence: Fluorescence measurements have been accomplished on a Perkin-Elmer 
MPF-66 apparatus at 20°C . λexc 345 nm, ∆λem 355-600 nm. 
Electro-chemical methods: Ciclic Voltammetry measurements have been 
accomplished on a Heka PG310 potenziostat, on a calomel reference electrode, a Pt 
counter-electrode and the gold substrate as work electrode. NaClO4 0.1M in MeCN 
(20ml) has been used as support electrolyte. For the photocurrent measurements a 
NaSO4 0.1M and triethanolamine (TEOA) 0.05M were prepared in bidistilled water 
(25mL). The experimental set consists in a Xenon lump (150W) and a mono-chromator 
of excitation (band with 15nm), whereas the current was measured with the same 
instrument utilized for CV. The Cyclic Voltammetry experiments have been 
accomplished in collaboration with prof. Venanzi group at the University of Roma-Tor 
Vergata.  
For photo-current generation, the experiments were carried out in a fluorescence Hellma 
quartz cell (for ensuring uniform irradiation) using the same experimental design of CV 
measurements. Cathodic photocurrent was detected utilizing 0.05M methyl viologen 
(C12H14Cl2N2) as electron donor (for gold) and acceptor (by Ferrocene). The 
photocurrent measurements have been carried out with 45 seconds irradiation, followed 
by 45 seconds of darkness. The measurements were performed between 600 and 250nm. 
X-Rays:  X-ray diffraction data were collected with an Agilent Technologies Gemini E 
four-circle kappa diffractometer equipped with a 92 mm EOS CCD detector, using 
graphite monochromated Cu Kα radiation (λ = 1.54178 Å). Data collection and 
reduction were performed with the CrysAlisPro software (version 1.171.35.11, Agilent 
Technologies). A semi-empirical absorption correction based on the multi-scan 
technique using spherical harmonics, implemented in SCALE3 ABSPACK scaling 
algorithm, was applied. (structure solved by Dr. Marco Crisma, CNR-ICB, Padova). 
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SYNTHESIS AND CHARACTERIZATION 
SYNTHESIS of Fmoc-Adt-OH 
Br
O
Br
H3CO
SH
O
S
H3CO
S
OCH3 1) NaCN, NaHCO3
2) HCl/H2O
S
OCH3
S
OCH3
HN
NH
O
O
1)NaOH 6N, sealed tube
170°C, 3 days
2) HCl/H2O
S
OCH3
S
OCH3
H2N COOHHCl.
 FmocOSu, NaHCO3
S S
HN COOH
O
O
1) TFA/H2O/anisole
2) I2(MeOH)
 
1,3-bis(4-methoxybenzylthio)propan-2-one  
12.2 mL (44 mmol) of (4-methoxyphenyl)methanethiol were dissolved into 100 mL of 
NaOH (aq.) 1N under magnetic stirring into a 500mL flask. A 40 mL solution 
containing 9.46 g of 1,3-dibromopropan-2-one (43.84 mmol) in EtOH was added 
dropwise within an hour. The reaction procedeed overnight. The suspension so formed 
was filtered with a gooch. The liquid phase was evaporated and estracted with  200 mL 
of dicloromethane, and this one washed with 1/1 HCl 0.5M/brine. Organic phases were 
collected, dried over MgSO4 and solvent removed at low pressure. A red oil was 
obtained (15 g). The product was purified with a chromatography on silica gel (eluant 
dichloromethane) obtaining 12.3g of pure product. Yield 77%. NMR (1H 300 MHz) 
δ ppm 7.19-7.14 (d, 4H, p-MeOBn aromatic rings), 6.79-6.76 (d, 4H, p-MeOBn 
aromatic rings), 3.72 (s, 6H, -OMe CH3), 3.57 (s, 4H, α-CH2), 3.16 (s, 4H, Bn CH2). 
NMR (13C 300 MHz) δ ppm 200.0, 158.8, 130.4, 129.0, 113.9, 55.3, 37.4, 35.5. FTIR 
(cm-1) 3080, 3035, 2994, 2953, 2933, 2908, 2835, 1679, 1605, 1580, 1507. m.p. 82-
84°C. 
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5,5-bis((4-methoxybenzylthio)methyl)imidazolidine-2,4-dione 
12 g of 1,3-bis(4-methoxybenzylthio) propan-2-one (33.2 mmol) were taken into a 1 L 
flask with a magnetic stirrer. Then 90 mL of EtOH and 60 mL of water were added. To 
this suspension 6.4 g of KCN and 13.1 g of NH4HCO3 were added. The reaction was 
heated at 75°C under reflux into a sealed reaction system for three days with an inflating 
balloon to avoid overpressures. The temperature was raised up to 90°C for 1 hour. Then 
the system was let cool down to room temperature. The solvent was evaporated at low 
pressure and the residue solved into EtOAc. The organic phase was washed several time 
with NaHCO3(sat.) and brine. Then it was dried over MgSO4. The product was obtained 
as a white solid by precipitation with EtOAc\PE. Yield 74%. NMR (1H 300 MHz 
CD3OD) δ ppm 7.13-7.10 (d, 4H, p-MeOBn aromatic rings), 6.75-6.72 (d, 4H, p-
MeOBn aromatic rings), 3.66 (s, 6H, -OMe CH3), 3.57 (s, 4H, β-CH2), 2.68-2.55 (q, 
4H, Bn CH2). FTIR (cm-1) 3387, 3252, 3076, 2917, 2831, 1752, 1728, 1699, 1613, 
1503. m.p. 120-125°C. 
3-(4-methoxybenzylthio)-2-((4-methoxybenzylthio)methyl)-2-aminopropanoic                 
acid hydrochloride  
10.5 g of 5,5-bis((4-methoxybenzylthio) methyl) imidazolidine-2,4-dione (25 mmol) 
were taken into 150 mL sealed glass reactor with a magnetic stirrer. Then 60 mL NaOH 
2 N were added. The reaction was heated at 170°C for three days. The system was let 
cool down to room temperature. The moisture was put into a 500 mL flask diluting to 
150 mL with water. The pH was lowered to 6 by carefully dropwise addition of HCl 2N, 
keeping the whole system into an ice bath and under continuos stirring. The suspension 
has so been filtered off on buchner and washed with cold ice and Et2O. The product 
obtained, has so been dried under vacuum at low pressure and didn’t need any other 
purification. Yield 96%.NMR (1H 300 MHz DMSO-d6) δ ppm 7.13-7.10 (d, 4H, p-
MeOBn aromatic rings), 6.75-6.72 (d, 4H, p-MeOBn aromatic rings), 3.66 (s, 6H, -OMe 
CH3), 2.82-2.48 (s, 4H, Bn CH2), 2.33 (s, 4H, α-CH2). FTIR (cm-1) 2998, 2953, 2839, 
2038, 1613, 1589, 1507. m.p. 195-200°C. 
3-(4-methoxybenzylthio)-2-((4-methoxybenzylthio)methyl)-2-(N-Fmoc)- amino 
propanoic acid  
10.6 g of 3-(4-methoxybenzylthio)-2-((4-methoxybenzylthio) methyl)-2- amino 
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propanoic acid hydrochloride (24 mmol) were taken into 1 L flask with a magnetic 
stirrer. The solid was suspended into 200 mL of water. Then the temperature was 
lowered to 0°C and 18 g (234 mmol) of NaHCO3 were added along with 100 mL of 
acetone containing 11 g of Fmos-OSu (30.34 mmol). So, the temperature was increased 
to r.t. and the system has left reacting for four days. The acetone has so been evaporated 
and water solution estracted several time with small portion of Et2O. The water solution 
was carefully acidified to pH 3 by means of HCl 2 N and estracted with EtOAc (5x100 
mL). The product was washed with HCl 0.5N and brine, then the acetate was dried over 
MgSO4. The product was precipitated from EtOAc\PE. Yield 90%.NMR (1H 300 MHz, 
MeOD) δ ppm 7.66-7.25 (m, 8H, Fmoc aromatic rings), 7.16-6.76 (dm, 8H, 2 pMeO-
Bz aromatic rings), 6.08 (s, 1H, NH), 4.53 (br, 2H, Fmoc CH2), 3.73 (s, 6H, 2 pMeO-Bz 
CH3), 3.47-2.91 (dd, 4H, β-CH2). FTIR (cm-1)  1719, 1607, 1503. m.p. 52-54°C. 
N-Fmoc-4-amino-1,2-dithiolane-4-carboxylic acid [Fmoc-Adt-OH]  
8 g of 3-(4-methoxybenzylthio)-2-((4-methoxybenzylthio) methyl)-2-(N-Fmoc)-amino 
propanoic acid (12.8 mmol) were taken into 500 L flask with a magnetic stirrer. The 
solid was solved into 80 mL of  TFA\H2O\anisole 20\1\1. The solution was kept under 
stirring at 75°C for 2 hours. So, the temperature was lowered to room temperature and 
the TFA removed under vacuum. 400 mL of methanol were added to the residue and a 
solution 0.1M of I2 in methanol was added dropwise under stirring till the colour was 
persistently dark yellow. The solution has so been decoloured with Na2S2O3(conc). The 
methanol was removed under vacuum, the residue diluted with water and estracted with 
EtOAc. Water phase was washed with EtOAc and organic phases dried over MgSO4. 
The product was eluted on silica gel (dichloromethane\methanol 95\5). Yield 
76%.NMR (1H 300 MHz, DMSO-d6) δ ppm 7.90-7.30 (m, 8H, Fmoc aromatic rings), 
4.22 (s, 3H, OMe), 3.71-3.51 (dd, 4H, β-CH2). TOF MS ES+ [m/z] M+H+ 388. FTIR 
(cm-1)  3351, 3050, 2942, 1684, 1591, 1510. m.p. 135-140°C. 
Synthesis of amino acids derivatives 
Fmoc-Adt-OMe 
2g of Fmoc-Adt-OH (5.2mmol) were solved in 40mL of MeOH. The temperature was 
lowered to 0°C and 48 µL of SOCl2 (5.2mmol) added to solution. Then, the reaction 
was heated at 65°C and left reacting overnight. The solvent and SOCl2 were removed 
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under vacuum and the residue taken several time in toluene and Et2O and evaporated. 
The product was a white sticking solid and didn’t need of further purification. Yield 
93%.NMR (1H 300 MHz) δ ppm 7.79-7.31 (m, 8H, Fmocarom.), 5.43 (s, 1H, AdtNH), 
4.43 (m, 2H, Fmoc CH2), 3.79 (s, 3H, -OCH3), 3.65-3.36 (2d, 4H, Adtβ-CH2). NMR 
(13C 300 MHz) δppm 155.1, 143.6, 141.4, 127.8, 127.1, 125.0, 120.1, 71.2, 67.1, 47.4, 
4è.1, 14.2. TOF MS ES+ [m/z] M+H+ 402.08, M+Na+ 424.07. FTIR (cm-1)  3343, 
3019, 2950, 1738, 1711, 1696, 1711, 1696, 1506. m.p. 65-70°C 
H-Adt-OMe 
1.92g of Fmoc-Adt-OMe(4.8mmol) were solved in 10mL of DCM/DEA 8/2 and left 
stirring for 2 hours. The solvent was removed at low pressure and product purified on 
silica gel (95/5 DCM/MeOH). The product was a sticky pale yellow solid. Yield 100%. 
NMR (1H 300 MHz) δ ppm  3.79 (s, 3H, -OCH3), 3.65-3.36 (2d, 4H, Adtβ-CH2), 2.11 
(br s, 2H,   NH2). TOF MS ES+ [m/z] M+H+ 180.01, M+Na+ 192 
Pyrene-CH2-CO-Adt-OMe  
58mg of Pyrene acetic acid (0.22mmol) were solved into 5mL of dry DCM. To this 
solution, at 0°C, 28mg of DMAP (0.22mmol), 51 mg of EDC (0.24 mmol) and 30 µL of 
NMM (0.24mmol) were added. The solution was left stirring at 0°C until the complete 
solubilization of starting material. 40mg of H-Adt-OMe (0.22mmol) was added and left 
stirring at room temperature under Ar atmosphere overnight. The solvent was removed 
under vacuum, the residue taken into EtOAc and washed with HCl 5%, water, 
NaHCO3(sat) and brine. The organic phase was dried over MgSO4. The product was 
purified on silica gel (DCM/EtOAc 95/5).Yield 50%.NMR (1H 300 MHz) δ ppm  8.15-
7.90 (m, 9H, arom.), 6.07 (s, 1H, AdtNH), 4.29 (s, 2H, pyrene-CH2-CO-), 3.72 (s, 3H, 
OMe),3.53-3.16 (2d, 4H, Adtβ-CH2). NMR (13C 300 MHz) δ ppm  170.9, 169.9, 
129.6, 128.4, 127.6, 127.4, 126.3, 125.6, 125.5, 125.2, 122.9, 70.7, 53.3, 46.9, 41.7. 
TOF MS ES+ [m/z] M+H+ 421. FTIR (cm-1)  3247, 3035, 2938, 1730, 1642, 1537. 
m.p. 181-185°C. 
Pyrene-CH2-CO-Adt-OH 
90mg of Pyrene-CH2-CO-Adt-OMe(0.21 mmol) were solved into 1 mL of MeOH. To 
this solution, 214 µL of a NaOH 2N solution in water (0.42 mmol) was added along 
with 2mL of THF for the solubility. The solution was left stirring at r.t. under Ar 
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atmosphere overnight. The solvent was removed under vacuum, the residue taken into 
10mL HCl 2N and estracted with EtOAc. The organic phase was dried over MgSO4 and 
then removed at low pressure. The product is a pale yellow solid. Yield 80%.NMR (1H 
300MHz DMF-d7) δ ppm  8.59-8.15 (m, 9H, pyrene), 4.81 (s, 2H, pyrene-CH2-CO), 
3.77-3.35 (br m, 4H, Adt β-CH2). NMR (13C 300MHz DMF-d7) δ ppm 206.1, 131.55, 
131.16, 129.04, 127.74, 127.51, 127.15, 126.36, 126.33, 125.23, 125.98, 124.60, 48.92, 
40.07, 20.57. TOF MS ES+ [m/z] M+H+ 408. FTIR (cm-1)  3346, 3256, 3039, 2921, 
2851, 1715, 1634, 1507. No m.p. detectable: decomposition above210°C. 
Ferrocene-CO-Adt-OMe 
116 mg of ferrocene carboxylic acid (0.5 mmol) were solved in 5 mL of dry DCM, 
along with 62 mg of DMAP (0.5 mmol), 116mg of EDC (0.6 mmol) and 72µL of 
NMM. The solution has been left stirring ay 0°C for 20’. Then, 75mg of H-Adt-
OMe(0.42 mmol) were added. The solution has been left stirring overnight. The solvent 
was removed under vacuum, the residue solved in EtOAc and washed with HCl 5%, 
water, NaHCO3(sat) and brine. The organic phase was dried over MgSO4. The solvent 
was evaporated yielding the product as a red solid.Yield 70%.NMR (1H 300 MHz) 
δ ppm  6.12 (s, 1H, NH), 4.78 (s, 2H, ferrocene), 4.46 (s, 2H, ferrocene), 4.36 (s, 5H, 
ferrocene), 3.74 (s, 3H, OMe), 3.63-3.40 (2d, 4H, Adtβ-CH2). NMR (13C 300 MHz) 
δ ppm 169.9, 71.3, 70.6, 53.5, 46.8. TOF MS ES+ [m/z] M+H+ 392. FTIR (cm-1)  
3282, 2946, 2927, 1738, 1618, 1533. Decomposition over 185°C. 
Ferrocene-CO-Adt-OH  
55 mg of Ferrocene-CO-Adt-OMe(0.141mmol) were solved in 1mL of MeOH. To this 
solution, 0.141 µL of NaOH 2 N (in water) were added along with 2mL of MeCN for 
the solubility. The reaction proceeded overnight. The solvent was removed at low 
pressure and r.t., the residue taken in HCl 2N and estracted with DCM. The organic 
phase was dried over MgSO4. The solvent was evaporated yielding the product as a red 
solid. Yield 99%.NMR (1H 300MHz DMF-d7) δppm  5.12 (s, 2H, ferrocene), 4.48 (s, 
5H, ferrocene), 4.24 (s, 2H, ferrocene), 4.20-3.30 (br m, 6H, Adtβ-CH2). NMR (13C 
300MHz) δppm 219.3, 202.8, 69.76, 50.85. TOF MS ES+ [m/z] M+H+ 377. FTIR 
(cm-1)  3378, 3351, 2923, 2848, 1730, 1626, 1499. Decomposition over 210°C. 
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Ferrocene-CO-Aib-OMe 
206 mg of Ferrocene carboxylic acid (0.89 mmol) were solved in 5 mL of dry DCM, 
along with 130 mg of OXYMA (0.89 mmol), 206mg of EDC (1.07 mmol) and 155 µL 
of DIEA. The solution has been left stirring ay 0°C for 10’. The solvent was evaporated 
and the residue purified on silica gel (pure DCM) yielding 180 mg of Ferrocene-CO-
OXYMA. Yield 57%. The product was straightly used for coupling with H-Aib-OMe. 
NMR (1H 300 MHz) δ ppm  4.96 (s, 2H, ferrocene), 4.57 (s, 2H, ferrocene), 4.48-4.41 
(q, 2H, OXYMA -CH2-), 4.23 (s, 5H, ferrocene), 1.40-1.36 (t, 3H, OXYMA –CH3). 
TOF MS ES+ [m/z] M+H+ 355 NMR (13C 300MHz) δppm 166.7, 166.1, 157.3, 130.4, 
73.4, 70.9, 70.59, 65.0, 64.4, 14.1. FTIR (cm-1)  2985, 1769, 1726, 1572,1256, 982. 
Decomposition over 105°C. 
175 mg of Ferrocene-CO-OXYMA were taken in 5mL of MeCN, along with 156 mg of 
HCl.H-Aib-OMe (1.02 mmol) and 150µL of DIEA. The system was left reacting 
overnight heating at 50°C under stirring. The solvent was removed under vacuum, the 
residue solved in EtOAc and washed with HCl 5%, water, NaHCO3(sat) and brine. The 
organic phase was dried over MgSO4. The solvent was evaporated yielding the product 
as a red solid.Yield 89% (over both the reactions).NMR (1H 300 MHz) δ ppm  6.26 (s, 
1H, NH), 4.71 (s, 2H, ferrocene), 4.38 (s, 2H, ferrocene), 4.29 (s, 5H, ferrocene), 3.78 
(s, 3H, OMe), 1.63 (s, 6H, Aibβ-CH3). TOF MS ES+ [m/z] M+H+ 330, M+Na+ 352. 
FTIR (cm-1)  3355, 3301, 3085, 2985, 2946, 1742, 1618, 1533. Decomposition over 
185°C. 
Ferrocene-CO-Aib-OH  
150 mg of Ferrocene-CO-Aib-OMe (0.456 mmol) were solved in 2.5 mL of MeOH. To 
this solution, 0.456 µL of NaOH 2 N (in water) were added along with 2 mL of MeCN 
for the solubility. The reaction proceeded overnight. The solvent was removed at low 
pressure and r.t., the residue taken in HCl 2 N and estracted with DCM. The organic 
phase was dried over MgSO4. The solvent was evaporated yielding the product as a red 
solid. Yield 99%. NMR (1H 300MHz) δ ppm  7.72 (s, 1H, NH), 4.77 (s, 2H, 
ferrocene), 4.36 (s, 2H, ferrocene), 4.25 (s, 5H, ferrocene), 1.51 (s, 6H, Aibβ-CH3). 
NMR (13C 300 MHz) δ ppm 69.8, 69.1, 67.9, 39.6, 39.3, 39.0, 38.7, 38.5, 24.3. TOF 
MS ES+ [m/z] M+H+ 316. FTIR (cm-1)  3328, 3098, 2986, 2927, 2851, 2553, 1711, 
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1624, 1513. Decomposition over 204°C. 
Synthesis of Adt containing peptide series 
Boc-L-Ala-L-Ala-OMe 
0.75 g of Boc-L-Ala-OH (3.9 mmol) were added into a 250 mL flask with a magnetic 
stirrer. The solid was suspended into 5 mL of THF and the temperature lowered to 0°C. 
Then, 0.53 g of HOBt (3.9 mmol), 0.74g of EDC (4 mmol) and 0.9 mL of DIEA (5 
mmol) were added. After 10’, 0,66g of HCl.H-L-Ala-OMe (0.44 mmol) along with 0.9 
mL of DIEA (5 mmol) were added to the solution and the temperature increased to 
room temperature. The reaction was followed via TLC. Then, the THF was removed 
under vacuum, the residue taken into EtOAc and washed with HCl 5%, water, 
NaHCO3(sat) and brine. The organic phase was dried over MgSO4. The product 
precipitated from EtOAc\PE. Yield 84%.NMR (1H 300 MHz) δppm 7.28 (d, 1H, Ala 
NH), 5.01 (d, 1H, Ala NH), 4.55 (m, 1H, Alaα−CH), 4,13 (m, 1H, Alaα−CH), 3.76 (s, 
3H, OMe CH3), 1.46 (s, 9H, Boc C(CH3)3), 1.43-1.36 (d, 6H, 2 Alaβ−CH3).            
FTIR (cm-1)  3313, 3255, 3081, 2981, 2934, 1734, 1676, 1649, 1553, 1518. [α]D25 -
40.0. m.p. 106-110°C. 
Fmoc-Adt-L-Ala-L-Ala-OMe 
0.51 g of Boc-L-Ala-L-Ala-OH (1.84 mmol) were added into a 250 mL flask with a 
magnetic stirrer. The solid was solved into 10 mL of HCl\Et2O and stirred overnight. 
Then, the solvent was removed under vacuum. The solid was added to a cooled solution 
of 0.7g Fmoc-Adt-OH (1.84mmol), 0.71g of HATU (1.83mmol) and 0.81µL of DIEA 
(4mmol). 0.53 g of HOBt (3.9mmol), 0.74 g of EDC (4mmol) and 0.9 mL of DIEA 
(5mmol) were added. After 10’, 0,66g of HCl.H-L-Ala-OMe (0.44 mmol) along with 
0.9mL of DIEA (5 mmol) were added to the solution and the temperature increased to 
room temperature. The reaction was followed via TLC. Then, the THF was removed 
under vacuum, the residue taken into EtOAc and washed with HCl 5%, water, 
NaHCO3(sat) and brine. The organic phase was dried over MgSO4. The product 
precipitated from EtOAc\PE. Yield 70%.NMR (1H 300 MHz) δ ppm 7.78-7.26 (m, 8H, 
Fmoc aromatic ring), 6.99-6.06 (d, 1H, NH Ala), 6.85 (br d, 1H, NH Ala), 5.65 (s, 1H, 
NH Adt), 4.51-4.46 (m, 2H, Fmoc CH2 + Alaα−CH) 4.23-4.21 (m, 1H, Ala NH), 3.72 
(s, 3H, OMe CH3), 3.72-3.35 (dm, 4H, Adt 2 β−CH2), 1.38-1.36 (d, 6H, 2 Alaβ−CH3). 
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NMR (13C 300 MHz) δ ppm 173.0, 171.3, 168.9, 143.3, 141.3, 127.9, 127.1, 127.1, 
124.8, 120.1, 71.69, 67.2, 52.4, 49.4, 48.2, 47.1, 38.8, 29.7, 17.8. TOF MS ES+ [m/z] 
M+H+ 544, M+Na+ 566. FTIR (cm-1)  3641, 3571, 3390, 3332, 2938, 1703, 1661, 1626, 
1506. [α]D25 -3.6°. m.p. 115-120°C. 
Ac-Adt-L-Ala-L-Ala-OMe 
20 mg of Fmoc-Adt-L-Ala-L-Ala-OH (0.04mmol) were added into a 50mL flask with a 
magnetic stirrer. The solid was solved into 1mL of DEA\dichloromethane 2\8 and 
stirred for 4h. The solvent was removed under vacuum. The solid was taken in 1mL 
anhydrous CH3CN and 3.8 µL of Ac2O (40 µmol) were added under stirring. The 
reaction was followed by TLC. After 2h the solvent was removed under vacuum and the 
residue taken into EtOAc, washing with HCl 5%, water, NaHCO3(sat) and brine. The 
organic phase was dried over MgSO4. The product was purified on silica gel column 
(dichloromethane\methanol 95\5). Yield 50%.NMR (1H 300 MHz) δppm 7.11- 7.08 (d, 
1H, Ala NH), 6.88-6.84 (d, 1H, Ala NH), 6.37 (s, 1H, Adt NH), 4.54, 4.44 (m, 2H, 2 
Alaα−CH), 3.74 (s, 3H, OMe CH3), 3.64-3.40 (m, 4H, Adt 2 β−CH2), 2.10 (s, 3H, Ac 
CH3), 1.44-1.40 (d, 6H, 2 Alaβ−CH3). TOF MS ES+ [m/z] M+H+ 364. FTIR (cm-1)  
3301, 2985, 2934, 1738, 1657, 1530. m.p. 80-85°C. 
Boc-L-Ala-Adt-L-Ala-L-Ala-OMe 
0.41 g of Fmoc-Adt-L-Ala-L-Ala-OH (0.76 mmol) were added into a 250mL flask with 
a magnetic stirrer. The solid was solved 5mL of DEA\dichloromethane 2\8 and stirred 
for 4h. The solvent was removed under vacuum. Then, 0.15 g Boc-L-Ala-OH (0.8 
mmol), 0.14 g of HOBt (1 mmol), 0.20g of EDC (1mmol) and 0.36 mL of DIEA (2 
mmol) were taken in dicloromethane at 0°C and this solution was added to the residue. 
The reaction was followed via TLC. DCM was removed under vacuum, the residue 
taken into EtOAc and washed with HCl 5%, water, NaHCO3(sat) and brine. The organic 
phase was dried over MgSO4. The product was purified on silica gel column 
(dichloromethane\methanol 95\5). Yield 64%. NMR (1H 300 MHz) δ ppm 7.76 (d, 1H, 
Ala NH), 7.32 (d, 1H, Ala NH), 6.85 (s, 1H, Adt NH), 5.23 (m, 1H, Ala NH), 4.6-4.4 
(m, 2H, 2 Alaα−CH), 3.9 (m, 1H, Alaα−CH), 3.74 (s, 3H, OMe CH3), 3.6-3.05 (dm, 
4H, Adt 2 β−CH2), 1.4-1.25 (m, 18H, tBut C(CH3)3 + 3 Alaβ−CH3). NMR (13C 300 
MHz) δ ppm 173.7, 173.1,171.8, 81.6, 70.9, 52.5, 52.3, 49.8, 48.1, 47.8, 46.0, 28.2, 
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17.7, 17.4. TOF MS ES+ [m/z] M+H+ 493, M+Na+ 515. FTIR (cm-1)  3317, 3293, 
2981, 2934,1738, 1661, 1645, 1518. [α]D25 -48.8°. m.p.110-115°C. 
Boc-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OMe 
0.22 g of Boc-L-Ala-Adt-L-Ala-L-Ala-OH (0.45 mmol) were added into a 100 mL flask 
with a magnetic stirrer. The solid was solved into HCl\Et2O and stirred for 2h. The 
solvent was removed under vacuum. Then, 0.17 g Boc-L-Ala-OH (0.9 mmol), 0.13 g of 
OXYMA (0.9 mmol), 0.21 g of EDC (1 mmol) and 0.36 mL of DIEA (2 mmol) were 
taken in dicloromethane at 0°C and this solution was added to the residue. The reaction 
was followed via TLC. DCM was removed under vacuum, the residue taken into EtOAc 
and washed with HCl 5%, water, NaHCO3(sat) and brine. The organic phase was dried 
over MgSO4. The product was purified on silica gel column (dichloromethane\methanol 
95\5). Yield 70%.NMR (1H 300MHz) δppm 7.76 (d, 1H, Ala NH), 7.32 (d, 1H, Ala 
NH), 6.85 (s, 1H, Adt NH), 5.23 (m, 1H, Ala NH), 4.6-4.4 (m, 2H, 2 Alaα−CH), 3.9 (m, 
1H, Alaα−CH), 3.74 (s, 3H, OMe CH3), 3.6-3.05 (dm, 4H, Adt 2 β−CH2), 1.4-1.25 (m, 
18H, tBut C(CH3)3 + 3 Alaβ−CH3). NMR (13C 300MHz) δppm 174.3, 173.7, 
173.1,171.8, 81.6, 70.9, 52.5, 52.3, 49.8, 48.1, 47.8, 46.0, 28.2, 17.7, 17.4. TOF MS 
ES+ [m/z] M+H+ 493, M+Na+ 515. FTIR (cm-1)  3278, 2981, 2927, 2857, 1738, 1657, 
1522. [α]D25 -20.0°. m.p. 95-100°C. 
Fmoc-Adt-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OMe 
0.13 g of Boc-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OH (0.23 mmol) were added into a 100 
mL flask with a magnetic stirrer. The solid was solved into HCl\Et2O and stirred for 2h. 
The solvent was removed under vacuum. 0.27 g Fmoc-Adt-OH (0.8 mmol), 0.13 g of 
HATU (0.8 mmol) and 0.24 mL of DIEA (1.4 mmol) had been taken in dicloromethane 
at 0°C and this solution was added to the residue. The reaction was followed via TLC. 
After 2 days DCM was removed under vacuum, the residue taken into EtOAc and 
washed with HCl 5%, water, NaHCO3(sat) and brine. The organic phase was dried over 
MgSO4. The product was purified on silica gel column (dichloromethane\methanol 
95\5). Yield 53%.NMR (1H 300MHz) δppm 7.82-7.28 (m, 12H, Fmoc aromatic rings 
+ 3 Ala NH + Adt NH), 6.85 (br d, 1H, NH Ala), 5.1 (s, 1H, NH Adt), 4.53-4.07 (m, 
6H, Fmoc CH2 + Alaα−CH) 4.2-3.2 (dm, 4H, Adt 2 β−CH2), 3.74 (s, 3H, OMe CH3), 
3.72-3.35 (dm, 4H, Adt 2 β−CH2), 1.38-1.36 (m, 12H, 4 Ala 2 β−CH3). NMR (13C 
300MHz) δppm 174.51, 174.46, 173.38, 172.82, 170.04, 156.82, 143.11, 141.37, 
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141.30, 128.0, 127.25, 127.16, 124.96, 124.67, 120.21, 71.75, 71.57, 67.53, 52.45, 
52.31, 52.13, 50.20, 49.07, 48.31, 47.63, 47.44, 47.08, 17.27, 17.17, 16.65, 15.90. TOF 
MS ES+ [m/z] M+H+ 833, M+Na+ 855. FTIR (cm-1)  3313, 2919, 2853, 1742, 1715, 
1649, 1514. [α]D25 -83.3°. m.p.110-115°C. 
Pyrene-CH2-CO-Adt-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OMe 
15mg (0.18 mmol) of Fmoc-Adt-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OMe were solved in 
2mL of DCM/DEA 8/2. The solution has been left stirring for 2 hours. After that 
solvent was removed under vacuum, washing several times with Et2O till the complete 
remotion of DEA. The product was purified on silica gel chromatography (DCM to 
DCM/MeOH 8.5/1.5).Besides, 50mg of pyrene acetic acid (180 µmol) were taken in dry 
and redistilled DCM (0.5 mL) under Ar atmosphere, along with 10 µL of dry DMF to 
achieve the complete solubility. To this solution, 0.5mL of dry and redistilled DCM 
containing 17 µL of (CO)2Cl2 were added dropwise within 2’, under Ar. After 1h, the 
solvent was removed under vacuum. The residue was solved in 1mL dry DCM, 100 µL 
of which straightly added to H-Adt-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OMe solved in 2mL 
dry DCM along with 4 µL of DIEA. The solution has been left under stirring and Ar 
atmosphere for 3 days. The solvent was evaporated and the product directly purified on 
TLC  preparative plate (9/1 DCM/MeOH). Yield 10%. MS ES+ [m/z] M+H+ 853. FT-
IR (cm-1)  3302, 2957, 2921, 2848, 1733, 1646, 1530, 1453.  
Ferrocene-CO-Adt-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OMe 
23 mg (41 µmol) of Boc-L-Ala-L-Ala-Adt-L-Ala-L-Ala-OMe were solved in 3 mL of 
DCM and 3 mL of HCl(Et2O) were added. The solution has been left stirring for 
overnight. After that solvent was removed under vacuum, washing several times with 
toluene and Et2O. The pepdide so obtained was suspended in 3 mL of dry DCM with 
14.8 mg of 11 (40 µmol), 14.7 mg of HATU (40 µmol) and 16 µL of DIEA. The 
solution has been left stirring for 7 days.The DMF was removed under vacuum and the 
product purified with TLC preparative plate (95/5 AcOEt/ pentane with 5% MeOH). 
Yield 70%.NMR (1H 300MHz, Pyridine-d5) δppm 9.87 (s, 1H, NH), 8.78 (d, 1H, 
NH), 8.61-8.59 (d, 1H, NH), 8.45 (s, 1H, NH), 8.44-8.41 (d, 1H, NH), 8.19-8.17 (d, 1H, 
NH), 5.07-5.00 (m, 4H, 2H cyclopentadienyl ring + 2 Ala α-CH), 4.61 (s, 2H, 
cyclopentadienyl ring), 2.64-4.51 (m, 2H, 2 Adt β-CH2), 4.51-4.45 (m, 2 Ala α-CH), 
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4.33 (m, 7H, 5H cyclopentadienyl ring + 2 Adt β-CH2), 4.15-4.13 (m, 2H, 2 Adt β-
CH2), 3.93-3.78 (m, 2H, 2 Adt β-CH2), 3.59 (s, 3H, -OMe -CH3), 1.79-1.75 (6H, m, 2 
Ala β-CH3), 1.61-1.58 (m, 3H, Ala β-CH3), 1.39-1.37 (m, 3H, Ala β-CH3). NMR (13C 
300MHz, Pyridine-d5) δppm175.4, 175.3, 173.9, 173.6, 173.4, 173.1, 170.8, 75.5, 
73.2, 73.0, 72.0, 70.6, 70.4, 69.0, 53.0, 52.3, 50.7, 50.1, 49.6, 49.2, 48.0, 18.2, 17.8, 
16.9, 16.8, 1.2.TOF MS ES+ [m/z] M+H+ 493, M+Na+515. FTIR (cm-1) 3313, 2919, 
2853, 1742, 1715, 1649, 1514.  
Boc-L-Ala-Aib-OMe 
Into a 500mL round bottom flask were put 4g of HCl.H-Aib-OMe (26.14mmol), 6.6g of 
Boc-L-Ala-OH (39.21mmol), 5.57g of OXYMA (39.21mmol), 7.52g of EDC 
(39.21mmol) and 7.7mL DIEA (44.5mmol) in 100mL of dried dichloromethane at 0°C. 
The reaction was checked with TLC for 1 days. The solvent was removed, the residue 
taken into EtOAc and washed with HCl 5%, water, NaHCO3(sat) and brine. The organic 
phase was dried over MgSO4 and solvent removed at low pressure. The product 
appeared as an uncolored oil. Yield 70%.NMR (1H 300MHz) δppm 6.73 (s, 1H, Aib 
NH), 5.0-4.95 (d, 1H, Ala NH), 4.10-4.95  (m, 1H, Ala α−CH), 4,13 (m, 1H, 
Alaα−CH), 3.73 (s, 3H, OMe CH3), 1.44 (s, 9H,), 1.43-1.30 (m, 15H, Boc C(CH3)3 + 
Alaβ−CH3 + Aib 2 β−CH3). TOF MS ES+ [m/z] M+H+ 289.[α]D25 -29.5° 
Fmoc-Adt-L-Ala-Aib-OMe 
Into a 250 mL round bottom flask were put 4g of Boc-L-Ala-L-Ala-OMe (10 mmol) 
and solved it into 20 mL of HCl(Et2O). The reaction was followed on TLC and finished 
after 3h. The solid was dried under vacuum and taken several time with Et2O. 
Separately, 3.5 g of Fmoc-Adt-OH (9.1mmol), 1.54 g of OXYMA (9.1mmol), 2.1 g of 
EDC (10.8 mmol) and 1.2 mL of DIEA (10.8 mmol) were taken together at 0°C in 
dichloromethane. This solution was left stirring for 10 minutes, then added to product of 
cleavage. The reaction was followed on TLC for five days, under stirring at room 
temperature The solvent was removed, the residue taken into EtOAc and washed with 
HCl 5%, water, NaHCO3(sat) and brine. The organic phase was dried over MgSO4 and 
solvent removed at low pressure. The crude product (3.5 g) was purified on silica gel 
chromatography (dichloromethane\methanol 9:1). Yield 50%. NMR (1H 300 MHz) 
δ ppm 7.55-7.11 (m, 8H, Fmoc aromatic rings + Ala NH), 6.46 (s, 1H, Aib NH), 5.56 
(s, 1H, Adt NH), 4.54-4.37 (m, 2H, Fmoc CH2 + Ala α-CH), 3.77 (s, 3H, OMe CH3), 
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3.72-3.35 (dm, 4H, Adt 2 β-CH2), 1.58-1.37 (m, 9H, Aibβ-CH3 + Ala 2 β-CH3). TOF 
MS ES+ [m/z]M+Na+ 580. FTIR (cm-1)  3328, 2996, 2946, 1746, 1726, 1645, 1507. 
m.p. 70-75°C. 
Boc-Aib-Adt-L-Ala-Aib-OMe 
Into a 250 mL round bottom flask were put 2.8 g of Fmoc-Adt-L-Ala-L-Ala-OMe (5.16 
mmol) and solved it into 20 mL of DCM/DEA 8/2. The reaction was followed on TLC 
and finished after 2h. The solution was dried under vacuum and taken several time with 
toluene and Et2O, achieving product as sticking solid. Product was purified on silica gel 
column (DCM 100%, then DCM/MeOH 8/2). Yield 100% (A). Separately, 1.12 g of 
Boc-Aib-OH (5.5 mmol) and 1.08 mL of cyanuric fluoride (11 mmol) were solved 
together into 1.08 mL of pyridine (10.8 mmol) at 0°C. The reaction was left stirring at -
15°C for 1h, then an hour at r.t. The solvent was removed under vacuum and residue 
taken several times in toluene and re-evaporated. The residue was solved in DCM and 
washed with cooled water. DCM was evaporated. Residue was an pale yellow oil (B). B 
was taken in 10 mL of  anhydrous DCM, 1.32 mL of NMM (12 mmol) added and the 
solution cooled at 0°C. Then, A was solved into 10mL of anhydrous DCM and added to 
B. The reaction was followed for 3d. The solvent was removed, the residue taken into 
EtOAc and washed with HCl 5%, water, NaHCO3(sat) and brine. The organic phase was 
dried over MgSO4 and solvent removed at low pressure. The crude product (2 g) was 
purified on silica gel chromatography (EtOAc/pentane 1/9 with 1% of MeOH added). 
The product crystallized spontaneously. Yield 59%.NMR (1H 300 MHz) δ ppm 7.98 
(d, 1H, Ala NH), 7.26 (s, 1H, AibNH), 6.71 (s, 1H, AdtNH), 5.00 (s, 1H, AibNH), 4.48-
4.40  (m, 1H, Alaα-CH), 3.68 (s, 3H, OMe CH3), 1.54-1.45 (m, 24H, Boc C(CH3)3 + 
Alaβ-CH3 + 2 Aib 2 β-CH3).FTIR (cm-1)  3317, 3293, 2981, 2934,1738, 1661, 1645, 
1518. [α]D25 +58.0°. m.p. 85-90°C. 
Boc-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
Into a 250 mL round bottom flask were put 0.74 g of Boc-Aib-Adt-L-Ala-Aib-OMe (1.4 
mmol) and solved into 10mL DCM/TFA 9/1. The solution was stirred for 4 hours. The 
solvent was removed under reduced pressure and the residue taken several time in 
toluene and HCl(Et2O). Separately, 0.265 g of Boc-L-Ala-OH (1.4 mmol), 0.528 mg of 
HATU (1.39 mmol) and 0.73 mL DIEA (4.2 mmol) were solved together in 10mL of 
anhydrous THF at 0°C. This solution was directly added to peptide. The system was left 
124  
Synthesis of peptides containing 4-amino-1,2-dithilane-4-carboxylic acid (Adt)  
reacting for 3d at r.t. The solvent was removed, residue taken in EtOAc and washed with 
HCl 5%, water, NaHCO3(sat) and brine. The organic phase was dried over MgSO4 and 
solvent removed at low pressure. The product was purified on silica gel (2/1 pentane 
with 1% MeOH added). Yield 52%. NMR (1H 300 MHz) δ ppm 7.97-7.93 (d, 1H, Ala 
NH), 7.67 (s, 1H, AibNH), 7.52 (s, 1H, Adt NH), 6.82 (s, 1H, Aib NH), 5.26 (d, 1H, 
Ala NH), 4.95-3.85 (m, 2H, 2 Alaα-CH), 1.60-1.30 (m, 27H, Boc C(CH3)3 + 2 Alaβ-
CH3 + 2 Aib 2 β-CH3). NMR (13C 300 MHz) δ ppm 175.1, 174.8, 173.5,169.1, 81.9, 
71.7, 56.5, 52.3, 50.0, 48.5, 47.6, 28.3, 26.8, 25.4, 23.4, 16.9. FTIR (cm-1)  3289, 2977, 
2930, 1738, 1665, 1653, 1522. [α]D25 +56.4°. m.p. 109-113°C. 
Ferrocene-CO-Aib-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
50 mg (84 µmol) of Boc-L-Ala-Aib-Adt-L-Ala-Aib-OMe were solved in 3 mL of DCM 
and 3 mL of HCl(Et2O) were added. The solution has been left stirring for overnight. 
After that solvent was removed under vacuum, washing several times with toluene and 
Et2O. The pepdide so obtained was suspended in 3 mL of dry DCM at 0°C with 40mg 
of Ferrocene-CO-Aib-OH (128 µmol) and 50mg of HATU (128 µmol). To this solution 
33µL of DIEA were added. The solution has been left stirring for 7 days at r.t.. The 
solvent was removed, the residue taken in CHCl3 and washed with HCl 5%, water, 
NaHCO3(sat) and brine. The organic phase was dried over MgSO4 and solvent removed 
at low pressure. The product was purified on silica gel (2/1 pentane with 1% MeOH 
added). Yield 70%. NMR (1H 300 MHz CD3CN) δ ppm 7.95 (s, 1H, NH), 7.91 (d, 1H, 
Ala NH), 7.81 (d, 1H, Ala NH), 7.61 (s, 1H, NH), 6.93 (s, 1H, NH), 4.84-4.81 (ds, 2H, 
2H cyclopentadienyl ring), 4.45 (s, 2H, 3H cyclopentadienyl ring), 4.26 (s, 5H, 
cyclopentadienyl ring), 4.17 (m, 1H, Ala α-CH), 4.01-3.93 (m, 3H, Ala α-CH + Adt β-
CH2), 3.68-3.52 (m, 4H, 2 Adt β-CH2), 3.61 (s, 3H, -OMe CH3), 3.30-3.22 (m, 2H, Adt 
β-CH2), 1.57-1.29 (m, 21H, 2 Ala β-CH3 + 3 Aib 2 β-CH3).TOF MS ES+ [m/z] 
M+H+ 789, M+Na+ 811. FTIR (cm-1) 3337, 3288, 2988, 2924, 2850, 1730, 1651, 1527.  
Pyrene-CH2-CO-Adt-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
15 mg of Pyrene-CH2-CO-Adt-OH (36.3µmol) were solved in 2mL of dry DCM at 0°C 
with 13.8 mg of HATU (36.3 µmol) and 20mg of HCl.H-Ala-Aib-Adt-L-Ala-Aib-OMe 
(36.3 µmol). To this solution 25µL of DIEA were added. The reaction proceeded at r.t. 
for 6 days. The solvent was removed, the residue was taken in CHCl3 and washed with 
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HCl 0.5N, water, NaHCO3(sat.) and brine. The organic phase was dried over MgSO4 and 
solvent removed at low pressure. The crude product was purified on silica gel (95/5 
DCM/MeOH). Yield 80%. NMR (1H 300 MHz CD3CN) δ ppm 8.39-8.03 (m, 9H, 
Pyrene), 7.93 (s, 1H, Adt1 NH), 7.62 (d, 1H, Ala5 NH), 7.56 (d, 1H, Ala2 NH), 7.16 (s, 
1H, Adt4 NH), 7.11 (s, 1H, Aib6 NH), 7.01 (s, 1H, Aib3 NH), 4.52-4.38 (dd, 2H, PyrAc 
CH2), 4.11 (m, 1H, Ala5 α-CH), 3.84 (m, 1H, Ala2 α-CH), 4.11-3.13 (m, 8H, 2 Adt 2 β-
CH2), 3.58 (s, 3H, OMe CH3), 1.43-1.25 (m, 12H, 2 Ala β-CH3, Aib6 2 β-CH3), 0.81-
0.51 (2s, 6H, Aib3 2 β-CH3).TOF MS ES+ [m/z] M+H+ 881, M+Na+ 903. FTIR (cm-1) 
3423, 3333, 2989, 1734, 1670, 1524. [α]D25 +136.9° (MeOH, c=0.3 g.mL-1).  
Ferrocene-CO-Adt-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
14mg of 11 (36.3 µmol) were solved in 2mL of dry DCM at 0°C with 13.8mg of HATU 
(36.3 µmol) and 20mg of HCl.H-Ala-Aib-Adt-L-Ala-Aib-OMe (36.3 µmol). To this 
solution 25µL of DIEA were added. The reaction proceeded at r.t. for 6 days. The 
solvent was removed, the residue was taken in CHCl3 and washed with HCl 0.5N, 
water, NaHCO3(sat.) and brine. The organic phase was dried over MgSO4 and solvent 
removed at low pressure. The crude product was purified on silica gel (95/5 
DCM/MeOH). Yield 80%. NMR (1H 300 MHz CD3CN) δ ppm 7.77 (d, 1H, Ala5 NH), 
7.64 (s, 1H, Aib3 NH), 7.59 (d, 1H, Ala2 NH), 7.55 (s, 1H, Adt4 NH), 7.25 (s, 1H, Aib6 
NH), 7.20 (s, 1H, Adt1 NH), 4.89-4.34 (m, 2H, 2H cyclopentadienyl ring), 4.30 (s, 5H, 
cyclopentadienyl ring), 4.16 (m, 1H, Ala5 α-CH), 4.00 (m, 1H, Ala2 α-CH), 4.01-3.28 
(mm, 8H, 2 Adt 2 β-CH2), 3.62 (s, 3H, -OMe CH3), 1.54 (s, 6H, Aib3 β-CH3), 1.44 (s, 
6H, Aib6 β-CH3), 1.38 (s, 3H, Ala2 β-CH3), 1.34 (s, 3H, Ala5 β-CH3).  TOF MS ES+ 
[m/z] M+H+ 851, M+Na+ 873. FTIR (cm-1) 3286, 3027, 2950, 2927, 2849, 2336, 1715, 
1487, 1406.  
Boc-Gly-Aib-OMe 
In a 500 mL flask were melted together 2 g of Boc-Gly-OH (11.4 mmol), 1.62 g of 
HOBt (11.4 mmol), 2.6 g of EDC (13.7 mmol) and 6 mL of DIEA (68.4 mmol) in dry 
DCM at 0°C. The mixture has been left stirring for 20’. Then 3.5 g of HCl.H-Aib-OMe 
(22.8 mmol) were added. The solution reacted overnight at r.t. The solvent was removed 
at low pressure and the the residue was taken in EtOAc and washed with HCl 0.5N, 
water, NaHCO3(sat.) and brine. The organic phase was dried over MgSO4 and solvent 
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removed at low pressure. The product was a white solid. Yield 99%. NMR (1H 300 
MHz) δ ppm 6.73 (s, 1H, Aib NH), 5.21-5.19 (m, 1H, Gly NH), 3.75-3.71 (d, 2H, Gly 
α-CH2), 3.74 (s, 3H, OMe CH3), 1.58 (s, 6H, Aib β-CH3), 1.44 (s, 9H, Boc 3 CH3). 
FTIR (cm-1)  3340, 3274, 3042, 2996, 2977, 2934, 1715, 1661, 1530, 1449. m.p. 92-
95°C. 
Boc-Aib-Gly-Aib-OMe 
2.9 g of Boc-Gly-Aib-OMe (10.5 mmol) were solved into 20 mL of a 8/2 DCM/TFA 
solution. After 3 hours the solvent was removed under vacuum and the residue taken 
several time in toluene, Et2O, and HCl(Et2O) in order to remove TFA unreacted and 
exchange trifluoroacetic salt with more safe cloridric salt. In the meanwhile, 2.23 g of 
Boc-Aib-OH (10.5 mmol), 1.56 g of OXYMA (10.5 mmol), 2.1g of EDC (10.5 mmol) 
and 2.01 mL of NMM (21 mmol) were solved together at 0°C in dry DCM and left 
stirring for 20’. Then, this solution was added to peptide. The reaction proceeded 
overnight at r.t. under stirring. The solvent was removed under vacuum, the residue was 
taken in EtOAc and washed with HCl 0.5N, water, NaHCO3(sat.) and brine. The organic 
phase was dried over MgSO4 and solvent removed at low pressure. The product was a 
white solid. Yield 70%. NMR (1H 300 MHz) δ ppm 7.30 (s, 1H, AibNH), 6.89-6.86 (t, 
1H, GlyNH), 4.96 (s, 1H, AibNH), 3.92-3.89 (d, 2H, Glyα-CH2), 3.69 (s, 3H, OMe 
CH3), 1.51-1.48 (s, 12H, 2 Aibβ-CH3), 1.43 (s, 9H, Boc 3 CH3). FTIR (cm-1)  3359, 
3301, 3282, 2992, 2946, 2328, 1738, 1692, 1653, 1533. m.p. 135-140°C. 
Boc-L-Ala-Aib-Gly-Aib-OMe 
2.4 g of Boc-Aib-Gly-Aib-OMe (6.7 mmol) were solved into 20mL of a 8/2 DCM/TFA 
solution. After 3 hours the solvent was removed under vacuum and the residue taken 
several time in toluene, Et2O, and HCl(Et2O) in order to remove TFA unreacted and 
exchange trifluoroacetic salt with more safe cloridric salt. In the meanwhile, 1.50g of 
Boc-L-Ala-OH (8 mmol), 1.14 g of OXYMA (8 mmol), 1.53 g of EDC (8 mmol) and 
1.83 mL of NMM (12 mmol) were solved together at 0°C in dry DCM and left stirring 
for 20’. Then, this solution was added to peptide along with 1.83 mL of NMM (12 
mmol). The reaction proceeded overnight at r.t; under stirring. The solvent was removed 
under vacuum, the residue was taken in EtOAc and washed with HCl 0.5N, water, 
NaHCO3(sat.) and brine. The organic phase was dried over MgSO4 and solvent removed 
at low pressure. The product was a white solid. Yield 87%. NMR (1H 300 MHz) δ ppm 
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7.34 (m, 2H, 2 Aib NH), 6.73-6.69 (m, 1H, Gly NH), 5.17 (d, 1H, Ala NH), 3.97-3.85 
(m, 3H, Ala α-CH + Gly α-CH2), 3.69 (s, 3H, OMe CH3), 1.51 (s, 12H, 2 Aib β-CH3), 
1.44 (s, 9H, Boc 3 CH3), 1.37-1.34 (d, 3H, Ala β-CH3). TOF MS ES+ [m/z] M+H+ 
431, M+Na+ 453. FTIR (cm-1)  3301, 3278, 2988, 2942, 1746, 1645, 1537, 1514. [α]D25 
-32.7°. m.p. 81-85°C. 
Boc-L-Ala-Aib-Gly-Aib-OH  
0.5 g (1.16 mmol) of Boc-Ala-Aib-Gly-Aib-OMe were solved in 10mL of a mixture 2/1 
THF/MeOH and 1.16mL of NaOH(aq.) 2N was added. The solution has been stirring for 
6 hours at room temperature. Then the solvent was removed under vacuum and the 
solution diluted in 20 mL HCl 2N and extracted with EtOAc. The organic phase was 
dried over MgSO4 and solvent removed at low pressure. The product was a  white 
crystalline powder. Yield 99%. NMR (1H 300 MHz) δ ppm 7.60-7.50 (m, 2H, 2 Aib 
NH), 6.65 (s, 1H, Aib NH), 5.10-5.09 (d, 1H, Ala NH), 3.96-3.90 (m, 3H, Alaα-CH + 
Gly α-CH2), 1.60-1.58 (m, 15H, Alaβ-CH3 + 2 Aibβ-CH3), 1.44 (s, 9H, Boc 3 CH3), 
1.37-1.34 (d, 3H, Alaβ-CH3). TOF MS ES+ [m/z] M+H+ 417, M+Na+ 439. FTIR (cm-
1)  3268, 2986, 1738, 1682, 1654, 1611, 1558, 1531. [α]D25 =-10°. m.p. 185-189°C. 
Boc-L-Ala-Aib-Gly-Aib-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
150 mg of Boc-L-Ala-Aib-Adt-L-Ala-Aib-OMe (0.254 mmol) were solved in 2 mL of 
dry DCM and 5 mL of 1M HCl(Et20) were added. The reaction proceeded overnight. The 
solvent was removed and the residue washed several time with toluene and Et2O. In the 
meanwhile, 90 mg of Boc-Ala-Aib-Gly-Aib-OH (0.217 mmol) were solved in 8 mL of 
dry DCM along with 83 mg of HATU (0.217 mmol) and 76 µL of DIEA (0.434 mmol). 
The reaction has been stirred at 0°C for 20’. Then, the chloridric salt of peptide 
previously made was added. The reaction has been left stirring at r.t. for 7 days. The 
solvent was removed, the the residue was taken in EtOAc and washed with HCl 0.5N, 
water, NaHCO3(sat.) and brine. The organic phase was dried over MgSO4 and solvent 
removed at low pressure. The product was a white solid that didn’t need further 
purification. Yield 70%. NMR (1H 300 MHz) δ ppm 7.97-7.95 (m, 2H, Aib NH + Gly 
NH), 7.68 (d, 1H, NH), 7.47 (m, 2H, 2 NH), 7.35 (s, 1H, NH), 6.88 (s, 1H, NH), 5.51 
(m, NH, Ala NH), 4.56 (m, 1H, Alaβ-CH), 3.95 (d, 2H, Glyα-CH2), 3.90-3.75 (m, 2H, 2 
Alaα-CH), 3.63 (s, 3H, OMe), 3.57-3.27 (2d, Adtβ-CH2), 1.49-1.33 (m, 42H, Boc CH3, 
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4 Aibβ-CH3, 3 Alaβ-CH3). TOF MS ES+ [m/z] M+H+ 890, M+Na+ 912. FTIR (cm-1)  
3289, 2973, 2930, 1734, 1653, 1518. [α]D25 +78.3°. m.p. 195-200°C. 
Pyrene-CH2-CO-Adt-L-Ala-Aib-Gly-Aib-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
15mg of Pyrene-CH2-CO-Adt-OH (36.3 µmol) were solved in 2 mL of dry DCM at 0°C 
with 13.8 mg of HATU (36.5 µmol) and 30mg of HCl.H-Ala-Aib-Gly-Aib-L-Ala-Aib-
Adt-L-Ala-Aib-OMe (36.3 µmol). To this solution 25 µL of DIEA were added. The 
reaction proceeded at r.t. for 6 days. The solvent was removed, the the residue was 
taken in CHCl3 and washed with HCl 0.5N, water, NaHCO3(sat.) and brine. The organic 
phase was dried over MgSO4 and solvent removed at low pressure. The crude product 
was purified on silica gel (95/5 DCM/MeOH). Yield 40%. NMR (1H 400 MHz, 
CD3CN) δ ppm 8.38-8.03 (m, 9H, Pyrene), 7.89 (d, 1H, Adt1 NH), 7.76 (d, 1H, Ala9 
NH), 7.74 (s, 1H, Aib7 NH), 7.68 (d, 1H, Ala2 NH), 7.60 (s, 1H, Aib5 NH), 7.57 (s, 1H, 
Adt8 NH), 7.48 (d, 1H, Ala6 NH), 7.40 (t, 1H, Gly4 NH), 7.26 (s, 1H, Aib10 NH), 6.79 
(s, 1H, Aib3 NH),  4.55-4.38 (dd, 2H, Pyrene-CH2), 4.13 (m, 1H, Ala9 α-CH), 4.00 (m, 
1H, Ala2 α-CH), 3.85 (m, 1H, Ala6 α-CH), 3.92-3.16  (mm, 8H, 2 Adt 2 β-CH2), 3.62 
(s, 3H, -OMe CH3), 3.59-3.53 (d, 2H, Gly4 α-CH2), 1.43 (s, 6H, Aib10 2 β-CH3), 1.41 (s, 
6H, Aib5 2 β-CH3), 1.40 (s, 6H, Aib7 2 β-CH3), 1.39 (s, 3H, Ala9 β-CH3), 1.33 (s, 3H, 
Ala6 β-CH3), 1.32 (s, 3H, Ala2 β-CH3), 0.59 (s, 6H, Aib3 2 β-CH3). TOF MS ES+ [m/z] 
M+H+ 1179, M+Na+ 1201. FTIR (cm-1) 2924, 2848, 1722, 1653, 1526. [α]D25 +143.8°. 
Ferrocene-CO-Adt-L-Ala-Aib-Gly-Aib-L-Ala-Aib-Adt-L-Ala-Aib-OMe 
14 mg of 11 (36.3 mol) were solved in 2mL of dry DCM at 0°C with 13.8 mg of HATU 
(36.5 µmol) and 30 mg of HCl.H-Ala-Aib-Gly-Aib-L-Ala-Aib-Adt-L-Ala-Aib-OMe. To 
this solution 25 µL of DIEA were added. The reaction proceeded at r.t. for 6 days. The 
solvent was removed, the the residue was taken in CHCl3 and washed with HCl 0.5N, 
water, NaHCO3(sat.) and brine. The organic phase was dried over MgSO4 and solvent 
removed at low pressure. The crude product was purified on silica gel (95/5 
DCM/MeOH). Yield 45%. 1H NMR (400 MHz, CD3CN) δ 7.87, 7.78, 7.64, 7.29, 7.16, 
4.90, 4.80, 4.49, 4.30, 4.15, 4.14, 4.12, 4.10, 4.07, 4.06, 4.03, 3.99, 3.96, 3.94, 3.92, 
3.71, 3.70, 3.67, 3.62, 3.52, 3.49, 3.48, 3.44, 3.30, 3.29, 3.23, 3.20, 1.53, 1.50, 1.48, 
1.44, 1.36, 1.29. TOF MS ES+ [m/z] M+H+ 1149, M+Na+ 1171. FTIR (cm-1) 3312, 
2922, 2853, 1729, 1652, 1528.  
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2D NMR SPECTRA 
PyrAc(AdtAlaAib)2OMe    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20 TOCSY spectrum of PyrAc(AdtAlaAib)2OMe in NHi →CHi and NHi →CH3 i regions for 
PyrAc(AdtAlaAib)2OMe . By means of these cross-couplings the two Ala spin systems have been 
assessed. Corrispondence in COSY spectrum (not shown). 
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Fig. 21 Assessment of the NHi →NHi+1 cross-couplings for PyrAc(AdtAlaAib)2OMe. 
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Fig. 22 Assessment of the CHi / CH2 i →NHi+n (n=0, 1, 2, 3, 4) cross-couplings in NOESY spectrum for 
PyrAc(AdtAlaAib)2OMe. 
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Fig. 23 Assessment of the CH3 i →NHi+n (n=0, 1, 2, 3) cross-couplings in NOESY spectrum for 
PyrAc(AdtAlaAib)2OMe. 
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Fc(AdtAlaAib)2OMe 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24 TOCSY spectrum of Fc(AdtAlaAib)2OMe in NHi →CHi and NHi →CH3 i regions for 
Fc(AdtAlaAib)2OMe . By means of these cross-couplings the two Ala spin systems have been assessed. 
Corrispondence in COSY spectrum (not shown). 
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Fig. 25 Assessment of the NHi →NHi+1 cross-couplings for Fc(AdtAlaAib)2OMe on ROESY spectrum. 
Probably the cross-peak of the coupling between Ala2 NH and Aib3 NH is hidden by diagonal peaks. 
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Fig. 26 Assessment of the CHi / CH2 i →NHi+n (n=0, 1, 2, 3, 4) cross-couplings in ROESY spectrum for 
Fc(AdtAlaAib)2OMe. 
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Fig. 27 Assessment of the CH3 i →NHi+n (n=0, 1, 2, 3) cross-couplings in ROESY spectrum for 
Fc(AdtAlaAib)2OMe. 
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ELECTROCHEMICAL AND RELATED MEASUREMENTS  
 
 
 
 
 
 
 
 
 
 
Fig. 28  Left: CV of the SAM at several scan rate: 50mV/s (red),75 (blue), 100 (green), 125 (black), 150 
(fuchsia), 175 (teal), 200 (yellow), 225 (orange), 250 (pale blue), 275 (grey), 300 (purple); Right: 
dependence of ∆E on scan rate. 
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CONCLUSIONS 
I 
The conformational preferences of a water-soluble peptide series made of a whole 
hydrophobic backbone, enclosing alternate-Aib-Ala- (2-mer to 9-mer) residues, have 
been investigated in water. The ECD measurements revealed at which stage of the 
peptide length the conformation switches from unfolded to 310- and from 310- to α-helix 
(6-mer and 8-mer respectively). These results are in agreement with other reported 
examples for Aib containing peptides. However this is the first ECD characterization of 
a whole peptide series in water. 
II 
A peptide-conjugated AuNp series was obtained from the corresponding peptide series 
of alternating Aib-Ala appropriately N-terminus functionalized. Conformational 
characterization of free peptides ligands and of the peptides bound to nanoparticles has 
been achieved. An ECD analysis on the optical and chiro-optical properties of the 
nanoparticles displayed a chiral plasmonic induction that take place from the peptides to 
the 2 nm sized metal core. The results show moderately strong ECD signals in the range 
of 300-650 nm, corresponding to the gold nanoparticle’s quantized electronic structure. 
Even though their only chiral amino acid in the peptide sequences is L-Ala, the resulting 
peptide-conjugated AuNps behave like pseudo-diastereoisomeric species, according to 
the number of amino acids in the sequence (odd or even) and with the type of amino 
acid closest to the gold surface (Aib or L-Ala). Such chiro-optical property appears to 
be strongly influenced by the related peptide the secondary structure when conjugated to 
the nanoparticles and vanishes when the sequence is long enough to assume a 310-helix 
conformation. 
 
III 
The main contribution of this work consists in the discovery that a series of Aib/Ala 
peptides, lacking any charge or polar group, dissolve in water through the formation of 
self-assembled superstructures. These aggregates are larger than a typical micelle, 
although it is not clear yet if they form vesicles or a different type of supramolecular 
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structure. Our contention, supported by X-ray diffraction data, is that a hydrophilic side 
(the N- and/or the C-terminus and/or a face of the helix) of the peptide has to be located 
on the outer layer of these aggregates. Encapulation experiments have also been 
performed on such supra-molecular assemblies and peptide coated-AuNps. TEM images 
of the encapsulated nanoparticles demonstrate the ability of such large spheres (~100nm 
sized) to encapsulate smaller ones (AuNPs display a hydrodynamic radius of 610 nm). 
Further experiments will clarify the training force for the aggregation process and 
whether or not  the peptide “vesicles” contain water inside. 
IV 
We have reported the synthesis of two new Cα-tetra substituted α-amino acids, each 
characterized by the presence of two (phenylazo)benzyl moieties in the side chains. A 
detailed analysis of the optical properties revealed the formation of intermediate chiral 
species during the isomerization process driven by light. Moreover, diastereomeric 
species were unambiguously detected when the (phenylazo)benzyl-type amino acids 
were coupled with a chiral protein amino acid and irradiated with UV light. The light 
driven process worked also in solid state, by irradiating directly Au nanoparticles coated 
with the(phenylazo)benzyl-containing amino acid. The nanoparticles exhibited also a 
magnetic susceptibility dependence as function of the photo-irradiation process, that can 
be simply detected by 1H-NMR spectroscopy. Based on this behavior, these amino acids 
are of relevant potential for the development of a novel class of photo-switchable 
materials. 
V 
A series of Ferrocene and Pyrene labeled helical peptides containing one or more 4-
amino-1,2-dithiolane-4-carboxylic acid (Adt) residues have been synthetized and 
chemically characterized. Such peptides have been designed to be employed in the 
formation of SAMs over gold surface (by means of linkage with the dithiolane Adt side 
chains) for electrochemical applications. A detailed conformational study on a hexamers 
series and electrochemical characterization have been performed. The Adt residues in 
the sequence imposed a parallel displacement (respect to the peptide axle) of the 
peptides over the gold surface. Cyclic Voltammetry experiments were accomplished for 
testing the redox properties of the Ferrocene bound to peptide. Moreover, preliminary 
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experiments aimed to generate photo-current have been investigated for the Ferrocene 
containing peptide. These last results indicated that these peptides are suitable to be 
good candidate for the light-current conversion process. 
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